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SUN  NARY 
The  primary  aim  of  this  research  was  to  develop  a  reliable  system  for 
gene  transfer  in  Bordetella  pertussis  to  facilitate  the  study  of  the  genetics 
of  virulence  in  this  species. 
The  starting  point  of  the  research  was  an  attempt  to  repeat  the  procedures 
of  Branefors  (1964)  and  of  Al-Sallami  (1981)  to  introduce  a  streptomycin 
resistance  (StrR)  chromosomal  gene  into  a  streptomycin  sensitive  (StrS) 
B.  pertussis  recipient  by  DNA-mediated  transformation.  However,  this  system 
proved  unsatisfactory  and  convincing  evidence  of  transformation  was  not 
obtained. 
Attention  was  next  turned  to  developing  a  transfer  system  using  conjugative 
R  plasmids  of  the  P  incompatibility  group.  These  were  successfully  employed 
to  mobilise  donor'B.  pertussis  nutritional  and  antibiotic  resistance  genes. 
Several  suitable  plasmids,  namely,  R68.45,  RP1  and  derivatives  containing 
transposon  Tn5Ol  and  TO  were  obtained  in  Escherichia  coli  hosts.  The  optimal 
conditions  for  plasmid  transfer  were  determined  for  E.  coli  donors  and 
recipients  and,  under  these  conditions,  the  plasmids  were  transferred  by 
conjugation  from  E.  coli  to  B.  pertussis. 
Having  successfully  transferred  the  plasmids  into  B.  pertussis,  the  next 
step  was  to  determine  if  B.  pertussis  chromosomal  genes  could  be  mobilised  by 
the  plasmids.  The  ability  of  each  plasmid  to  mobilise  antibiotic  resistance 
genes  between  E.  coli  strains  was  first  determined  and  all  except  one  plasmid 
R68.45supdnaG315  mobilised  genes  at  satisfactory  frequencies.  In  B.  pertussis, 
mobilisation  of  streptomycin  and  nalidixic  acid  resistance  markers  occurred 
but  the  relative  mobilising  abilities  of  the  various  plasmids  differed.  The 
presence  of  transposon  TO  on  a  plasmid  appeared  to  enhance  mobilisation 
whereas  transposon  Tn501  had  the  opposite  effect. 19 
The  isolation  of  auxotrophic  mutants  of  B.  pertussis  which  could  be  used 
as  recipients  for  mobilised  donor  prototrophic  genes  was  explored.  This 
required  the  development  of  a  minimal  medium  for  isolation  of  auxotrophic 
mutants  and  for  selection  of  prototrophic  recombinants.  These  studies  co- 
incided  with  the  report  by  Imaizumi  et  al.  (1983)  of  the  stimulatory  effect 
of  methylated  ß-cyclodextrin  on  the  growth  of  B.  pertussis  on  defined  solid 
medium.  In  the  present  investigation,  Cyclodextrin  Solid  Medium  (CSM)  was 
found  to  be  suitable  for  the  isolation  and  characterisation  of  the  nutritional 
requirements  of  B.  pertussis  auxotrophic  mutants.  These  were  obtained  by 
mutagenesis  followed  by  enrichment  by  penicillin  treatment. 
The  R  plasmids  were  tested  for  their  ability  to  mobilise  prototrophic 
markers  between  strains  of  B.  pertussis.  In  one  case,  linkage  of  the  Gly+ 
(glycine  biosynthesis)  and  Na1R  (nalidixic  acid  resistance)  markers  was  demon- 
strated. 
Next,  the  expression  of  B.  pertussis  genes  in  B.  parapertussis  was 
studied.  Using  R  plasmid-mediated  chromosome  mobilisation,  it  was  possible 
to  obtain  expression  of  donor  B.  pertussis  genes  in  a  chloramphenicol  resistant 
recipient. 
A  transposon  insertion  mutant  of  B.  pertussis  was  used  in  preliminary 
experiments  aimed  at  mobilising  a  virulent  phase  marker,  haemolysin  production 
(Hly+),  from  a  suitable  donor.  Although  no  mobilisation  of  Hly+  was  obtained, 
mobilisation  of  another  donor  gene,  Str',  occurred. 
Plasmids  which  fail  to  replicate  in  B.  pertussis  were  used  to  introduce 
transposons  Tn5  and  Tn501  into  the  organism  to  generate  transposon  insertion 
mutations.  Although  such  mutations  were  generated,  they  were  not  characterised 
further. 20 
A  study  was  undertaken  to  attempt  the  isolation  of  bacteriophage  from 
B.  pertussis.  No  such  bacteriophage  were  found,  but  the  ability  of 
B.  pertussis  to  support  lytic  cycle  growth  of  a  mutant  of  bacteriophage  Mu 
was  demonstrated. 
The  susceptibility  of  B.  pertussis  and  B.  parapertussis  chromosomal  DNA 
to  digestion  by  restriction  endonucleases  EcoRI  and  Hindill  was  investigated 
to  determine  if  the  DNA  was  modified  at  Hindill  restriction  sites.  This  was 
found  to  be  the  case. 
Since  the  long  term  aim  of  this  work  was  to  further  the  study  of  the 
genetics  of  B.  pertussis  virulence,  an  opportunity  was  taken  to  examine  the 
effect  of  plasmid  presence  on  the  interaction  of  B.  pertussis  with  neutrophils. 
With  B.  pertussis  BPT2  and  E.  coli  JC3272  transconjugants,  the  presence  of 
plasmids  altered  the  levels  of  neutrophil  stimulation,  as  measured  by  chemi- 
luminescence,  while  little  effect  was  apparent  with  B.  pertussis  44122/7R 
transconjugants. 
In  conclusion,  the  way  is  now  clear  for  detailed  investigation  of  the 
genetics  of  B.  pertussis  virulence  using  R  plasmid-mediated  mobilisation  of 
chromosomal  genes.  This  would  also  allow  further  studies  on  linkage  of  anti- 
biotic,  resistance  and  nutritional  markers.  The  apparent  ease  with  which 
B.  pertussis  genes  can  be  recombined  and  expressed  in  B.  parapertussis  makes 
the  latter  a  suitable  recipient  and  lends  support  to  the  idea  that 
B.  parapertussis  should  be  regarded  as  a  variant  of  B.  pertussis  rather  than 
as  a  separate  species. 21 
1,  '  INTRODUCTION 22 
1.1  WHOOPING  COUGH  -  THE  DISEASE 
1.1.1  Historical  background 
The  first  clinical  description  of  whooping  cough  was  given  by  Guillaume 
de  Baillou  (153b-1b16)-(cited  by  Castiglioni,  1947),  during  an  epidemic  in 
France  in  1578.  He  called  it  "quinta"  or  "quintana"  but  it  later  became 
known  as  "coqueluche".  Baillou  described  "quinta"  in  Epidem.  et  ephemer 
Lib  II  p.  237,  published  posthumously  in  1640  (cited  by  Castiglioni,  1947). 
In  the  18th  century,  there  ensued  a  rapid  spread  of  the  disease,  particularly 
in  northern  countries.  For  example,  in  Sweden  alone,  40,000  children  died 
of  the  disease  between  1749  and  1764  (Castiglioni,  1947). 
The  aetiological  agent  of  the  disease  was  first  cultured  by  Bordet  and 
Gengou  (1906).  Initially,  the  organism  was  classified  as  a  member  of  the 
genus  Haemophilus  due  to  its  apparent  requirement  for  growth  on  blood-containing 
media,  but  when  the  organism  was  later  shown  not  to  be  dependent  on  blood 
nutritional  factors,  it  was  reclassified  into  a  new  genus.  Thus,  the  organism 
responsible  for  whooping  cough  is  now  known  as  Bordetella  pertussis  (Moreno- 
Lopez,  1952). 
1.1.2  Clinical  symptoms 
The  onset  of  the  disease  is  mild  and  is  usually  not  recognised  as  being 
pertussis.  Normally,  the  period  of  incubation  is  about  7  days  and  several 
distinct  stages  occur  during  the  course  of  pertussis. 
(i)  Catarrhal  stage.  Upon  inhalation  of  the  organisms  by  a  susceptible 
individual,  the  bacteria  lodge  between  the  cilia  of  the  respiratory  tract 
epithelial  cells  where  attachment  to  the  cells  may  be  mediated  by  the  fimbriae 
(Pittman,  1979).  At  this  stage,  the  symptoms  are  those  of  a  mild  cold  with 
some  coughing  episodes  which  increase  in  severity  over  the  next  10  to  15  days. 23 
(ii)  Paroxysmal  stage.  The  coughing  attacks  continue  to  increase  in  number 
and  severity,  with  the  characteristic  "whoop"  appearing  due  to  inspiration  of 
air  through  the  narrowed  glottis,  into  the  lungs.  At  this  stage,  live' 
organisms  cannot  usually  be  isolated  from  the  patient.  Patho-physiological 
changes  at  areas  of  the  body  distant  from  the  infectious  site  occur. 
Systemic  manifestations  of  the  disease  include  lymphocytosis/leukocytosis, 
effects  on  blood  glucose  levels,  possible  neurotoxicity  and  sensitivity  to 
histamine,  caused  by  the  action  of  pertussis  toxin.  (Sanyal,  1960;  Tsukimoto 
and  Lampkiss,  1976;  Askelof  and  Bartfai,  1979;  Askelof  and  Gillenius,  1982; 
Hewlett  et  al.,  1983).  Toxic  damage  may  extend  to  lung  tissues  and  blockage 
of  bronchioles  may  lead  to  areas  of  lung  collapse  and  emphysema.  The  most 
serious  complications  of  the  disease  are  secondary  infections,  seizures, 
encephalopathy  and  death.  In  treatment  of  pertussis,  erythromycin  is  the 
antibiotic  of  choice  as  it  is  effective  and  safe  for  use  in  infants  (Islur 
et  al.,  1975).  Prophylactic  erythromycin  treatment  for  whooping  cough  contacts 
has  been  proposed  but  there  is  no  evidence  that  this  prevents  the  disease 
(Grob  et  al.,  1981;  Spencely  and  Lambert,  1981). 
1.1.3  Vaccine 
In  the  last  one  hundred  years,  the  mortality  rate  from  pertussis  has 
declined  rapidly  due  to  improved  health  care  and  the  introduction  of  pertussis 
vaccine.  Field  trials  in  the  1920's  demonstrated  that  vaccine  prophylaxis 
could  control  spread  of  the  disease  (Madsen,  1933).  Vaccines  used  in  these 
trials  consisted  of  heat-killed  cells  of  fresh  isolates  and  similar  results 
were  obtained  using  a  phenol-inactivated  (Sauer  1933;  1937)  and  a  thimerosal- 
inactivated  vaccine  (Kendrick  and  Eldering,  1936),  but  Doull'et  al.  (1936) 
showed  no  significant  protective  effect  between  vaccinated  and  non-vaccinated 
groups.  Such  differences  in  protective  efficacy  led  to  the  introduction  of 24 
the  Intracerebral  Mouse  Protection  Test  which  allowed  comparison  of  vaccine 
efficacy  and  potency  (Kendrick  et'al.,  1947).  Field  trials  in  the  U.  K. 
with  whole  cell  vaccines  demonstrated  that  they  were  reasonably  safe  and 
effective  in  the  control  of  pertussis  (MRC,  1951;  1956).  Present  whole  cell 
vaccines  are  suspensions  of  heat-killed'B.  pertussis  cells  which  invariably 
contain  agglutinogens  1,2  and  3.  Some  problems  exist  in  that  the  vaccines 
are  reactogenic  but  public  concern  that  the  vaccine  may  constitute  a  greater 
risk  than  the  disease  (Miller  et  al.,  1982)  and  be  associated  with  brain 
damage  in  children  (Stewart,  1979)  appears  to  be  unfounded.  The  U.  K.  National 
Childhood  Encephalopathy  Study  findings  indicate  that  no  causal  relationship 
exists  between  vaccine  and  serious  neurological  illness.  (Joint  Committee 
on  Vaccination  and  Immunisation  ,  1981;  Klein  et  al.,  1982). 
Current  research  in  the  area  of  pertussis  vaccine  concentrates  on  the 
development  of  acellular  vaccines,  in  particular,  the  isolation  and  purification 
of  LPF  (pertussis  toxin)  and  filamentous  haemagglutinin  (F-HA)  (Munoz  et  al., 
1981;  Irons  and  MacLennan,  1979a,  b;  Sato  et  al.,  1983).  Since  October  1981, 
an  acellular  vaccine  consisting  mainly  of  F-HA,  formalin-detoxified  LPF  and  a 
trace  of  endotoxin  has  been  in  prophylactic  use  in  Japan.  This  may  be 
regarded  as  a  first-generation  acellular  vaccine  (Manclark  and  Cowell,  1984). 
Second  generation  vaccines  may  be  more  uniform  in  potency  and  in  specified 
constituents  and  should  have  little  or  no  endotoxin  and  little  LPF  toxicity. 
Third  generation  vaccines  may  include  antigens  involved  in  attachment  and 
toxoids.  Genetically-engineered  antigens  would  allow  production  of  cross- 
reactive  peptides  which  are  immunogenic  but  not  toxic  and  could  be  produced, 
probably  more  economically,  in  an  organism  other  than  B.  Pertussis.  Cloning 
and  expression  of  B.  pertussis  outer  membrane  protein  genes  in'E.  ''cöli  has 
been  demonstrated  (Shareck  and  Cameron,  1984).  Current  studies  on  the  genetic 
structure  of  B.  pertussis  will  aid  in  the  understanding  of  the  control  and 
expression  of  the  virulence  factors  and  protective  antigens  of  the  organism. 25 
1.2  B.  PERTUSSIS  -  THE  ORGANISM 
1.2.1  Growth 
The  initial  isolation  of  B.  pertussis  in  the  early  1900's  was  on  a  medium 
which  consisted  of  potato  starch  infusion,  glycerol  and  defibrinated  blood 
(Bordet  and  Gengou,  1906).  In  honour  of  the  discoverers  of  the  bacterium, 
the  medium  is  now  known  as  Bordet-Gengou  Agar  (BGA).  B.  pertussis  is  a 
Gram-negative  coccobacillus  which  varies  in  size  from  0.2  to  0.811m.  When 
grown  on  BGA  at  350C,  the  organism  produces  a  glistening  convex  colony  which 
may  exhibit  a  hazy  zone  of  haemolysis.  Carbohydrates,  lactate,  pyruvate  and 
intermediates  of  the  Embden-Meyerhoff  pathway  are  not  utilised  (Jebb  and 
Tomlinson,  1957;  Rowatt,  1955;  Parker,  1976).  Glutathione  and  ascorbic  acid 
are  required  for  growth  in  some  media  and  there  is  an  absolute  requirement  for 
nicotinamide  or  nicotinic  acid.  On  BGA,  cultures  grown  from  small  inocula 
may  not  produce  colonies  for  48-72h.  In  liquid  culture,  growth  from  small 
inocula  can  be  obtained  in  medium  containing  nicotinamide,  glutathione,  ascorbic 
acid,  salts,  cysteine,  glutamic  acid  and  proline  (Stainer  and  Scholte,  1971). 
This  was  the  first  defined  medium  described  for  the  growth  of  B.  pertussis, 
all  previous  liquid  media  having  contained  casamino  acids  or  casein  hydro- 
lysate  (Hornibrook,  1939;  Cohen  and  Wheeler,  1946).  Various  blood-containing 
media,  were  used  for  growth  of  B.  pertussis  until  it  was  realised  that  unsat- 
urated  fatty  acids  present  in  media  constituents,  such  as  agar  and  peptone, 
and  in  cotton  stoppers  and  on  glassware,  were  toxic  to  the  organism  (Pollock, 
1949;  Proom,  1955;  Rowatt,  1957a,  b;  Field  and  Parker,  1979).  Additives  to 
media  which  would  adsorb  fatty  acids  and  permit  growth  of  the  organism 
included  starch,  charcoal,  anion-exchange  resins,  blood,  albumin  and  HeptaKis 
2,6-0  dimethyl  8-Cyclodextrin  (Me8CD)  (Sutherland  and  Wilkinson,  1961;  Parker, 
1976;  Kloos  et  al.  1978;  Imaizumi  et'al.  1983).  The  last  named  was  capable, 
upon  incorporation  in  a  solid  medium,  of  supporting  growth  from  small  inocula 26 
as  efficiently  as  BGA.  No  minimal  medium  suitable  for  genetic  and  nutritional 
studies  on  B.  pertussis  has  yet  been  developed,  although  several  attempts  have 
been  made  (Parker,  1976;  Kloos  et  al.  1978).  Addition  of  MeßCD  to  a  solid 
medium  may  be  an  important  step  in  the  development  of  such  a  medium. 
1.2.2  Variation  in  B.  pertussis 
B.  pertussis  is  known  to  undergo  two  types  of  variation. 
1.2.2.1  Phase  variation 
Upon  repeated  subculture,  virulent  strains  of  B.  'pertussis  undergo  a 
simultaneous  loss  of  the  ability  to  synthesise  virulence  factors  such  as  pertussis 
toxin,  adenylate  cyclase,  haemolysin,  filamentous  haemagglutinin  and  other  com- 
ponents  such  as  cytochrome  d-629  and  several  outer-membrane  proteins  (Wardlaw 
and  Parton,  1979;  Wolff  et  al.,  1980;  Ezzell  et  al.,  1981;  Peppler,  1982; 
Cowell  et  al.,  1982;  Katada  and  Ui,  1982).  The  terminology  used  to  describe 
phase  variation  has  not  been  standardised,  the  process  having  been  referred  to 
as  change  from  phase  I  to  phase  III  (Kasuga  et  al.,  1953),  phase  I  to  phase  IV 
(Leslie  and  Gardner,  1931),  fresh  isolate  to  degraded  state  (Parker,  1979)  or 
domed/haemolytic  to  flat/non-haemolytic  (Peppler,  1982).  However,  the  phase 
designations  of  Kasuga  et  al.  are  not  equivalent  to  those  of  Leslie  and 
Gardner  :  domed  colony  type  and  haemolysin  production  refer  to  only  two  of 
the  many  properties  lost  in  phase  shift  and  these  have  been  mutated  indepen- 
dently  of  other  phenotypic  characteristics  of  the  virulent  state  (Weiss  et  al., 
1983).  A  more  descriptive  designation  -  virulent  phase  to  avirulent  phase  - 
has  been  used  as  a  term  for  the  potential  of  the  bacteria  to  cause  disease 
when  they  express  all  of  the  virulence-associated  properties  (Weiss  et  al., 
1983).  Regulation  of  virulence-associated  genes  may  have  a  hereditary  compon- 
ent  since,  under  permissive  conditions,  the  progeny  of  virulent  or  avirulent 
phase  strains  inherit  the  same  phase.  The  change  from  virulent  to  avirulent 
phase  was  thought  to  occur  by  mutation  and  kobt  irreversible  (Parker,  1979), v 
Figure  1:  A  model  for  the  regulation  of  virulence  association 
genes  by  a  positive  effector  in  B.  pertussis. 
The  lines  represent  the  DNA  coding  regions  for  the  regulatory 
gene  and  the  virulence-associated  genes.  The  circles  represent  the 
sites  of  action  for  the  regulatory  element.  The  trans-acting  positive 
effector  may  be  a  protein  encoded  by  the  virulent-phase  inducer  gene,  or 
this  gene  couldSrx47  an  activity  which  synthesised  a  product  required  for 
the  expression  of  virulence  associated  genes.  Environmental  signals 
such  as  temperature,  Mg 
2+ 
ions  or  nicotinic  acid  could  modulate  expression 
of  the  positive  effector.  The  molecular  mechanism  of  the  ON/OFF  switch 
is  unknown,  but  may  be  an  invertible  sequence. 
(After  Weiss  and  Falkow,  1984). 27 
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but  in  one  instance  phase  change  has  been  shown  to  be  reversible  and  may 
perhaps  be  due-to  regulation  by  a"trans-acting  gene  product  which  induces 
virulence-associated  genes  and  may  itself  be  under  the  control  of  a  DNA 
'"Saýelra-  rearrangement  similar  to  that  which  controls  pilus  expression  in 
._  (Weiss  and  Falkow,  -1984;  7 
1.2.2.2  Antigenic  modulation 
Lacey  (1960)_  reported  that  B.  pertussis  underwent  an  antigenic  transition 
when  grown  on  BGA  in  which  NaCl  was  replaced  by  MgSO4.  The  change  was  rever- 
sible,  growth  on  NaCl  giving  rise  to  the  virulent  phenotype  while  growth  on 
MgSO4  gave  rise  to  the  avirulent  phenotype.  These  were  referred  to  as  X-mode 
and  C-mode  respectively  due  to  their  colony  appearance  (X-xanthic,  C-cyanic), 
and  the  effect  was  termed  'antigenic  modulation'.  Other  factors  which 
induced  modulation  included  growth  in  medium  containing  one  of  several  salts, 
growth  in  high  nicotinic  acid  concentration  and  growth  at  28°C  (Pusztai  and 
Joo,  1967;  Holt  and  Spasojevic,  1968;  Livey  et  al.,  1978;  Wardlaw  and  Parton, 
1979).  Several  virulent  phase  properties  are  lost  during  modulation  : 
pertussis  toxin  (PT)  activities  such  as  HSF  and  LPF  activity,  heat-labile 
toxin  (HLT),  cell-envelope  polypeptides,  filamentous  haemagglutinin  (F-HA), 
agglutinogen  1  and  adenylate  cyclase  (Holt  and  Spasojevic,  1968;  Livey  et'al., 
1978;  Dobrogesz  et  al.,  1979;  Wardlaw  and  Parton,  1979).  Some  of  these 
components  such  as  adenylate  cyclase,  PT,  HLT  and  F-HA  may  play  a  role  in  the 
pathogenesis  of  whooping  cough  (Pittman,  1979;  Confer  and  Eaton,  1982),  while 
the  role  of  factors  such  as  the  membrane  polypeptides  are  unclear. 
Antigenic  modulation  may  be  under  the  control  of  the'trans-acting  gene 
product  discussed  previously.  This  gene  product  may  be  repressed  when  bacteria 
are  in  the  C-mode  condition  and  regulation  of  the  gene  may  occur  in  response 
to  environmental  conditions  such  as  temperature,  magnesium  ion  or  nicotinic 
acid  concentrations  (see  Diagram,  Figure  1)  (Weiss  and  Falkow,  1984). 29 
1.2.2.3  Variation  as  a  survival  strategy. 
Avirulent  phase  organisms  have  been  isolated  from  patients  during  the 
course  of  infection  (Kasuga  et  al.,  1954);  the  proportion  of  avirulent  phase 
organisms  increasing  as  the  infection  proceeded.  Expression  of  virulence 
factors  occurs  only  during  the  virulent  or  Phase  I  stage,  although  loss  of  one 
virulence  associated  gene  product  does  not  lead  to  the  loss  of  others  (Weiss 
et  al.,  1983).  Thus  mechanisms  which  allow  switching  on  and  off  of  virulence 
factor  synthesis  may  be  essential  for  the  existence  of  the  organism'in  vivo. 
Phase  change  may  be  a  mechanism  which,  by  regulation  of  virulence  factor  express- 
ion  via  the  trans-acting  effector  protein,  allows  escape  from  immune  detection. 
Accompanying  phase  change  there  is  an  increased  tolerance  to  erythromycin  and 
other  antibiotics  (Weiss  and  Falkow,  1984;  Peppler  and  Schrumpf,  1984).  This 
may  permit  survival  of  avirulent  phase  organisms  in  the  presence  of  antibiotics 
used  in  treatment  of  whooping  cough.  Environmental  signals  such  as  temperature, 
Mg2+  ions,  nicotinic  acid  or  the  immune  status  of  the  host  may  modulate  expression 
of  the  positive  effector.  The  phase  switch  could  therefore  allow  survival  of 
the  organism  in  human  or  non-human  environments  in  an  asymptomatic  state,  until 
a  switch  back  to  the  virulent  phase  occurs  in  a  susceptible  individual. 
1.2.3  Virulence  factors  of  B.  pertussis. 
The  organism  produces  a  range  of  biologically  active  components  which  may 
contribute  to  the  ability  of  the  organism  to  cause  disease. 
1.2.3.1  Filamentous  haemagglutinin  (F-HA) 
This  component  is  a  protein  of  molecular  weight  107,000  to  130,000  Daltons 
(Sato  et  al.,  1983)  and  appears,  in  electron  microscopy,  as  filaments  40-100nm 
in  length  (Arai  and  Sato,  1976;  Sato  et  al.,  1982).  The  protein  is  most 
efficiently  isolated  from  supernates  of  cultures  grown  statically  in  shallow 30 
culture  (Arai  and  Munoz,  1979;  Ashworth:  et  al.,  1982)  or  in  shake  flasks  with 
Cyclodextrin-containing  media  (Suzuki  et  al.,  1984).  It  can  be  purified  by 
column  chromatography  on  hydroxylapatite  with  removal  of  contaminating  LPF  by 
passage  through  haptoglobin  -  or  fetuin  -  Sepharose  (Cowell  et  al.,  1982;  Sato 
et  al.,  1983).  The  protein  is  a  haemagglutinin  and  is  subject  to  inhibition 
by  cholesterol  (Irons  and  MacLennan,  1979a)  and  may  be  fimbrial  in  origin  (Sato 
et  al.,  1979),  although  recent  findings  have  cast  doubt  on  this  hypothesis 
(Ashworth  et  al.,  1982). 
1.2.3.2  Pertussis  toxin 
Also  known  as  Lymphocytosis-Promoting  Factor  (LPF),  Histamine-Sensitising 
Factor  (HSF),  Islet-Activating  Protein  (IAP)  and  Pertussigen,  the  array  of  names 
used  to  describe  this  protein  reflects  its  wide  range  of  biological  activities. 
It  is  produced  by  Phase  I  (X-mode)  cells  and  is  believed  to  be  a  major  virulence 
factor  and  protective  antigen,  since  highly  purified  crystalline  toxin  is 
protective  and  remains  so  after  toxoiding  (Munoz  et  al.,  1981).  The  concept 
that  a  single  component  may  be  responsible  for  mouse-protective  activity, 
histamine  sensitisation  and  heat-labile  adjuvancy  was  first  proposed  in  a 
'Unitarian  Hypothesis'  (Levine  and  Pieroni,  1966).  HSF  was  later  shown  to  be 
a  haemagglutinin  distinct  from  F-HA  (Arai  and  Sato,  1976;  Morse  and  Morse,  1976) 
and  to  be  responsible  for  production  of  leucocytosis  (Lehrer  et  al.,  1974) 
implying  that  a  single  component  was  responsible  for  these  activities. 
Pertussis  toxin  is  a  globular  protein  which  can  be  purified  from  culture 
supernates  by  chromatography  and  gel  filtration  on  haptoglobin  or  fetuin. 
These  sialic  acid-containing  proteins  are  known  to  inhibit  haemagglutination 
by  pertussis  toxin  (Irons  and  MacLennan,  1979a,  b).  Molecular  weight  estim- 
ations  vary  from  about  80,000  (Yajimct  -et  al.,  1982)  to  117,000  (Tamura  et  al., 
1982).  The  protein  appears  to  be  composed  of  five  subunits  (Tamura  et  al., 31 
1982)  termed  S-1  to  S-5,  with  molecular  weights  of  28,000,23,000,22,000, 
11,700  and  9,300  respectively.  S-2  to  S-5  form  the  binding  or  B-oligomer 
which  can  block  action  of  the  whole  toxin  by  competing  for  receptor  occupancy 
and  may'mediate  toxin  binding  to  host  cell  membranes.  This  oligomer  may  be 
responsible  for  several  of  the  biological  activities  (Nogimori'et  al.,  1984). 
The  S-1  subunit  (active  or  A-protomer)  interacts  with  the  B-oligomer  to  form 
intact  toxin  and  has  been  shown  to  be  an  ADP-ribosyl  transferase  which  catalyses 
ADP  ribose  transfer  from  NAD+  to  a  41,000  Dalton  host  cell  membrane  protein 
(Tamura  et  al.,  1982;  Hildebrandt  et  al.,  1983). 
1.2.3.3  Agglutinogens 
The  genus  Bordetella  can  be  differentiated  by  species-specific  agglutino- 
gens  (Anderson,  1953;  Eldering  *et'al.,  1957).  Agglutinogen  7  is  common  to 
all  members  of  the  genus,  and  agglutinogen  1  is  present  in  all  B.  pertussis 
strains  while  2,3,4,5  and  6  may  vary  between  strains.  Although  the  nature 
and  location  of  these  antigens  is  uncertain,  Ashworth'et  al.  (1982)  have 
suggested  that  agglutinogen  2  is  located  on  fimbriae.  It  may  be  that  agglutin- 
ogens  are  important  protective  antigens  and  should  be  included  in  acellular 
vaccines  (Preston  1963;  Eldering'et  al.,  1967)  since  disease  does  not  occur  in 
the  presence  of  agglutinins  of  high  titre  (Miller  et  al.,  1943). 
1.2.3.4  Adenylate  cyclase 
B.  pertussis  produces  a  heat-stable,  calmodulin-activated,  adenylate 
cyclase  which  is  extracytoplasmic  and  can  be  released  into  the  supernate  or 
remain  cell-associated.  The  enzyme,  in  supernates,  has  a  molecular  weight  of 
about  70,000  (Hewlett  and  Wolff,  1976).  It  may  contribute  to  virulence  by 
interfering  with  the  function  of  phagocytic  cells  (Confer  and  Eaton,  1982), 
allowing  survival  in  a  hostile  environment,  and  it  also  exhibits  effects  such 32 
as  a  reduction  in  host  inflammatory  response  and  enhancement  of  primary 
infection.  Further  evidence  for  a  role  in  virulence  now  exists,  since  strains 
which  do  not  produce  the  enzyme  are  severely  impaired  in  their  ability  to 
infect  mice  (Weiss  et  al.,  1984). 
1.2.3.5  Heat-labile  toxin  (HLT) 
HLT  (Dermonecrotic  Toxin)  can  be  isolated  from  the  cytoplasmic  fraction 
of  cell  lysates  of  B.  pertussis  and  is  sensitive  to  heating  at  560C  for  10 
minutes  (Munoz  et  al.,  1959;  Cowell  et  al.,  1979).  When  toxoided,  active 
HLT  becomes  antigenic  (Munoz,  1971).  Purification  of  HLT  from  B.  Pertussis 
and  B.  bronchiseptica,  which  is  free  from  pertussis  toxin  has  been  carried  out. 
The  toxin  preparation  induced  vasoconstriction,  in  peripheral  blood  vessels  in 
guinea-pigs  or  mice,  leading  to  formation  of  local  lesions,  partial  haemorrhage 
and  oedema  (Nakase.  and  Endoh,  1984).  Anti-inflammatory  agents,  such  as  pre- 
dnisolone  and  meclofenamate  were  found  to  inhibit  the  skin  reactions  in  young 
mice  (Parton,  1986). 
1.2.3.6  Lipopolysaccharide  endotoxin  (LPS) 
Two  distinct  LPS  endotoxins  exist  in  B.  pertussis,  designated  LPS-I  and 
LPS-II  (Le  Dur  et  al.,  1978).  Like  other  bacterial  LPS,  it  exhibits  toxicity 
and  pyrogenicity  in  animals,  Shwartzmann  reaction,  adjuvanticity  and  non- 
specific  resistance  to  infection  (Farthing,  1961).  Although  the  LPS  role 
in  pathogenesis  is  unclear,  antibodies  are  produced  in  humans  following 
vaccination  with  whole-cell  vaccine  (Ashworth  et  al.,  1983). 33 
1.3  GENETIC  TRANSFER  IN  PROKARYOTES 
Three  mechanisms  exist  which  allow  transfer  of  genetic  information 
between  bacteria. 
1.3.1  Transformation 
Genetic  transformation  is  a  process  by  which  a  bacterial  cell  takes  up 
DNA  from  the  surrounding  medium  and  incorporates  it  into  the  genome  to  acquire 
an  altered  genotype  that  is  heritable.  In  genera  such  as'Bacillus,  Strepto- 
coccus  and  Haemophilus  transformation  is  comparable  in  importance  to  conjugation 
and  transduction  as  a  means  of  gene  transfer  (Graham  and  Istock,  1978;  Smith 
et  al.,  1981).  These  organisms  have  evolved  highly  efficient  mechanisms  for 
release,  uptake  and  incorporation  of  DNA.  The  transformation  process  was 
first  observed  in  the  pneumococcus  (Griffith,  1928)  and  can  be  divided  into 
several  discrete  steps  :  - 
(i)  Development  of  the  ability  to  take  up  DNA  (competence) 
(ii)  Binding  and  uptake  of  DNA. 
(iii)  Preintegration  and  integration. 
Both  Gram-positive  and  Gram-negative  bacteria  follow  these  basic  steps, 
although  they  employ  different  mechanisms  to  perform  each  step,  possibly 
reflecting  differences  in  cell  envelope  structure.  In'Haemophilus  and  Neisseria 
sp.  recognition  of  the  species  own  DNA  occurs  at  the  cell  surface  and  in 
Haemophilus,  an  11  base  pair  sequence  in  the  donor'DNA  identifies  the  DNA  to 
the  cell(-Zoon  eL  al,  1ýiibýý 
1.3.1.1  Transformation  in  Gram-negative  bacteria 
The  initial  stage  in  transformation,  in'H.  influenzae  is  competence  devel- 
opment.  This  occurs  in  conditions  which  allow  protein  synthesis  to  continue 34 
but  do  not  permit  cell  division  (Herriott*et'al.,  1970).  Accompanying  this 
are  a  number  of  changes  in  the  cell  surface,  such  as  induction  of  specific 
inner  and  outer  membrane  proteins  which  parallel  competence  development  (Zoon 
and  Scocca,  1975;  Zoon  et  al.,  1976)  and  the  transfer  of  cytoplasmic  proteins 
to  the  cell  membrane.  Under  conditions  conducive  to  transformation,  some 
cells  in  the  population  release  DNA  by  autolysis  or  secretion,  following  which, 
binding  to  the  recipient  and  uptake  occurs.  Competent  cells  usually  bind  and 
absorb  only  double  stranded  DNA  from  the  same  or  closely  related  species,  due 
to  the  specificity  of  the  DNA  uptake  system  (Scocca  et  al.,  1974;  Dougherty 
et  al.,  1979).  Foreign  DNA  may  bind  to  the  cell  surface  but  does  not  compete 
well  with  homologous  DNA  for  uptake.  Donor  DNA  enters  the  recipient  cell  as 
double-stranded  molecules  via  membraneous  extensions  -  transformasomes  -  which 
protect  the  DNA  from  exonuclease  or  restriction  enzyme  action  (Kahn  et  al., 
1984).  One  strand  of  the  DNA  is  incorporated  into  the  host  chromosome  (Natani 
and  Goodgal,  1966)  while  the  other  strand  and  the  displaced  host  strand  are 
degraded  (Steinhart  and  Herriott,  1968). 
1.3.1.2  Transformation  in  Gram-positive  bacteria 
In  Gram-positive  bacteria,  the  onset  of  competence  is  due  to  secretion  of 
a  small  protein  called  competence  factor  (Tomasz  and  Hotchkiss,  1964),  although 
the  mechanism  of  action  remains  obscure.  Binding  of  double-stranded  DNA  is 
followed  by  uptake  into  a  cell  compartment  such  as  the  periplasmic  space  or 
the  cytoplasm.  Heterologous  DNA  is  taken  up,  so  no  system  of  specific  sequence 
recognition  is  present  (Ciferri  et  al.,  1970;  Ranhand,  1980).  Uptake  is 
accompanied  by  degradation  of  one  of  the  strands  (Lacks,  1962)  while  the  other 
forms  a  temporary  eclipse  complex  before  integration.  The  eclipse  complex 
consists  of  the  single-stranded  donor  associated  with  a  polypeptide  and  in 
this  state,  the.  transforming  activity  is  temporarily  lost.  Integration  occurs 35 
by  displacement  of  a  homologous  strand  of  the  recipient  chromosome. 
1.3.2  Generalised  transduction. 
Generalised  transduction  occurs  when  bacterial  DNA  is  encapsulated  within 
a  phage  head  during  the  lytic  cycle,  in  a  donor  cell,  and  is  carried  by  the 
resultant  hybrid  particle  to  a  recipient  cell.  The  bacteriophage  promotes 
entry  of  the  transducing  DNA  into  the  recipient  cell  by  the  mechanism  used 
for  infection  of  normal  phage  genomic  DNA.  Within  the  recipient  cell,  the 
transduced  DNA  may  undergo  recombination  with  the  host  genome  to  yield  a  stable 
transductant  or,  more  likely,  it  will  fail  to  do  so  and  will  be  lost  from  the 
d 
population.  Generalised  transruction  was  discovered  in  1952  by  Zinder  and 
Lederberg  during  a  search  for  conjugation-mediated  recombination  between 
auxotrophs  of  Salmonella  typhimurium.  The  transducing  agent  was  found  to  be 
bacteriophage  P22  and  later,  phage  P1  of'E.  coli  was  found  to  be  capable  of 
mediating  generalised  transduction  (Lennox,  1955).  Compared  with  specialised 
transduction,  generalised  transduction  is  a  more  significant  means  of  gene 
transfer  since  any  chromosomal  gene  may  be  carried  from  donor  to  recipient, 
while  in  specialised  transduction,  mediated  by  phage  such  as  lambda  (X),  the 
only  genes  which  can  be  transduced  are  those  which  are  adjacent  to  the  site  of 
lysogeny. 
Transducing  phage  such  as  P1  and  P22  are  packaged  from  concatamers  of 
several  genome  equivalents  and  the  formation  of  transducing  phage  occurs  when 
the  packaging  mechanism  seizes  upon  host  DNA  instead  of  the  phage  concatamers 
(Ikedu-and  Tomizawa,  1965).  Upon  injection  into  the  recipient  cell,  one  of 
three  possible  fates  awaits  the  transduced  gene  :  - 
(i)  Recombination  with.  a  homologous  area  of  the  chromosome  to  yield  complete 
transductants. 36 
(ii)  Persistence  in  the  cytoplasm  in  a  non-replicating,  but  stable  state  - 
this  is  called  abortive  transduction. 
(iii)  Total  degradation  by  nuclease  action. 
The  processes  which  lead  to  recombination  of  transduced  DNA  with  homolo- 
gous  DNA  are  unknown  (Masters,  1985).  Most  of  the  transducing  DNA  is  abortive 
and  does  not  undergo  recombination.  There  is  little  understanding  of  the 
processes  which  regulate  establishment  of  complete  transductants.  In  abortive 
transduction,  the  DNA  fragment,  although  capable  of  complementing  a  mutation, 
cannot  replicate  and  so,  upon  cell  division,  the  gene  segregates  to  only  one 
of  the  daughter  cells.  However,  the  protein  gene  product  is  divided  between 
daughter  cells,  a  process  which  continues  until  a  daughter  is  produced  with 
insufficient  product  to  allow  growth.  This  gives  rise  to  a  small  colony 
which  is  incapable  of  exponential  growth.  Thus,  abortive  transductants  are 
recognised  as  very  small  colonies  among  the  normal  sized  colonies  of  complete 
transductants  (Ozeki  and  Ikeda,  1968). 
1.3.3  Plasmidsand  conjugation 
Plasmids  are  extra-chromosomal  circular  pieces  of  DNA  which  can  be  stably 
inherited  without  being  linked  to  the  bacterial  chromosome.  They  are  not 
essential  for  the  normal  growth  of  their  host  but  can  confer  upon  the  host, 
selective  benefits.  Plasmids  are  classified  into  incompatibility  groups,  a 
group  comprising  plasmids  which  cannot  co-exist  together  in  the  same  host  cell: 
(Datta,  1975).  Plasmids  can  be  either  conjugative  or  non-conjugative.  Those 
which  are  conjugative  are,  as  their  name  implies,  capable  of  promoting  con- 
jugation,  a  process  whereby  DNA  is  transferred  between  bacterial  cells  by  a 
mechanism  requiring  cell  to  cell  contact  (Davis,  1950).  For  several  years, 
the  sex  factor  F  (Hayes,  1952)  was  considered  to  be  the  only  conjugative  plasmid 
and  conjugation  was  thought  to  be  an  unusual  phenomenon  (Clark  and  Warren,  1979). 37 
However,  conjugation  and  conjugative  plasmids  are  now  known  to  be  common  to 
many  bacterial  genera  and  over  20  incompatibility  groups  have  been  established, 
with  plasmids  of  the  same  group  possessing  similar  conjugation  systems  (Datta, 
1975). 
Of  the  many  plasmid  conjugation  systems,  only  that  of  F  has  been  studied 
in  detail  (Willetts  and  Skurray,  1980).  Conjugation  can  be  divided  into  two 
major  components  :  formation  of  mating  pairs  and  DNA  transfer.  During  mating 
pair  (or  aggregate)  formation,  the  cells  are  brought  together  by  the  plasmid 
encoded  F-pilus  (Bradley,  1980)  which  recognises  the  recipient  cell.  Following 
this,  surface  exclusion  proteins  in  the  membrane  prevent  the  cell  being  used 
as  a  recipient  by  another  donor  cell  which  carries  the  same  plasmid  or  one  of 
the  same  incompatibility  group.  Upon  contact  between  pilus  and  recipient, 
the  pilus  may  act  as  a  DNA  transfer  bridge  (Ou  and  Anderson,  1970)  or  the  pilus 
retracts  bringing  donor  and  recipient  into  contact,  allowing  DNA  transfer  to 
take  place  (Novotny  and  Fives-Taylor,  1978;  Achtman  et  al.,  1978).  Next,  a 
plasmid  strand  is  nicked  and  transferred  to  the  recipient  cell,  led  by  the  5' 
terminus  (Rupp  and  Ihler,  1968;  Ohki  and  Tomizawa,  1968)  beginning  at  the 
transfer  origin  (ori  T).  The  transferred  strand  is  replicated  in  the  recipient 
cell  by  host  specific  enzymes,  and  only  the  initiation  of  transfer  requires 
expression  of  the  plasmid  tra  genes  (Kingsman  and  Willetts,  1978).  Meanwhile, 
the  strand  remaining  in  the  donor  is  also  replicated.  Tra  genes  occupy  about 
one  third  of  the  F  plasmid  while  the  on  T  region  is  located  at  one  end  of  the 
transfer  genes. 
1.3.3.1  Chromosome  transfer  by  the  F  factor 
The  F  plasmid  is  capable  of  promoting  transfer  of  donor  chromosomal  markers 
by  two  discrete  systems  :- 38 
i.  Formation  of  F-primes  (F') 
An  F-prime  is  formed  by  pickup  of  chromosomal  DNA  by  recombination  into, 
and  aberrant  excision  from,  the  bacterial  chromosome  by  the  F  plasmid  (Jacob 
and  Wollman,  1961;  Campbell,  1969).  Single  genes  may  be  transferred  at  low 
frequencies  and  the  system  does  not  allow  the  determination  of  the  order  of 
donor  chromosomal  genes. 
ii.  High  frequency  of  recombination  (Hfr) 
Hfr  strains  are  capable  of  promoting  transfer  of  donor  chromosomal  genes 
at  high  frequencies  and  in  one  direction  from  the  origin  of  transfer  (Jacob 
and  Wollman,  1958).  This  arises  by  physical  integration  of  the  F  plasmid  into 
the  chromosome  by  recombination  between  homologous  regions  and  allows  ordered 
transfer  of  chromosomal  genes  (Davidson  et  al.,  1975). 
1.3.3.2  R  plasmids 
R  plasmids,  a  group'of  conjugative  plasmids  much  more  widely  distributed 
than  F,  were  discovered  in  1959  in  Japan  as  the  cause  of  multiple  drug  resistance 
in  Shigella.  R  plasmids  have  now  been  found  in  many  bacterial  species  which 
are  pathogenic  for  man  and  animals  and  are  particularly  common  in  the  Entero- 
bacteriaceae  such  as  E.  coli,  Salmonella.  sp.  Shigella  sp.  and  in  Pseudomonas  sp. 
Those  plasmids  which  belong  to  the  P  incompatibility  group  may  be  especially 
important  in  disseminating  drug  resistance  to  a  wide  range  of  organisms.  Use 
of  antibiotics  has  not  induced,  but  has  selected  for,  resistance  plasmids  since 
strains  of  E.  coli  which  were  freeze-dried  before  the  widespread  use  of  anti- 
biotics  have  been  found  to  carry  R  plasmids  (Smith,  1967). 
Typical  R  plasmids  are  large  broad  host-range,  low  copy  number,  self- 
transmissible  plasmids  with  two  functionally  distinct  parts  :  the  resistance 39 
transfer  factor  which-contains  genes  for  replication  and  conjugation  (tra  genes), 
and  the  resistance  determinant,  many  of  which  are  located  on  transposable 
elements  (Datta  et  al.,  1971).  The  medical  significance  of  such  plasmids  cannot 
be  underestimated  since  selection  for  R  plasmids  creates  a  growing  threat  to  the 
successful  use  of  antibiotics  in  treatment  of  bacterial  disease  (Falkow,  1975). 
The  occurrance  of  two  epidemics  in  Central  America  within  a  short  space 
of  time  caused  by  Shigella  dysenteriae  and  Salmonella  typhi  strains  which  showed 
identical,  transferable  antibiotic  resistance  patterns  (Farrar  and  Eidson,  1971; 
Gangarosa  et  al.,  1972),  but  which  produced  a  more  severe  and  protracted  typhoid 
epidemic  than  is  typical  of  the  disease,  led  to  speculation  that  the  R  plasmid 
may  have  increased  the  virulence  of  these  pathogens  (Gangarosa'et  al.,  1972). 
This  may  be  the  case  since  R  plasmid-encoded  functions  have  subsequently  been 
shown  to  increase  resistance  to  the  bactericidal  action  of  serum  (Fietta'at'al., 
1977)  and  to  enhance  resistance  to  phagocytosis  (Agvero'et  al.,  1984)  by  modif- 
ication  of  the  cell  envelope  to  favour  invasiveness. 
1.3.4  Bacterial  transposable  elements 
Transpositional  recombination  is  a  chromosome  restructuring  mechanism  in 
which  the  vectors  of  recombination,  called  transposable  elements,  are  specific 
DNA  sequences  that  can  move  from  one  genetic  location  to  another  in  the  absence 
of  the  normal  homology-dependent  recombination  systems.  Although  studied 
mainly  in  bacteria,  transposable  elements  were  initially  discovered  in  maize 
(McClintock,  1941).  Three  classes  of  transposable  elements  exist. 
1.3.4.1  IS  (insertion  sequence)  elements. 
IS  elements  are  short  DNA  segments  (760-1600bp)  which  encode  only  one  or 
two  genes  involved  in  transpositional  recombination.  They  are  found  singly  as 
natural  constituents  of  chromosomes,  or  as  pairs,  acting  as  the  driving  force 40 
for  transposition  in  composite.  transposons  (DNA  segments  which  may  carry  on 
antibiotic  resistance  gene,  flanked  by  two  copies  of  the  IS).  IS  elements 
were  first  identified  as  DNA  insertions  which  induced  polar  mutations  in  the 
control  rggion  of  the  gal  operon  of  E.  coli  (Jordan  et"al.,  1968;  Hirsch  et  al., 
1972).  IS  elements  encode  a  protein,  a  transposase,  which  is  required  for. 
recombination  and  transposition.  This  may  be  either  a  replicative  process, 
in  which  a  copy  of  the  IS  element  is  retained  at  the  donor  site,  or  a  conser- 
vative  process  in  which  the  element  is  excised  from  the  donor  without  replication. 
1.3.4.2  Drug  resistance  transposons. 
Drug  resistance  transposons  can  be  divided  into  two  categories  -  class  I 
and  class  II  -  by  their  physical  organisation.  Class  I  transposons  are  composed 
of  a  drug  resistance  determinant  flanked  by  copies  of  an  IS  element  which  provide 
the  transposition  functions  and  act  in  unison  to  transpose  the  intervening  drug 
resistance  gene.  A  typical  class  I  transposon  is  Tn5  which  encodes  kanamycin 
resistance.  The  properties  of  class  I  transposons  are  similar  to  those  of  IS 
elements.  Tn5  is  also  known  as  IS50  and  because  it  has  no  preferential  site  of 
insertion  in  the  chromosome  of  many  bacteria,  it  has  been  widely  used  in  creation 
of  transposon  insertion  mutants. 
Class  II  transposons  contain  a  sequence  which  encodes  transposition  functions 
and  drug  resistance  and  is  flanked  by  inverted  repeats  30  to  40bp  in  length. 
The  prototype  of  the  group  is  TnA,,  now  known  as  Tnl,  which  is  identical  to  the 
best  studied  member  of  the  group,  TO.  The  Tn3  family  form  a  distinct  class 
of  transposons  which  share  a  common  two-step  transposition  mechanism  (Heffron 
et  al.,  1977; 
. 
Gill  et  al.,  1979.;  Grindley  and  Reed,  1985).  Transposon  encoded 
antibiotic  resistance  was  first  observed  as  a  transfer  of  penicillinase  activity 
between  plasmids  and  between  plasmids  and  chromosomes  (Datta'et  al.,  1971; 
Richmond  and  Sykes,  1972).  Tn3-like  transposons  produce  two  gene  products 41 
which  are  essential  in  transposition  :a  transposase  (MW  =  120,00a  )  and  a 
resolvase  (MW  21,000  ).  Upon  transposition,  a  5bp  target  site  is  duplicated, 
The  Tn3  family  can  be  divided  into  two  subgroups  based  on  the  genetic  organis- 
ation  and  ability  of  recombination  functions  to  complement  one  another.  These 
two  groups  can  be  represented  by  Tn3  and  Tn501.  Tn3  transposition  involves 
fusion  of  donor  and  target  replicons  by  the  transposase.  This  forms  a  cointe- 
grate,  a  structure  which,  under  normal  conditions,  is  rapidly  broken  down  by 
the  resolvase  to  yield  an  insertion  of  the  transposon  in  the  target  replicon 
and  regeneration  of  the  donor  replicon  (Shapiro,  1979;  Gillet  al.,  1979). 
Tn501,  initially  discovered  on  a  Pseudomonas  plasmid  (Stanisich  et'al.,  1977), 
has  similar  transposase  activity  to  Tn3,  but  efficient  cointegrate  resolution 
only  occurs  in  the  presence  of  mercury  salts.  Although  transposition  can  occur 
in  the  absence  of  mercury  salts,  little  or  no  cointegrate  resolution  occurs 
(Sherratt  et  al.,  1980). 
Transposon  Tn7  is  a  class  II  transposon  which  differs  from  the  Tn3  family 
in  several  respects.  It  encodes  resistance  to  trimethoprism  and  streptomycin 
in  E.  coli  (Barth  et  al.,  1976).  It  differs  from  TO-like  transposons  in  that 
it  is  larger  and  encodes  a  third  transposition  function  which  is  required  only 
for  transposition  from  chromosome  to  plasmid  (Hauer  and  Shapiro,  1984).  The 
inverted  repeats  which  flank  the  transposition  and  resistance  genes  are  shorter 
than  those  in  TO,  being  about  19bp  long.  TO  has  been  shown  to  insert  pre- 
ferentially  into  chromosomal  hot-spots  in  several  species  (Barth  et  al.,  1976; 
Lichtenstein  and  Brenner,  1981;  Ely,  1982;  Thomson  et  al.,  1981). 
1.3.4.3  Bacteriophage  Mu.  ' 
Mu  represents  the  transposing  bacteriophages  and  was  the  first  prokaryote 
transposable  element  to  be  described  (Taylor,  1963).  It  shares  with  IS  elements 
and  transposons,  all  the  properties  characteristic  of  transposable  elements 42 
and  transposes  at  random,  inactivating  the  gene  in  which  it  inserts.  Trans- 
position  occurs  in  both  lytic  and  lysogenic  cycles  and  by  inducing  rearrange- 
ments  of  its  host  genome  while  it  transposes,  Mu  generates  mutations  in  about 
3%  of  the  lysogens.  During  the  ]ytic  cycle,  Mu  generates  DNA  rearrangements 
by  transposing  to  new  locations  on  the  chromosome  which  results  in  formation 
of  strong  polar  mutations  (Jordan  et  al.,  1968).  The  functions  required  for 
integration  appear  to  be  expressed  early  in  the  lytic  cycle  and  Mu  integration 
may  be  related  to  the  formation  of  covalently  closed  circles  which  appear  after 
prophage  induction  (Waggoner  et  al.,  1974;  Razzaki  and  Bukhari,  1975).  Many 
properties  of  Mu  are  shared  with  the  IS  elements  and  transposons,  so  that  Mu 
is  now  thought  to  be  a  large  transposon  of  39kb,  which  can  exist  as  a  virus. 
1.3.4.4  Transposon  mutagenesis 
Transposons  are  convenient  tools  for  use  in  genetic  analysis  of  bacteria, 
since  they  carry  antibiotic  resistance  which  are  selectable  properties.  They 
are  powerful  mutagens  since  they  can  insert  into  DNA  replicons  in  the  absence 
of  the  recA  gene  function.  Where  insertion  into  a  gene  occurs,  non-leaky  polar 
mutations  arise  and  insertion  can  be  mapped  by  the  presence  of  the  antibiotic 
resistance  marker.  The  insertion  mutations  are  generated  by  introducing  the 
transposon  into  the  bacterial  cell  on  a  conjugative  plasmid  which  fails  to 
replicate  in  the  new  recipient.  Several  bacterial  properties  have  been  studied 
using  such  a  system  :  the  nitrogenase  activity  of  Rhizobium  japonicum  (Horn 
I'F 
et  al.,  1984),  motility  in  Caulobacter  crescentus  (Ely  and  Croft,  1982)  and 
bioluminescence  in  marine  Vibrio  sp.  (Belas  et  al.,  1984).  Tn5  mutagenesis  in 
Erwinia  carotovora  has  yielded  auxotrophic  mutants  and  mutants  defective  in 
carbohydrate  metabolism  (Zink  et'al.,  1984)  while  bacteria  of  medical  and 
agricultural  importance  such  as  Vibrio'cholerae,  'Agrobacterium'tumefaciens 
and'B.  'pertussis  have  been  studied  using  these  techniques  (Newland'et  al.,  1984; 
Pischl  and  Farrand,  1984;  Weiss  and  Falkow,  1983). 43 
1.3.4.5  Role  of  IS  elements  and  transposons  in  chromosome  mobilisation. 
As  discussed  above,  the  sex  plasmid  F  can  promote  mobilisation  at  high 
frequencies,  by  formation  of  Hfr  donors.  Integration  of  the  plasmid  into 
the  chromosome  of  E.  coli  K12  is  now  known  to  occur  by  homologous  recombination 
via  insertion  sequences  carried  on  the  F  plasmid  and  on  the  bacterial  chromo- 
some  (Ohtsubo  et  al.,  1974;  Deonier  and  Davidson,  1976;  Cullum  and  Broda,  1979). 
R  plasmids  such  as  RP1,  RP4  and  R68  were  found  to  be  capable  of  promoting 
mobilisation  of  the  bacterial  chromosome  in  strains  of  Ps.  aerüginosa  (Stanisich 
and  Holloway,  1971).  Examination  of  crosses  in  which  the  donor  strain  carried 
plasmid  R68  showed  that  the  plasmids  present  in  recombinant  clones  had  acquired 
increased  chromosome  mobilising  ability  (Cma)  (Haas  and  Holloway,  1976;  1978). 
one  such  plasmid  was  designated  R68.44,  which  tended  to  lose  Cma  and  kanamycin 
resistance  concurrently.  A  mutant  of  this  plasmid,  R68;  45,  was  a  thousand 
times  more  efficient  than  R68  at  promoting  mobilisation  and  the  stability  of 
C  ma  could  be  increased  by  maintenance  on  kanamycin  (Haas  and  Holloway,  1976). 
Cma  in  R68.45  is  associated  with  a  DNA  insertion  of  about  2.05kb  (Jacob'et  al., 
1977)  which  is  a  repeat  of  a  sequence  already  present  on  R68  (Riess  et  al., 
1980)  and  is  close  to  the  kanamycin  resistance  determinant  (Currier  and  Morgan, 
1982).  The  duplicated  regions  may  be  insertion  sequences  -  IS  elements  - 
and  duplication  may  be  the  result  of  intra-molecular  transposition.  Such  an  IS 
element,  IS21,  exists  on  R68.45  and  the  C.  ma  of  this  plasmid  may  be  due  to 
formation  of  an  R68.45-chromosome  cointegrate  during  transposition  of  IS21 
(Willetts  et  al.,  1981),  although  the  exact  mechanism  remains  unclear. 
The  ability  of  plasmid  R68.45  to  promote  chromosome  mobilisation  can  be  improved 
by  insertion  into  the  plasmid  and  into  the  chromosome  of  homologous  nucleotide 
sequences  such  as  transposons,  which  can  promote  formation  of  Hfr-like  donors 
by  recombination  of  the  plasmid  into  the  chromosome.  This  has  been  demonstrated 
using  R68.45::  Tn5  in'Agrobacteriüm'tumifaciens  (Pischl  and  Farrand,  1983)  and 44 
with  RP1::  Tn50l  in  Rhodopseudomonas  sphaeroides  (Pemberton  and  Bowen,  1981). 
Recent  advances  have  used  the  oriT  region  of  RP4  cloned  into  Tn5  which,  in  the 
presence.  of  a  helper  plasmid  to  supply  transfer  functions  in'trans  mobilises 
the  chromosome  at  high  frequencies  (Simon,  1984;  Zokobson  and  Guiney,  1984). 
Many  studies  on  gene  transfer  in  Gram-negative  bacteria  have  used  a 
conjugation-mediated  system  with  R  plasmids  of  the  P  incompatibility  group. 
The  plasmids  have  a  broad  host  range  (Datta  and  Hedges,  1972;  Olsen  and  Shipley, 
1973)  and  are  capable  of  promoting  recombinational  exchange  of  chromosomal  genes 
in  many  Gram-negative  bacteria  (Holloway,  1979)  such  as  Rhodopseudomonas  sphaer--: 
oides  (Tucker  and  Pemberton,  1979),  methylotrophic  Pseudomonas  (Tatra  and  Goodwin, 
1983)'and  Legionella  pneumophila  (Dreyfus  and  Iglewski,  1985).  Such  studies, 
combined  with  the  use  of  transposons,  as  mutagens  permits  genetic  analysis  of 
poorly  characterised  organisms. 
1.4  GENETICS  OF  B.  PERTUSSIS. 
1.4.1  Transformation 
Branefors  (1964)  transformed  streptomycin  resistance  to  a  strain  of 
B.  Pertussis  with  DNA  from  a  StrR  donor.  In  addition,  starch  independence  was 
believed  to  have  been  co-transferred.  Further  transformation  studies  used 
auxotrophic  mutants  of  B.  pertussis  as  recipients  which  were  reported  to  have 
been  transformed  to  prototrophy  by  DNA  from  prototrophic  donor  strains;  the 
first  study  of  genes  associated  with  biosynthesis  in  B.  pertussis  (Kloos  et  al., 
1978).  Al-Sallami  (1981),  in  repeating  the  work  of  Branefors,  associated  trans- 
formation  of  StrR  with  increased  virulence  in  mice,  and  characterised  the 
Branefors  strains  with  respect  to  their  biological  properties.  No  subsequent 
reports  of  transformation  by  chromosomal  genes  have  appeared,  but  transformation 
by  plasmid  DNA  was  demonstrated  (Weiss  and  Falkow,  1982)  by  using  cold  shock  and 
freeze-thaw  procedures.  However,  plasmid  DNA  from'E.  "cöli  could  not  be  trans- 45 
formed  if  the  DNA  contained  Hindill  restriction  sites.  This  supported  the 
findings  of  Greenaway  (1981)  who  reported  the  presence  of  A'HindIII-like 
restriction  enzyme  in'B.  pertüssis. 
1.4.2  Theories  of  phage  conversion  of'B.  pertussis. 
The  first  suggestion  of  the  existence  of  bacteriophage  specific  for 
B.  pertussis  was  a  report  of  lytic  activity  against  the  organism  observed  in 
respiratory  secretions,  homogenised  human  lung  and  soil  (Grant,  1979). 
Mebel  et  al.  (1981)  demonstrated  mitomycin  C  induction  of  bacteriophage  which  gave 
rise  to  plaques  on  B.  parapertussis  indicator  bacteria.  In  addition,  spontan- 
eous  release  of  phage  from  B.  pertussis  vaccine  strains  was  observed.  Further 
study  showed  that  lysogenisation  of  B.  parapertussis  by  phage  from  B.  Pertussis 
caused  expression  and  production  of  toxic  properties  and  agglutinogens  which 
were  characteristic  of  the  donor  (Lapaeva  et  al.,  1982),  but  the  lysogens  did 
not  possess  protective  activity.  These  findings  led  to  theories  of  conversion 
of  B.  parapertussis  to  B.  Pertussis  by  uptake  of  a  lysogenic  phage  (Mebel  and 
Lapaeva,  1982;  Granstrom  and  Askelof,  1982)  which  may  explain  some  anomolous 
observations  from  Linnemann  (1977).  He  isolated'B.  'pertussis  from  family 
members  and  relatives  of  children  infected  with  B.  parapertussis  and  demonstrated 
that  infection  with  this  organism  produced  lymphocytosis.  These  observations 
could  be  explained,  however,  by  the  Weiss  and  Falkow  model  of  phase  variation 
and  virulence  factor  expression,  if  it  is  accepted  that  avirulent  phase  variants 
of  B.  pertussis  were  misidentified  as  being'B.  parapertussis. 
1.4.3  Plasmids  in  B.  'pertussis. 
The.  first  report  of  plasmid  DNA  in'B:  'pertussis  was  of  a  small  cryptic 
plasmid  in  several  strains  of  the  organism,  and  in'B.  paiapertussis  (Kloos  et'  1., 
1978).  Strains  of'  B.  'bronchiseptica  have  been  shown  to  harbour  large  R  plasmids 46 
(Terakado  et  al.,  1973;  Hedges,  and  Jacob,  1974),  although  to  date,  no  such 
plasmids  have,  been  found  Ln'B.  'pertussis.  It  has  been  possible  however,  to 
transfer  plasmids  into  the  organism  by  conjugation  with'E;  'coli  donors.  The 
broad  host-range  plasmids  R388  and  RP4  have  been  introduced  into  the  organism 
in  this  way  (Weiss  and  Falkow,  1982).  Although  less  promiscous  plasmids  of 
the  FI  and  FII  groups  did  not  transfer  to'B.  pertussis,  a  chimeric  plasmid 
pUW942  was  used  to  introduce  Tn501  into  'B.  pertussis  and  by  promoting  integration 
into  the  chromosome,  create  genetic  donors  (Sato  et  al.,  1981;  Weiss  and  Falkow, 
1983),  which  could  mobilise  chromosomal  markers.  A  second  chimeric  plasmid, 
pUW964  was  subsequently  used  to  begin  a  new  approach  to  the  determination  of 
the  role  of  each  virulence  factor  in  the  establishment  of  whooping  cough.  This 
plasmid  was  used  to  deliver  Tn5  transposition  induced  mutations  in  virulence- 
associated  genes  and  allowed  study  of  virulence  factor  expression  and  phase 
variation,  leading  to  a  model  for  virulence  factor  expression  (Weiss  and  Falkow, 
1983;  1984;  Weiss  et  al.,  1983;  1984). 
1.4.4  Development  of  a  minimal  medium  for  B.  pertussis. 
The  development  of  a  gene  transfer  system  in  B.  pertussis  has  been  hampered 
by  the  lack  of  suitable  markers  which  could  act  as  selectable  properties.  The 
development  of  a  minimal  medium  was  considered  by  Parker  (1976)  who,  in  attempts 
to  isolate  mutants  resistant  to  inhibitors  or  deficient  in  amino  acid  metabolsim 
used  a  medium  based  on  Stainer  and  Scholte  liquid  medium  (Stainer  and  Scholte, 
1971).  The  medium  included  sodium  acetate,  which  is  stimulatory  for 
B.  pertussis  (Bundeally  and  Rao,  1965),  Dowex-1  chloride  to  remove  inhibitors 
(Sutherland  and  Wilkinson,  19612  and  agarose.  Agar  was  unsuitable  as  a  solidif- 
ying  agent  since.  it  is  inhihitory  td'B.  'pertustis  (Verwey  et  al.,  1949).  The 
Parker  medium  supported  growth  of*B.  pertussis  vaccine  strains  and  fresh  isolates 
from  small  inocula.  No  attempt  was  made  to  isolate  auxotrophic  mutants. 47 
Kloos  et  al.  (1978)  extended  the  transformation  studies  of  Branefors 
(1964)  to  include.  genes,  associated  with  biosynthesis  of  amino  acids.  For 
these  studies,  a  medium  based  on  that  of  Stainer  and  Scholte  (1977)  was  used 
which  contained  casein  hydrolysate  or,  for  screening  and  selection  of  auxo- 
trophs  and  prototrophic  recombinants,  a  combination  of  up  to  11  amino  acids. 
For  growth  of  Phase  I  strains,  activated  charcoal  was  added  but  this  was 
omitted  for  Phase  IV  strains,  SSA  containing  casamino  acids  being  selective 
for  Phase  IV  strains,  -- 
(Dobrogosz  et  al.,  1979).  This  selective  medium,  with 
1%  Noble  Agar  as  a  solidifying  agent,  was  used  to  isolate  colonial  variants 
of  B.  pertussis  which  had  lost  some  Phase  I  characteristics  (Peppler,  1982). 
The  medium  used  in  his  study  also  contained  BSA  addition  of  which  allowed  growth 
of  Phase  I  organisms  and  may  have  overcome  the  inhibitory  effect  of  agar.  In 
their  studies  on  Tn501-induced  donor  formation,  Weiss  and  Falkow  (1983)  used 
Stainer  and  Scholte  agarose  (SSA)  plates  containing  BSA  to  select  recombinant 
prototrophic  colonies  which  carried  a  mobilised  donor  nutritional  marker. 
The  most  significant  development  was  the  discovery  that  cyclodextrins,  in 
particular  Heptakis  (2,6-0-Dimethyl)$-Cyclodextrin,  (MeßCD)  when  incorporated 
in  SSA,  allowed  growth  of  B.  pertussis  from  small  inocula  (Imaizumi  et  al., 
1983).  This  medium,  Cyclodextrin  Solid  Medium  (CSM)  supported  growth  at  a 
level  comparable  to  that  of  BGA,  and  may  be  suitable  for  use  as  a  B.  pertussis 
minimal  medium. 48 
OBJECT  OF  RESEARCH 49 
The.  primary  objective  of  this  research  was  to  develop  a  system  of  genetic 
transfer  in'Bdrdetella'pertüssis  which  would  enable  virulence  determinants 
to  be  expressed  individually  in  suitable  recipient  strains.  Procedures 
such  as  transformation  and  plasmid-mediated  chromosome  mobilisation  were 
explored  for  this  purpose,  together  with  attempts  to  identify  bacteriophage 
in  B.  pertussis. 
In  parallel  with  these  studies,  markers  suitable  for  following  genetic 
exchange  were  created  by  the  isolation  of  drug  resistant  and  auxotrophic 
strains  of  B.  pertussis. 50 
2.  MATERIALS  AND  METHODS 51 
2.1  BACTERIOLOGICAL 
2.1.1  Bacteria  and  plasmids 
B.  pertussis  strains  44122/7R  and  44122/7S  as  used  in  studies  on  trans- 
formation  by  Branefors  (1964)  and  Al-Sallami  (1981)  were  employed.  The  latter 
author  also  characterised  the  strains  with  respect  to  intranasal  and  intra- 
cerebral  virulence,  and  HSF  activity.  44122/7R  is  resistant  to  streptomycin 
(>500pgml  1) 
while  44122/7S  is  sensitive.  44122/7S  has  been  used  for  vaccine 
production  in  Sweden.  Both  strains  were  obtained  from  P.  Branefors,  Karolinska 
Institute,  Stockholm,  Sweden. 
Taberman.  This  strain  was  isolated  pernasally  before  the  death  of  an 
infant,  and  was  obtained  from  Professor  G.  T.  Stewart,  Ruchill  Hospital,  Glasgow. 
Since  the  wild-type  is  sensitive  to  most  antibiotics  which  are  commonly  used 
for  selection  in  genetic  transfer  systems,  several  antibiotic  resistant  mutants 
were  isolated.  R1,  R2,  R3  are  rifampicin  resistant  mutants,  while  P1,  P2  and 
P3  are  phosphonomycin  resistant  mutants  which  were  obtained  by  N-Methyl-N'- 
nitro-N-nitrosoguanidine  (NTG)  mutagenesis. 
BPT1  to  BPT6  are  nalidixic  acid  resistant  mutants  which  were  also  obtained 
by  NTG  mutagenesis.  BPT2  was  used  in  subsequent  genetic  manipulations. 
Tohama.  This  strain  was  obtained  from  Dr.  A.  Robinson,  PHLS,  Porton  Down, 
Wiltshire  and  was  used  in  gene  transfer  studier  by  Weiss  and  Falkow  (1983). 
A  nalidixic  acid  resistant  mutant  (BPN6)  was  obtained  which  was  subsequently 
used  for  isolation  of  threonine  requiring  aux3trophic  mutants  of  B.  pertussis 
(BPN6  Thr  )  (see  Results). 
D30042  Phase  I. 
Harrow,  Middlesex. 
was  obtained  from  Dr.  J.  Dolby,  Clinical  Research  Centre, 
A  streptomycin  resistant  mutant  was  isolated  (CSP1)  and 
was  used  for  subsequent  isolation  of  two  auxotrophic  mutant  strains  (CSP1 52 
Trp  and  CSP  I  Gly  ),  which  are  tryptophan  and  glycine  requiring  respectively. 
L84  Phase  I  was  obtained  from  the  Microbiology  Department  culture  collect- 
ion. 
18334  was  originally  obtained  from  Connaught  Laboratories,  Toronto, 
Canada  and  is  used  in  vaccine  production. 
18323  was  obtained  from  Dr.  F.  Sheffield,  National  Institute  for  Biolog- 
ical  Standards  and  Control,  Hampstead,  London,  and  is  virulent  for  mice  by  the 
intracerebral  route  being  the  standard  intracerebral  challenge  strain. 
134.  This  strain  was  obtained  from  the  departmental  culture  collection. 
It  was  the  strain  used  by  Pillemer  (1950)  in  preparation  of  his  erythrocyte 
adsorbed  protective  antigens. 
BP  347.  This  strain  was  obtained  from  A.  A.  Weiss,  Stanford  University 
School  of  Medicine,  Stanford,  California,  U.  S.  A.  and  is  a  transposon  Tn5- 
induced  mutant  defective  in  production  of  haemolysin,  fimbrial  haemagglutinin, 
pertussis  toxin  and  dermonecrotic  toxin.  (Weiss  et  al.,  1983). 
B.  parapertussis  NCTC  10520,  a  strain  which  carried  intrinsic  resistance 
to  chloramphenicol  and  streptomycin,  was  used  as  a  recipient  in  genetic  transfer 
studies. 
Several  strains  of  E.  coli  were  also  used  :- 
E.  coli  K12.  A  prototrophic  strain  commonly  used  in  genetic  studies. 
J53-1.  This  strain  has  a  chromosomal  mutation  which  confers  resistance 
to  nalidixic  acid  (Na1R),  in  addition  to  mutations  which  make  it  auxotrophic 
for  proline  (pro)  and  methionine  (met).  J53-1  carries  plasmid  R68-45. 
JC3272..  This  strain  carries  chromosomal  mutations  which  render  it 
auxotrophic  for  histidine,  (his),  tryptophan  (trp)  and  lysine  (lys),  and 
resistant  to  streptomycin  (Achtman'et  al.,  1971).  J53-1  and  JC3272  were 53 
supplied  by  Dr.  B.  E.  B.  Moseley,  Department  of  Microbiology,  University  of 
Edinburgh. 
JMP543.  This  strain  is  auxotrophic  for  threonine  (thr),  leucine  (leu), 
serine  (ser)  and  vitamin  B1,  (thi)  and  carries  plasmid  RP1  containing  the 
mercury  resistance  transposon  Tn501.  JMP543  is  also  resistant  to  streptomycin 
(Str 
R) 
and  rifampicin  (Rif  R). 
JMP502.  This  strain  differs  from  JMP543*only  in  that  Tn501  is  not  present  on 
the  plasmid  RP1.  Both  strains  were  obtained  from  J.  M.  Pemberton,  University 
of  Queensland,  Australia. 
UW937/pUW942.  This  strain  is  auxotrophic  for  threonine  (thr),  leucine 
(leu),  thiamine_(thi)  and  also  carries  lac  Y1,  sup  E44,  ton  A21  and  gyr  A 
mutations.  Plasmid  pUW942  is  present  in  this  strain. 
HB101/pUW964.  This  strain  is  deficient  in  arabinose  fermentation  (ara) 
and  is  auxotrophic  for  proline  (pro).  It  also  carries  the  lac  Yl  mutation 
R 
and  is  Str.  This  strain  carries  plasmid  pUW964. 
J53-1/RP4::  Tn7.  This  is  the  same  J53-1  host  strain  as  described  above,  but 
contains  plasmid  RP4  carrying  the  trimethoprim  and  streptomycin  resistance 
transposon  Tn7. 
Strains  UW937/pUW942  and  HB101/pUW964  were  obtained  from  A.  A.  Weiss, 
University  of  Virginia  Medical  School,  U.  S.  A.  and  J53-1/RP4::  Tn7  was  obtained 
from  D.  Platt,  Glasgow  Royal  Infirmary. 
Plasmids. 
R68.45,  RP1  and  RP4.  These  plasmids  were  present  in  E.  coli  hosts  as 
described  above.  The  plasmids  are  members  of  the  P-1  incompatibility  group 
and  encode  resistance  to  kanamycin,  carbenicillin,  tetracycline  and  neomycin. 
Derivatives  were  also  used  which  contained  transposons  Tn5Ol  (plasmid:  RP1:: 
Tn501)  and  Tn7  (plasmid:  RP4::  Tn7). 54 
R68.45supdnaG315  This  plasmid  is  a  dnaG  suppressing  mutant  of  R68.45 
which  enhances  chromosome  mobilisation  in  Rhizobium  sp.  (Ludwig  and  Johansen, 
1980).  It  was  obtained  from  Dr.  E.  Johansen,  Massachusetts  Institute  of 
Technology,  Cambridge,  Massachusetts,  U.  S.  A. 
pUW942.  This  is  a  derivative  of  the  chimeric  plasmid  pAS8  Rep-1  (Sato 
et  al.,  1981).  It  carries  RP4  conjugation  genes  and  a  Col  El  replication 
origin  and  will  only  replicate  in  a  limited  number  of  species.  In  addition, 
it  contains  transposon  Tn501  (Weiss  and  Falkow,  1983). 
pUW964.  This  is  also  a  chimeric  plasmid  of  the  type  described  above  and 
was  constructed  from  a  derivative  of  pRK2013,  called  pRKTV5  (Figurski  and 
Helinski,  1979),  in  which  a  kanamycin  resistance  determinant  had  been  inact- 
ivated  by  a  Tn7  insertion  thus  allowing  transposition  of  Tn5,  which  encodes 
resistance  to  kanamycin,  onto  the  plasmid.  This  plasmid  is  also  limited  in 
its  host  range  (Weiss  et  al.,  1983). 
RP4::  Mucts62.  This  plasmid  is  the  P  group  plasmid  RP4  carrying  the 
thermosensitive  transposable  bacteriophage  Mucts62  (Howe,  1973;  Boucher  et  al., 
1977).  At  42°C,  the  lytic  cycle  of  infection  is  induced  giving  rise  to  viable 
phage  particles. 
2.1.2  Media 
For  growth  of  E.  coli,  B.  pertussis  and  B.  parapertussis,  and  selection 
of  transconjugants,  four  types  of  media  were  used. 
Bordet-Gengou  Agar  (BGA)  (Gibco  Europe  Ltd.,  Paisley,  Scotland)  supplemented 
with  20%  sterile  defibrinated  horse  blood  (Gibco)  (Appendix  1)  was  used  for 
routine  growth  of  B.  pertussis. 
Cyclodextrin  Solid  Medium  (CSM)  was  prepared  according  to  the  recipe  of 
Imaizumi  et  al.  (1983)  (Appendix  1)  when  used  for  routine  growth  of  B.  pertussis 
the  medium  contained  Casamino  Acids  (Casein  Hydrolysate  Acid,  Peptone  No.  5,  Gibco). I 
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For  isolation  of  auxotrophic  mutants  and  selection  of  prototrophic  recombin- 
ants  in  gene  transfer  experiments,  casein  hydrolysate  was  omitted  but  amino 
acid  'pools'  were  incorporated  in  the  medium  (Appendix  2).  Methylated  ß- 
cyclodextrin  (MeßCD)  was  obtained  from  Dr.  Imaizumi,  Teijin  Institute  for 
Biomedical  Research,  Tokyo,  Japan.  MacConkey  Agar  (Difco)  was  used  for  growth 
of  B.  parapertussis  as  was  BGA. 
E.  coli  strains  were  grown  on  nutrient  agar  (Gibco). 
E.  coli  K12  recombinants  were  selected  on  E.  coli  Minimal  Agar  (ECMA) 
(Clowes  and  Hayes,  1968)  (Appendix  1). 
In  liquid  culture,  B.  pertussis  and  B.  parapertussis  were  grown  in  Cohen- 
Wheeler  Medium  (Cohen  and  Wheeler,  1946)  (Appendix  1)  or  Stainer-Scholte 
defined  liquid  medium  (Stainer  and  Scholte,  1971)  (Appendix  1). 
E.  coli  liquid  cultures  were  grown  in  nutrient  broth  (Gibco). 
2.1.3  Growth  of  bacteria 
Freeze-dried  cultures  of  B.  pertussis  were  reconstituted  in  1%  (w/v) 
Casamino  Acids  (CAA)  (Appendix  1)  and  plated  on  BGA.  Plates  were  incubated 
at  37°C  for  2-4  days  in  a  closed  plastic  box  containing  a  beaker  of  water  to 
saturate  the  atmosphere. 
Cultures  were  grown  from  frozen  stocks  by  thawing  and  spreading  100pl  of 
bacterial  suspension  on  BGA,  and  incubating  as  above. 
B.  pertussis  was  grown  in  25m1  amounts  of  Cohen-Wheeler  Medium  in  dimpled  250ml 
flasks  at  37°C  for  48-72h  with  shaking  on  an  orbital  incubator  at  70  r.  p.  m. 
Where  B.  pertussis  transconjugants  were  used  subsequently  as  genetic  donors, 
or  for  plasmid  DNA  preparations,  tetracycline  (10pg/ml)  was  added  to  the 
medium. 
B.  parapertussis  was  grown  from  frozen  stocks,  on  nutrient  agar  or  on  BGA. 56 
Nutrient  agar  was,  on  occasion,  supplemented  with  tyrosine  (0.2%  w/v). 
B.  parapertussis  was  also  grown  on  MacConkey  Agar.  All  plates  were  incubated 
at  37°C  for  2-3  days,  in  a  moist  atmosphere. 
In  liquid  culture,  B.  parapertussis  was  grown  in  25m1  amounts  of  Cohen 
and  Wheeler  medium  or  nutrient  broth  at  37°C  for  48h  with  shaking  at  70  r.  p.  m. 
Freeze-dried  E.  coli  strains  were  reconstituted  in  nutrient  broth  and 
l00µ1  of  the  suspension  was  spread  on  nutrient  agar.  Plates  were  incubated 
at  37°C  overnight. 
Liquid  cultures  of  E.  coli  were  grown  in  25m1  amounts  of  nutrient  broth 
overnight  at  37°C  with  shaking.  Where  E.  coli  strains  were  used  as  genetic 
donors,  or  for  preparation  of  plasmid  DNA,  the  medium  was  supplemented  with 
tetracycline  (lOpg  ml-1). 
2.1.4  Culture  purity  checks 
All  strains  were  checked  regularly  for  purity  by  Gram  stain.  B.  pertussis 
Phase  I  cultures  were  also  checked  by  their  inability  to  grow  on  nutrient  agar, 
and  their  ability  to  agglutinate  in  specific  antiserum  (concentrated  rabbit 
anti-B.  pertussis  sonicate,  prepared  by  J.  Hertz,  1978).  Two  drops  of  a 
turbid  cell  suspension  were  placed  on  a  clean  microscope  slide  about  4cm  apart. 
To  one,  a  drop  of  antiserum  was  added  while  saline  was  added  to  the  other. 
The  slide  was  agitated  gently  for  several  minutes  to  allow  agglutination  to 
occur. 
2.1.5  Determination  of  antibiotic  sensitivity. 
a)  Faintly  turbid  cell  suspensions  of  B.  pertussis  cells  were  made  in  1% 
Casamino  Acids  solution  (CAA).  From  the  suspension,  loopl  was  spread  on  BGA 
and  allowed  to  dry.  An  Oxoid  S3  Multodisk  (Appendix  2)  was  placed,  using 57 
sterile  forceps,  on  the  surface  of  the  plate,  which  was  incubated  as 
described  previously.  After  48h,  test  strains  were  determined  to  be 
resistant  (R)  or  sensitive  (S)  to  each  antibiotic. 
b)  Varying  concentrations  of  the  test  antibiotic  were  incorporated  in  BGA 
by  adding  the  sterile  antibiotic  solution  before  pouring.  Plates  were 
streaked  with  the  test  organism  and  incubated  as  described  previously. 
The  Minimum  Inhibitory  Concentration  (MIC)  of  the  antibiotic  was  recorded 
as  being  the  lowest  concentration  of  antibiotic  which  gave  complete  inhib- 
ition  of  bacterial  growth. 
2.1.6  Preparation  of  antibiotic  solutions. 
Stock  solutions  of  antibiotics  were  made  at  the  following  concentrations 
(ý  w/v)  :- 
streptomycin  (Sm)  -  4%,  kanamycin  (Km)  -  2%,  carbenicillin  (Cb)  -  2%, 
tetracycline  (Tc)  -  0.2%,  nalidixic  acid  (Nal)  -  0.4%,  chloramphenicol  (Cm)  -  1%, 
trimethoprim  (Tp)  -  4%,  erythromycin  (Em),  -  0.25%,  phosphonomycin  (Pm)  -  0.5%, 
rifampicin  (Rif)  -  0.4%,  penicillin  G  (PenG)  -  1000  units  ml-1. 
Streptomycin,  kanamycin,  chloramphenicol,  carbenicillin,  phosphonomycin  and 
penicillin  G  were  dissolved  in  distilled  water  and  filter  sterilised  by  passing 
the  solutions  through  a  Sartorius  Minisart  NML  filter  (pore  diameter  0.4511m). 
Nalidixic  acid  and  trimethoprim  were  dissolved  in  methanol,  in  a  hot  water 
stream  to  ensure  solubility,  while  tetracycline,  erythromycin  and  rifampicin 
dissolved  readily  in  methanol  at  room  temperature.  All  antibiotic  solutions 
were  stored  at  -20°C  except  nalidixic  acid  and  trimethoprim  which,  due  to  their 
tendency  to  come  out  of  solution,  were  prepared  fresh  immediately  before  use. 
All  antibiotics  were  obtained  from  the  Sigma  Chemical  Co.,  Poole,  Dorset. 58 
2.1.7  Mercuric  chloride  solution. 
2%  (w/v)  stock  solutions  were  prepared  by  dissolving  mercuric  chloride  (Koch- 
Light  Laboratories,  Buckinghamshire)  in  distilled  water  and  filter  sterilising 
as  described  above.  The  stock  solutions  were  stored  at  -20°C. 
2.2  GENETIC 
2.2.1  Preparation  of  chromosomal  DNA. 
Chromosomal  DNA  from  several  strains  of  B.  pertussis  was  prepared 
Using  a  combination  of  lysis,  by  the  procedure  of  Schwinghamer  (1980),  and 
extraction  by  the  method  of  Marmur  and  Lane  (1961).  To  avoid  DNA  shearing 
during  mechanical  cell  disruption  lysozyme  was  used  to  produce  sphaeroplasts 
for  gentle  lysis  of  cells.  A  mild  osmotic  shock  in  the  presence  of  EDTA 
allows  lysozyme  to  penetrate  the  outer  membrane  and  to  degrade  the  murein 
layer.  The  procedure  was  as  follows  : 
500ml  of  a  48h  shaken  culture  of  a  shaken  culture  of  B.  pertussis 
was  centrifuged  at  12000xg  for  20  min  at  4°C,  and  the  cell  pellet.  was 
resuspended  in  50ml  cold  0.05M  Tris-HC1  buffer  containing  0.05M  NaCl  pH  8.0. 
2ml  of  sodium  lauryl  sarcosinate  2.5%  w/v  was  added  and  the  mixture  vortexed 
for  30  sec,  followed  by  centrifugation  at  12000xg  at  4°C  for  20  min.  The 
supernate  was  discarded  and  the  pellet  drained  well.  Cells  were  resuspended 
in  0.8m1  0.05M  Tris-HC1  buffer,  pH  8.0  containing  0.05M  NaCl.  O.  7m1  of  1.6M 
sucrose,  0.55M  Tris,  O.  1M  EDTA  was  added.  The  mixture  was  then  kept  on  ice 
for  20  min,  after  which  0.3ml  of  lysozyme  (Sigma)  (5mg  ml-1  in  0.05M  Tris, 
pH  8.0)  was  added,  followed  by  7.2m1  of  cold  0.01M  EDTA.  The  mixture  was 
kept  on  ice  for  a  further  20  min.  Next,  5.  Oml  of  sodium  lauryl  sarcosinate 
2.5%  w/v  was  added  and  mixed  slowly  to  give  a  clear  lysate.  The  lysate  was 
extracted  twice  with  phenol,  followed  by  extraction  twice  with  ether.  One 59 
tenth  volume  of  3M  sodium  acetate  was  added,  followed  by  addition  of  two 
volumes  of  cold  absolute  alcohol.  After  mixing,  the  preparation  was  stored 
at  -20°C  overnight.  Following  centrifugation  at  12000xg  the  supernate  was 
discarded  and  the  pellet  was  dissolved  in  2.  Oml  SSC  (0.15M  NaCl,  0.015M 
trisodium  citrate,  pH  7.0).  O.  lml  of  Y 
U"  1'%_  ONase,  4_  (5t-,  4  t  0'15'  M 
oH  . 
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was  added.  To  destroy  DNase  activity  the  RNase  was 
heated  at  80°C  for  10  min  before  addition.  The  preparation  was  incubated  at 
37°C  for  a  further  30  min.  The  mixture  was  extracted  several  times  with  phenol, 
until  the  interphase  between  the  two  layers  was  clear.  This  was  followed  by 
extraction  twice  with  ether,  followed  by  addition  of  one  tenth  volume  of  3M 
sodium  acetate  and  two  volumes  of  cold  absolute  alcohol  to  precipitate  DNA. 
The  DNA  was  spooled  off  on  a  glass  rod  and  dissolved  in  1.  Oml  of  TE  buffer 
(0.01M  Tris  -HC1,0.001M  EDTA  pH  8.0).  Half  the  volume  of  7.5M  ammonium 
acetate  was  added,  followed  by  2  volumes  of  cold  absolute  alcohol.  Following 
mixing,  the  preparation  was  stored  at  -20°C  overnight  then  centrifuged  at 
2900xg.  The  pellet  was  taken  up  in  0.5ml  TE  buffer.  The  DNA  was  stored  in 
test  tubes  in  5xO.  lml  aliquots  at  -20°C. 
2.2.2  Preparation  of  plasmid  DNA. 
Plasmid  DNA  was  isolated  from  E.  coli  and  B.  pertussis  using  two  rapid 
extraction  methods. 
i)  Single  colony  final  sample  buffer  (SCFSB). 
This  procedure  is  commonly  used  in  the  laboratory  of  D.  J.  Sherratt, 
Institute  of  Genetics,  University  of  Glasgow.  From  growth  on  solid  media, 
bacteria  were  removed  using  a  sterile  toothpick  and  were  resuspended  in  200111 
SCFSB.  This  was  prepared  as  a  5x  normal  strength  solution  containing  Ficoll 
10%  w/v  (Sigma),  sodium  dodecyl  sulphate  5%  w/v  and  bromophenol  blue  0.05% 
w/v  and  was  diluted  to  normal  strength,  in  distilled  water,  before  use. 6o 
Following  suspension  of  bacteria,  the  preparation  stood  at  room  temperature 
for  5-10  min,  and  was  then  centrifuged  at  12000xg  for  15  min  at  room  temper- 
ature  (MSE  Micro  Centaur),  giving  a  gelatinous  pellet.  2Opl  of  the  supernate 
was  examined  by  agarose  gel.  electrophoresis. 
ii)  Boiling  procedure. 
Plasmid  DNA  was  also  prepared  using  the  method  of  Holmes  and  Quigley 
(1981).  Cells  from  1.5ml  of  an  overnight  E.  coli  or  48h  B.  pertussis  liquid 
culture  were  harvested  by  centrifugation  at  20,  "OO.  Oxg  in  a  Sarstedt  Microfuge. 
The  pellet  was  drained  well  on  tissue  paper  and  resuspended  in  350p1  of  STET 
Buffer.  (sucrose  8%  w/v,  EDTA  50mM,  Tris-HC1  50mM,  Triton  X-100  5%  v/v,  pH  8.0). 
25pl  of  lysozyme  (10mg  ml-1  freshly  prepared  in  STET)  was  added  and  mixed  well. 
Tubes  were  then  placed  in  a  boiling  water  bath  for  40  sec,  followed  immediately 
by  centrifugation  at  4°C  for  15  min  at  20,000xg,  to  remove  cell  debris.  The 
pellet  was  removed  with  a  toothpick.  The  condition  of  the  pellet  gave  an 
indication  of  how  well  the  lysis  procedure  worked,  a  white  'fluffy'  pellet 
indicating  good  lysis.  40p1  of  3M  sodium  acetate  was  added  to  the  supernate, 
followed  by  400111  of  ice  cold  isopropanol.  The  two  phases  were  mixed  by 
inversion  of  the  tube  and  were  centrifuged  at  20,000xg  for  7  min  at  4°C.  The 
supernate  was  discarded  and  the  pellet  was  drained  well  on  tissue  paper  before 
addition  of  lm1  ethanol,  70%  v/v.  This  was  discarded  after  a  few  seconds,  without 
resuspending  the  pellet  which  was  white  at  this  stage.  The  pellet  was  dried  in 
a  vacuum  dessicator  followed  by  incubation  at  37°C  for  10-15  min,  to  drive  off 
the  remaining  ethanol.  The  pellet  was  now  gelatinous  and  transparent  and  was 
dissolved  in  50111  of  TE  buffer.  Plasmids  were  visualised  by  electrophoresis 
in  0.6%  agarose  gels  (Section  2.2.9). TEXT  CUT 
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2.2.3  Isolation  of  antibiotic  resistant  B.  pertussis  mutants. 
To  increase  the  range  of  mutants  which  would  be  suitable  for  use  in  gene 
transfer  experiments,  the  following  procedure  was  used.  A  filter  paper  disk 
(Whatman  No.  1),  0.5cm  in  diameter,  was  soaked  in  a  solution  of  N-methyl, 
N'-nitro,  N-nitrosoguanidine  (NTG)  (Aldrich  Chemicals,  Wembley,  Middx.  ) 
(20011g  ml-1).  A  heavy  suspension  of  the  strain  in  use  was  adjusted  to  contain 
about  109  bacteria  per  ml  by  comparison  with  the  Fifth  International  Reference 
of  Opacity  (World  Health  Organisation  International  Laboratory  for  Biological 
Standards,  National  Institute  for  Biological  Standards  and  Control,  Holly  Hill, 
London  NW3  6RB).  100pl  of  the  suspension  was  spread  on  BGA  containing  the 
selective  antibiotic  and  allowed  to  dry.  The  NTG  soaked  disk  was  placed  in  the 
centre  of  the  plate,  which  was  then  incubated  at  37°C  as  previously  described. 
After  4-5  days  incubation,  antibiotic-resistant  mutants  had  grown  to  single 
colonies  at  a  distance  of  1-2cm  from  the  centre  of  the  disk.  These  colonies 
were  subcultured  on  BGA  containing  the  antibiotic. 
2.2.4  Isolation  of  B.  pertussis  auxotrophic  mutants. 
B.  pertussis  was  grown  in  25m1  Stainer  and  Scholte  medium  for  48h  at  37°C, 
with  shaking.  NTG  was  added  to  a  final  concentration  of  200pg  ml-1  and  incub- 
ation  continued  for  a  further  5h  at  37°C.  4ml  of  this  culture  was  transferred 
to  fresh  Stainer  and  Scholte  medium  and  incubated  for  a  further  48h  at  37°C. 
From  this  culture,  0.4m1  was  transferred  into  1.6ml  of  sterile  saline  (0.85% 
w/v)  and  the  total  2m1  volume  was  used  to  inoculate  25m1  of  Stainer  and  Scholte 
medium.  Penicillin  G  was  then  added  to  a  final  concentration  of  6  Units  ml- 
and  the  culture  was  incubated  at  37°C  for  24h.  During  this  time  any  proto- 
trophs  would  be  subject  to  the  action  of  penicillin  and  would  be  killed, 
whereas  non-growing  auxotrophs  would  remain  viable.  Following  incubation,  six 
platings  each  of  100u1  were  made  from  each  dilution  in  a  series  of  10-fold  dilutions 62 
of  the  cultures.  Platings  were  on  BGA  and  following  incubation  for  4-5  days 
at  37°C,  single  colonies  were  restreaked  on  CSM  without  CAA,  as  well  as  on 
BGA.  Plates  were  incubated  for  48h,  following  which  presumptive  auxotrophs 
were  identified  as  those  colonies  which  failed  to  grow  on  CSM  but  grew  on  BGA. 
The  nutritional  requirement  of  each  presumptive  auxotroph  was  characterized  by 
restreaking  on  a  series  of  CSM  plates,  each  of  which  contained  a  combination 
of  amino  acids,  purines  and  pyrimidines  (see  Appendix  2).  Amino  acids,  purines 
and  pyrimidines  were  each  present  in  the  pools  at  concentrations  of  0.2%  and 
lOOul  amounts  were  spread  on  a  CSM  plate,  giving  a  'pool  plate'  which  contained 
approximately  lOpg  ml-1  of  each  amino  acid  in  the  pool. 
2.2.5  Transformation  procedures 
100ml  of  Cohen  and  Wheeler  medium  was  inoculated  from  a  BGA  plate  on  which 
a  recipient  strain  had  been  grown  from  a  freeze-dried-cülture.  The  Cohen  and 
Wheeler  medium  contained  casein  hydrolysate,  1%  w/v  and  was  incubated  at  37°C 
for  18-30h.  This  gave  the  pre-culture  from  which  10ml  aliquots  were  trans- 
ferred  to  several  flasks  each  containing  100ml  of  Cohen  and  Wheeler  medium, 
containing  varying  amounts  (0.03%  to  1%  w/v)  of  casein  hydrolysate.  This  was 
followed  by  a  further  incubation  period  of  30h  to  allow  the  development  of 
competence.  At  the  end  of  this  incubation,  2m1  samples  from  each  culture  were 
centrifuged  at  2900xg  for  20  min  at  4°C  and  the  pellet  was  resuspended  in  10ml 
Cohen  and  Wheeler  medium  containing  the  same  casein  hydrolysate  concentration 
as  had  been  used  previously.  2ml  of  this  suspension  was  treated  with  donor 
DNA  (final  concentration  5pg  ml-1)  and  incubated  at  37°C  for  10h,  to  allow 
incorporation  of  DNA.  After  this  time,  100u1  was  spread  on  BGA  containing 
streptomycin  (20opg  ml-1)  and  incubated  for  4-5  days  at  37°C  to  allow  growth 
of  StrR  transformants. 63 
2.2.6  Effect  of  calcium  chloride  on  transformation. 
From  the  pre-culture,  0.2m1  aliquots  were  transferred  to  4x  1/2"  test 
tubes  and  calcium  chloride  (10%  or  1%  solution)  sterilised  by  membrane  filtra- 
tion,  was  added  to  give  a  range  of  concentrations  from  10 
1M 
to  10 
4M. 
These 
cells  were  chilled  on  ice  for  2h  after  which  donor  DNA  was  added  to  a  final 
concentration  of  5pg  ml-1.  This  was  followed  by  a  further  40  min  on  ice, 
then  5Opl  of  cell  suspension  was  transferred  to  2ml  of  fresh  Cohen  and  Wheeler 
medium  and  incubated  at  37°C  for  24h  without  shaking.  l00u1  from  each  sus- 
pension  was  then  spread  on  BGA  containing  streptomycin  (200pg  ml-1)  and 
incubated  at  370C  for  4-5  days. 
2.2.7  Plasmid  transfer  procedures. 
Donor  and  recipient  E.  coli  were  grown  in  25m1  amounts  of  nutrient  broth 
overnight  at  37°C,  with  shaking.  The  donor  culture  contained  tetracycline  to 
maintain  the  plasmid  (10pg  ml-1)  or  kanamycin  (20pg  ml-1). 
i)  Filter  matings. 
Donor  and  recipient  E.  coli  strains  were  mixed  in  a  1:  5  ratio  and  passed 
through  an  Oxoid  membrane  filter  (47mm  x  0.45µm  pore  diameter)  under  negative 
pressure.  A  similar  volume  of  donor  and  recipient,  filtered  separately, 
acted  as  controls.  Filters  were  transferred  to  nutrient  agar  plates  and 
incubated  at  37°C  overnight.  The  growth  was  resuspended,  using  a  sterile 
glass  rod  in  2m1  of  sterile  saline  (0.85%  w/v)  from  which  10-fold  dilutions  were 
made  in  sterile  saline.  For  selection  of  transconjugants  and  determination 
of  recipient  viable  count,  50111  amounts  of  each  dilution  was-spread  on  nutrient 
agar  plates  containing  antibiotics  at  the  following  concentrations 
kanamycin  -  20pg  ml-1,  carbenicillin  -  50ug  ml-1,  streptomycin  -  200pg  ml-1. 
For  determination  of  chromosomal  mobilisation  frequency,  nutrient  agar  con- 
taining  nalidixic  acid  (40ug  ml-1)  and  streptomycin  was  used. 64 
For  filter  matings  between  E.  coli  and  B.  pertussis  filters  were  incubated 
on  BGA  and  transconjugants  were  selected  on  BGA  containing  antibiotics.  The 
donor:  recipient  ratio  was  1:  10  and  filters  were  incubated  for  48h.  Selection 
plates  were  incubated  for  4-5  days  at  37°C. 
ii)  Broth  matings. 
Donor  and  recipient  E.  coli  were  grown  as  before.  From  each,  a1  in  20 
dilution  was  made  in  fresh  nutrient  broth  and  incubated  for  a  further  3h  at 
37°C.  Donor  and  recipient  were  then  mixed  in  equal  volumes  and  the  mixture 
diluted  by  transferring  1ml  to  1ml  of  fresh  nutrient  broth.  This  was  incubated 
at  37°C  for  6h.  Transconjugants  were  selected  by  spreading  50p1  of  the  mating 
mixture  on  nutrient  agar  containing  antibiotics  as  described  previously.  On 
occasion,  the  mating  mixture  was  supplemented  with  agar,  0.1%  (Oxoid  Agar 
Technical  No.  3)  to  facilitate  enhanced  plasmid  transfer  (Groot  Obbink  and 
Ackerman,  1980). 
iii)  Plate  matings. 
These  were  carried  out  by  the  method  of  Bradley  et  al.  (1981).  Donor 
and  recipient  E.  coli  were  mixed  initially  in  various  ratios,  to  determine  the 
optimum  ratio  for  plasmid  transfer.  0.3m1  of  the  mating  mixture  was  spread 
on  nutrient  agar  and  allowed  to  dry  at  room  temperature.  The  plates  were  then 
incubated,  surface  uppermost,  for  4-6h  at  37°C.  Following  incubation,  growth 
was  resuspended  in  2m1  of  sterile  saline.  The  suspension  was  transferred  to 
a  sterile  4x  1/2"  test  tube  and  10-fold  dilutions  made,  from  which  50111  of 
each  dilution  was  spread  on  NA  containing  antibiotics  as  before. 
Plate  matings  which  used  E.  coli  K12  as  recipient  and  an  auxotrophic 
donor  were  modified.  Following  resuspension  of  growth  from  the  mating  plate, 
the  mixture  was  centrifuged  at  2900xg  (MSE  Bench  Centrifuge).  The  pellet  was 
resuspended  in  1ml  of  sterile  saline  and  transconjugants  of  K12  selected  by 65 
spreading  50p1  of  each  10-fold  dilution  on  ECMA  containing  kanamycin 
(20pg  ml-1)  and  carbenicillin  (50pg  ml-1).  Mobilisation  of  streptomycin 
resistance  from  the  donor  was  detected  by  spreading  the  mating  mixture  on 
ECMA  containing  streptomycin  (200pg  ml-1)  and  kanamycin  (20pg  ml-1). 
Plate  matings  between  E.  coli  and  B.  pertussis  were  carried  out  in  a 
similar  fashion.  B.  pertussis  was  grown  in  Cohen  and  Wheeler  medium  for  48h 
and  was  mixed  in  a  1:  1  ratio  with  E.  coli  donor.  Mating  was  performed  by 
spreading  0.4m1  of  the  mixture  on  BGA  containing  cephalexin  (40pg  ml-1)  and 
incubating  at  37°C  for  24h.  A  modification  of  the  procedure  was  that  0.4m1 
of  the  48h  recipient  B.  pertussis  was  plated  on  BGA  and  incubated,  surface 
uppermost,  for  48h  at  37°C.  0.4m1  of  an  overnight  E.  coli  donor  was  spread 
on  the  B.  pertussis  lawn,  and  incubation  continued  for  a  further  4-6h  at  37°C. 
The  resulting  growth  was  resuspended  in  2m1  saline  and  transconjugants  were 
selected  on  BGA  containing  kanamycin  (20pg  ml-1),  carbenicillin  (50pg  ml-1) 
and  streptomycin  (200pg  ml-1).  For  plate  matings  between  strains  of  B.  pertussis 
and  between  B.  pertussis  and  B.  parapertussis,  a  1:  1  donor/recipient  ratio  was 
used,  O.  4m1  was  spread  on  BGA  and  transconjugants  were  selected  after  48h 
incubation.  For  selection,  BGA  contained  the  following  antibiotics  - 
kanamycin  -  20pg  ml-1,  carbenicillin  -  50pg  ml-1,  streptomycin  -  200pg  ml-I 
nalidixic  acid  -40pg  ml-1,  chloramphenicol  -  lOpg  ml-1,  erythromycin  -  0.3pg  ml-1, 
rifampicin  -  10ug  ml- 
For  selection  of  recombinant  prototrophs  of  B.  pertussis  CSM  containing 
BSA  (0.05%  w/v),  streptomycin  (200pg  ml-1)  or  nalidixic  acid  (40pg  ml-1)  was 
used.  Casamino  acids  was  not  included. 66 
2.2.8  Determination  of  plasmid  transfer  and  chromosome  mobilisation 
frequencies  and  spontaneous  mutation  frequencies. 
Plasmid  transfer  frequencies  were  expressed,  in  all  experiments,  as  the 
number  of  transconjugants  divided  by  the  total  recipient  viable  count. 
Chromosome  mobilisation  frequency  was  expressed,  in  all  cases,  as  the  number 
of  recombinants  carrying  the  mobilised  marker  divided  by  the  total  viable 
count. 
Spontaneous  mutation  rates  were  obtained  from  the  control  plates.  In 
all  experiments,  donor  and  recipient  strains  were  plated  separately  on  the 
mating  medium  and  resuspended  and  spread  on  selective  media  as  for  the  test 
plates.  Mutation  rates  were  expressed  as  a  fraction  of  the  total  viable 
count  of  the  donor  or  recipient.  In  cases  where  mutation  rates  are  expressed 
as  being  less  than  a  given  value,.  this  signifies  that  in  100pl  of  an 
undiluted  bacterial  suspension  from  the  control  plate,  less  than  one  colony 
has  grown  on  the  selective  medium.  Therefore,  the  spontaneous  mutation  rate 
is  less  than  10  c.  f.  u.  ml-l  divided  by  the  total  viable  count. 
2.2.9  Restriction  enzyme  analysis  of  DNA. 
Plasmid  DNA  was  digested  with  restriction  endonuclease  enzymes'EcoRI 
and  HindIIl.  (Bethesda  Research  Laboratories,  Maryland,  U.  S.  A.  ).  The  enzymes 
were  obtained  from  the  manufacturer  as  concentrated  solutions  (10  units  ul-1) 
and  an  enzyme  mix  was  made  before  use  consisting  of  concentrated  enzyme  (2u1) 
distilled  water  (36'.  5p1)  and  BRL  Core  Buffer  (14il).  15pl  of  this  was  added 
to  25u1  of  plasmid  DNA  and  incubated  at  37°C  for  2-3h,  the  final  concentration 
of  each  enzyme.  being  about  3  units.  Restriction  fragments  were  visualised 
by  agarose.  gel  electrophoresis. 
Chromosomal  DNA  prepared  from  strains  of'  B.  'pertüSsis  and'B.  pärapertüssis 
was  digested  with'HindIIl.  An  enzyme  mix  was  prepared  by  adding  2ul 67 
of  undiluted  enzyme  to  18il  of  BRL  Core  Buffer.  The  digestion  mixture 
contained  10u1  of  sterile  distilled  water,  2pl  of  BRL  Core  Buffer,  5pl  of 
DNA  and  2pl  of  diluted  enzyme.  Following  incubation  at  37°C  for  2-3h 
restriction  fragments  were  visualized  by  agarose  gel.  electrophoresis. 
2.2.10  Agarose  gel  electrophoresis. 
Electrophoresis  of  DNA  was  performed  in  agarose  gels.  For  visualis- 
ation  of  whole  plasmids,  0.6%  gels  were  used  while  electrophoresis  of  digested 
plasmid  and  chromosomal  DNA  was  performed  in  0.7%  gels.  An  LKB  2117  multi- 
phor  gel  system  (Bromma,  Sweden)  was  used,  consisting  of  a  horizontal  gel 
and  continuous  buffer  system.  The  running  buffer  used  was  GGB  which  was 
made  up  as  20x  normal  strength.  (Tris  96.88g/l,  Na  acetate  32.8g/l,  EDTA 
5.84g/l  adjusted  to  pH  8.3  with  acetic  acid). 
Gels  were  prepared  by  adding  the  appropriate  weight  of  agarose  (Sigma, 
Type  IV)  to  5ml  of  GGBx20  and  95m1  of  distilled  water,  and  steaming  for  10  min 
to  dissolve  the  agarose.  Before  pouring,  ethidium  bromide  (5mg  ml 
1) 
was 
added  to  a  final  concentration  of  0.5ug  ml-l. 
2Oµ1  volumes  of  sample  were  added  to  the  wells  and  electrophoresis  was 
carried  out  at  lOmA  overnight  for  whole  plasmids,  or  at  50-6OmA  for  several 
hours  for  digested  DNA.  Following  electrophoresis,  DNA  was  visualised  by 
U.  V.  light,  using  a  long  wave  transilluminator  (Ultra-Violet  Products  Inc. 
California,  U.  S.  A.  )  and  gels  were  photographed  using  a  Polaroid  800  Camera 
containing  Type  47  film  with  a1  second  exposure  time. 
2.2.11  Induction  of  lysogenic  bacteriophage  from'B.  pertussis. 
Attempts  to  detect  the  presence  of  a  lysogenic  bacteriophage  in'B.  pertus$is 
were  carried  out  using  an  agarose  overlay  technique.  '  'B.  '  pertüssis  strain  134 
and  B.  parapertüssis  10520  were  grown  in  Cohen  and  Wheeler  medium  as  described 68 
previously.  Mitomycin  C  (Sigma)  was  added  to  B.  pertussis  at  final  concen- 
trations  of  1,5  and  long  ml-1  and  incubation  at  37°C  was  continued  for  a 
further  20  min,  1-Y  h  and  2-5*.  h.  Cells  were  removed  by  centrifugation  (20,000xg 
for  1  min  in  Sarstedt  Microfuge)  and  the  supernate  from  each  culture  was  filtered 
through  a  0.45Tim  filter  ,  (Sartorius  Minisart  NML).  As  a  control  the  same  pro- 
cedure  was  carried  out  without  the  addition  of  Mitomycin  C.  3m1  amounts  of 
agarose  1%  (Sigma,  Type  IV)  were  dispensed  in  4x  1/2"  test  tubes,  melted 
before  use  and  maintained  at  40°C.  To  each  tube,  0.  lml  of  maltose,  20%  (Koch- 
Light  Laboratories  Ltd.  Buckinghamshire),  0.  lml  of  B.  parapertussis  indicator 
bacteria  and  0.  lml  of  B.  pertussis  phage  lysate  were  added,  having  been  pre- 
warmed  to  40°C  before  addition.  The  contents  of  the  tube  were  mixed  and 
poured  over  the  surface  of  a  nutrient  agar  plate,  giving  an  even  overlay  which 
was  left  to  solidify  at  room  temperature.  Plates  were  incubated  at  37°C  for 
24-48h  after  which  time  any  lytic  phage  present  would  produce  plaques  on  the 
B.  parapertussis  lawn. 
2.3  OTHER  MATERIALS  AND  METHODS 
2.3.1  DNase  test  for  B.  pertussis 
The  method  of  testing  for  DNase  production  by  B.  pertussis  was  a  modif- 
ication  of  that  of  Jeffries  et  al.  (1957).  Cyclodextrin  Solid  Medium  was 
supplemented  by  the  addition  of  42g1-1  of  DNase  Test  Agar  (Difco).  Agar  Tech- 
nical  No.  3  was  omitted  from  CSM.  Test  organisms  were  streaked  on  the 
medium  and  plates  were  incubated  at  37°C  for  48h.  The  plates  were  then 
flooded  with  1N  HC1  to  precipitate  nucleic  acids.  DNase  activity  was 
observed  as  a  zone  of  clearing  of  the  precipitate  round  the  bacterial  growth. 69 
2.3.2  Sodium  dodecyl  sulphate  polyacrylamide  gel  electrophoresis  (SDS-PAGE). 
Whole  cells  were  prepared  for  SDS-PAGE  by  harvesting  from  lud  of  48h 
liquid  cultures  in  a  Sarstedt  Microfuge.  The  cells  were  washed  once  in 
saline  and  resuspended  to  an  optical  density  of  0.8  at  600nm  wavelength 
(Pye-Unicam  SP6-500  Spectrophotometer).  100pi  of  cell  suspension  was  trans- 
ferred  to  lml  solubilising  buffer  (125mM  Tris-HC1  pH  6.8;  SDS  4%  w/v; 
ß-mercaptoethanol  10%  v/v;  glycerol  20%  v/v;  bromophenol  blue  0.002%  w/v) 
and  heated  in  a  boiling  water  bath  for  5  min.  Alternatively,  a  dense  cell 
suspension  was  made  in  solubilising  buffer  directly  from  growth  on  a  BGA  plate. 
Stacking  gels  contained  3-4m1  of  acrylamide  (30%  v/v);  5.  Oml  of  0.5M  Tris-HC1 
pH  6.8;  100  ill  of  SDS  (20%  w/v);  2S4  of  TEMED;  2ml  of  ammonium  persulphate 
(1%  w/v)  and  9.5m1  of  water.  Separating  gels  contained  27.5ml  of  acrylamide 
(30%  v/v);  28.1ml  of  1M  Tris-HC1  pH  8.8;  375iil  of  SDS  (20%  w/v);  19111  of  TEMED; 
7.5m1  of  ammonium  persulphate  (1%  w/v)  and  11.5ml  of  distilled  water.  TEMED 
is  N,  N,  N',  N',  -Tetramethyl  ethylenediamine.  25-50111  of  sample  was  loaded  into 
each  well  and  electrophoresis  was  carried  out  at  l5mA  for  21-3h.  Gels  were 
immersed  in  staining  /fixing  solution  for  60-90  min.  This  contained  Coomassie 
Blue  R250  (1.25g),  46m1  of  glacial  acetic  acid  and  454ml  of  50%  methanol  (v/v). 
Gels  were  destained  by  soaking  in  several  changes  of  destaining  solution  con- 
taining  50ml  methanol;  75m1  glacial  acetic  acid  and  875m1  of  distilled  water. 
For  molecular  weight  comparisons,  a  mixture  of  marker  proteins  (200ug  ml 
-1 
final  concentration)  was  in  each  gel.  The  mixture  contained  BSA  (MW 
66000),  ovalbumin  (45000),  pepsin  (34700),  trypsinogen  (24000),  ß-lacto- 
globulin  (18400)  and  lysozyme  (14300). 70 
2.3.3  Measurement  of  phagocytosis  by  chemiluminescence. 
Bacteria  were  grown  on  nutrient  agar  (E.  coli)  or  BGA'(B.  'pertüssis) 
containing  streptomycin  (200pg  ml-1),  giving  a  lawn  of  bacteria.  Following 
incubation,  growth  was  resuspended  in  2m1  of  Hepes-buffered-saline  (HBS) 
(Appendix  3)  and  transferred  to  a  universal  bottle.  The  volume  was  adjusted 
to  3ml  with  HBS  and  cell  suspensions  were  standardised  to  an  Optical  Density 
of  0.8  at  600nm  (Pye-Unicam  SP6-550  Spectrophotometer). 
Polymorphonuclear  leucocytes  were  obtained  by  injecting  New  Zealand  white 
rabbits  intraperitoneally  with  500ml  of  0.85%  (w/v)  saline  containing  glycogen 
0.1%  w/v  (Sigma).  The  peritoneal  exudate  was  drained  off  5h  later  and  was 
stored  at  4°C  overnight.  The  exudate  was  used  within  3  days  of  isolation. 
Before  use,  the  phagocytic  cells  were  washed  once  in  divalent  cation-free 
HBS-EDTA  (Appendix  3)  then  in  HBS.  Contaminating  erythrocytes  were  removed 
after  the  first  wash  by  hypotonic  lysis.  Washed  cells  were  used  within  2h 
of  preparation.  Cell  suspensions  contained  over  95%  neutrophils  and  cell 
viability  was  greater  than  95%,  as  determined  by  Trypan  Blue  exclusion. 
Phagocytosis  of  whole  bacteria  was  measured  by  chemiluminescence  using  an 
LKB  Luminometer  connected  to  a  BBC  Acorn  Microcomputer.  Before  use  bacterial 
suspensions  were  diluted  1  in  3  and  kept  on  ice.  The  neutrophil  count  was 
adjusted  to  2x  106  cells  ml-1  with  HBS.  The  experimental  mixture  contained 
100pl  of  test  agent  (bacteria),  500ul  of  neutrophil  cell  suspension,  3Oµ1  of 
HBS  and  70pl  of  luminol  (10 
4M 
final  concentration)  (5-amino-2,3-dihydro-1, 
4-phthalazinedione)  (Sigma).  Before  the  addition  of  luminol  and  test  agent, 
phagocytes  were  pre-incubated  for  5  min  at  37°C.  All  chemiluminescence 
studies  were  carried  out  at  37°C.  The  count  time  of  each  sample  was  30  sec 
and  duplicate  counts  were  taken  over  90  min. 71 
3.  RESULTS 72 
3.1  Development  of  media  for  growth  and  selection  of  recombinant 
and  auxotrophic  organisms. 
31.1  B.  pertussis 
In  developing  a  gene  transfer  system,  various  types  of  media  which  are 
suitable  for  the  selection  of  transconjugants  and  recombinants  of  the  organism 
under  study  are  required.  With  B.  pertussis,  development  of  such  media  has 
to  take  into  account  the  fastidious  nature  of  the  organism  and  its  sensitivity 
to  inhibition  by  fatty  acids  in  the  medium.  Bordet-Gengou  Agar  (BGA)  is  the 
medium  used  for  routine  growth  of  B.  pertussis  but  is  unsuitable  for  isolation 
of  auxotrophic  mutants.  Although  BGA  was  used  in  this  study  to  obtain  plasmid 
carrying  transconjugants,  it  could  not  be  used  as  a  selective  medium  in  the 
study  of  mobilisation  of  donor  nutritional  markers.  Therefore,  for  these 
purposes,  development  of  a  suitable  minimal  medium  was  a  priority. 
Initial  attempts  to  grow  phase  I  B.  pertussis  on  Cohen  and  Wheeler  medium 
or  Stainer  and  Scholte  medium,  solidified  by  addition  of  1%  Agar  Technical  No.  3 
(Oxoid)  proved  unsuccessful.  Imaizumi  et  al.  (1983)  used  a  solid  medium, 
based  on  Stainer  and  Scholte  medium,  but  containing  1mg  ml-1  (Heptakis  (2-6-0 
Dimethyl)  ß-Cyclodextrin  (MeßCD),  to  allow  growth  of  colonies  of  B.  pertussis 
from  small  inocula.  Therefore,  MeßCD  was  incorporated  in  Stainer  and  Scholte 
Medium  at  a  concentration  of  1mg  ml-1.  The  medium  was  solidified  by  addition 
of  1.5%  w/v  Agar  (Oxoid).  To  determine  how  efficiently  the  medium  supported 
growth  of  B.  pertussis  l00u1  of  a  series  of  10-fold  dilutions  made  from  a  sus- 
pension  of  approximately  109  cells  ml-1  of  strain  Tohama  was  spread  on  each  of 
the  following  types  of  medium 
i.  BGA 
ii.  CSM 
iii.  CSM  containing  Casamino  acids  (CAA)  (Casein  hydrolysate) 
iv.  CSM  containing  CAA  and  bovine  serum  albumin  (BSA  0.15%) 
V_.  CSM  containing  BSA  alone. 73 
Table  1.  Comparison  of  ability  of  BGA  and  CSM  to  support  B:!  pertüssis 
growth  from  small  inocula.  100  Iii  aliquots  of  10-5  and  10-7 
dilution  of  a  suspension  of  strai  n  Tohama  was  spread  on  each 
type  of  medium.  Results  are  the  number  of  cells  per  ml  which 
are  capable  of  growth  on  each  med  ium.  Efficiency  of  plating 
(EOP)  is  defined  as  viable  count  on  each  type  of  medium  divided 
by  viable  count  on  BGA  multiplied  by  100. 
cf.  u.  ml-1  at  di  lutions  of 
10-5  10-7 
Medium 
f  l-1  EOP  %  f  l-1  c  um  um  c  EOP  % 
BGA  1.82  x  109  100  2.4  x  109  100 
CSM  6x  106  0.33  00 
7.1  x  108  39  ý'ý0  x  108  16.6  Casamino  Acids 
1  44  109  79  7  0 
8 
BSA  +  CAA  .  x  .  x  10  29.1 
CSM  +  BSA 
9.8  x  108  53.8  6  0x  108  25  only  . 
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After  4-5  days  incubation  of  plates  at  37°C,  the  number  of  colonies  on 
each  was  counted  and  the  efficiency  of  plating  (EOP)  determined.  This  was 
expressed  as  a  percentage  value  of  the  number  of  colonies  on  BGA,  for  each 
type  of  medium  (Table  1).  CSM  without  addition  of  BSA  or  Casamino  Acids 
supported  growth  from  single  colonies  at  a  much  lower  level  than  BGA. 
Addition  of  Casamino  Acids  increased  the  EOP  value  about  100  fold  to  about 
39%.  When  BSA  was  added  to  the  medium  in  the  presence  of  Casamino  Acids, 
a  higher  EOP  was  obtained,  and  colonies  grew  at  a  faster  rate,  taking  about 
3  days  to  develop,  as  opposed  to  the  4  or  5  days  in  the  absence  of  BSA.  If 
CSM  was  to  be  used  as  a  minimal  medium  for  B.  pettussis,  then  Casamino  Acids 
had  to  be  omitted  since  it  contained  a  heterogenous  mixture  of  amino  acids 
which  would  permit  growth  of  auxotrophs.  Therefore,  in  order  to  produce  good 
growth  of  single  colonies  on  a  defined  medium,  CSM  containing  0.15%  BSA  was 
found  to  be  the  medium  of  choice  since  it  produced  a  high  EOP  and  colonies  grew 
in  3-4  days.  It  may  be,  however,  that  this  concentration  of  BSA  would  provide 
a  sufficient  amino  acid  supply  to  allow  an  auxotrophic  mutant  to  overcome  the 
mutation  and  behave  as  a  prototroph.  Therefore,  the  minimum  concentration  of 
BSA  which  would  allow  growth  of  B.  pertussis  was  determined.  Since  no 
auxotrophic  mutant  of  B.  pertussis  with  which  the  medium  could  be  tested  was 
available,  at  this  stage,  an  auxotrophic  strain  of  E.  coli  which  produced  small 
colonies  on  CSM  +  CAA  was  tested  in  parallel  with  the  B.  pertussis  prototrophic 
strain  (Table  2).  Cultures  were  grown  and  standardised  as  described  previously 
and  100PI  of  each  of  a  series  of  10-fold  dilutions  was  plated  on  CSM  containing 
a  range  of  BSA  concentrations  from  0  to  0.2%  (w/v).  Following  incubation,  the 
auxotrophic'E:  'coli  strain  could  not  grow  on  CSM  in  the  absence  of  Casainino  Acids, 
but  B.  pertusgis  growth  was  supported  by  a  minimum  BSA  concentration  of  0.05%. 
Lower  concentrations  were  not  tested.  B.  pertüssis  failed  to  grow  when  BSA 
was  omitted  from  the  medium. 75 
Table  2.  Determination  of  BSA  requirement  of  B.  pertussis  Tohama,  and  an 
E.  coli  auxotroph  for  growth  on  CSM.  100  ul  aliquots  of  10-6 
and  10-7  dilutions  of  a  suspension  of  B.  yertussis  Tohama  or  a 
10-7  dilution  of  E.  coli  JC3272  were  spread  on  CSM  containing 
various  BSA  concentrations. 
Strain  Dilution 
B.  pertussis 
Tohama 
E.  coli 
JC3272 
Number  of  colonies  at  the  following 
BSA  concentration  (%  w/v) 
0  0.05  0.1  0.15  0.2 
0  459  448  488  354  10_6 
10-7 
10-7 
0  38 
00 
41  44  39 
0  0  0 76 
CSM  containing  0.05%  BSA,  but  without  the  addition  of  Casamino  Acids 
was  subsequently  used  in  two  experimental  procedures;  a)  To  isolate'B.  pertussis 
auxotrophic  mutants  and  b)  To  obtain  prototrophic  recombinants  carrying  mobil- 
ised  chromosomal  markers,  in  gene  transfer  experiments. 
3.1.2  B.  parapertussis 
To  allow  the  selection  of  plasmid  carrying  transconjugants  of'B.  'para- 
p  ertussis  or  strains  carrying  mobilised  antibiotic  resistance  markers,  a 
suitable  selection  mechanism  was  required.  Several  types  of  media  were  studied 
for  their  ability  to  support  single  colony  growth  of  'B.  'parapertussis  while 
failing  to  support  growth  of  '  B:  'pertussis.  The  media  studied  were  BGA,  nutrient 
agar;  E.  'coli  Minimal  Agar  (ECMA),  Stainer  and  Scholte  Agar  (SSA)  and  MacConkey 
Agar.  From  a  cell  suspension  standardised  as  before,  50pl  of  10-fold  dilutions 
were  spread  on  each  type  of  medium.  Single  colony  growth  of  B.  '  parapertussis 
was  supported  by  BGA,  SSA  and  MacConkey  Agar,  but  growth  on  MacConkey  Agar  was 
not  as  efficient  as  on  the  other  media  since  only  a  fraction  of  the  total 
viable  count,  by  comparison  with  growth  on  BGA,  was  supported  by  MacConkey  Agar. 
Growth  on  SSA  was  more  efficient  than  on  MacConkey  Agar  giving  a  viable  count 
which  was  about  one-third  of  that  obtained  on  BGA.  However,  only  very  small 
colonies  were  supported  by  this  medium.  Growth  on  nutrient  agar  was  at  a 
higher  plating  efficiency  than  that  of  MacConkey  Agar  while  ECMA  failed  to 
support  growth  of  B.  parapertussis. 
It  was  observed  that  colonies  which  grew  on  MacConkey  Agar  produced,  after 
about  6  days  incubation,  outgrowths  from  the  periphery  of  the  colony  giving  a 
star-like  appearance.  To  determine  if  growth  on  MacConkey  Agar  gave  rise  to 
a  variant  of'B.  'parapertüssis,  a  single  colony  from  a  MacConkey  plate  was 
inoculated  into  Cohen  and  Wheeler  broth  and  incubated  for  48h  at  37°C. 
Cell  suspension  was  standardised  as  before,  and  50u1  from  the  10-6  dilution 77 
was  spread  on  each  type  of  medium  under  study.  The  efficiency  of  plating 
on  each  type  of  medium  was  determined  (Table  3).  EOP  on  MacConkey  Agar  was 
much  increased,  and  EOP  on  SSA  and  MacConkey  was  higher  than  on  nutrient  agar. 
Thus,  not  all  B.  parapertussis  capable  of  growth  on  BGA  can  grow  on  MacConkey 
Agar  which  may  select  for  variants  within  the  population.  To  test  this  hypo- 
thesis,  50  colonies,  originally  grown  on  BGA,  were  restreaked  on  MacConkey  Agar. 
Only  two  were  capable  of  growing  on  this  medium. 
MacConkeys  Agar,  SSA  and  nutrient  agar,  therefore,  whilst  being  suitable 
for  use  as  selective  media  in  plasmid  transfer  and  chromosomal  mobilisation 
studies  using  B.  parapertussis  recipients,  appear  to  be  selective  for  variants 
in  the  population,  which  would  interfere  with  accurate  determination  of  transfer 
and  recombination  frequencies.  A  more  suitable  selection  mechanism  would  be 
to  make  use  of  an  intrinsic  antibiotic  resistance  marker  in'B.  päräpertüssis, 
with  selection-of  transconjugants  and  recombinants  on  BGA  containing  this 
antibiotic.  Such  an  intrinsic  resistance  was  subsequently  shown  to  exist  in 
B.  parapertussis  strain  10520. 
3.2  Isolation  of  antibiotic  resistant  mutants  of  B.  '  'pertussis. 
Using  the  NTG  disk  method,  nalidixic  acid  resistant  colonies  of'B.  pertussis 
strain  Tohama  were  obtained  (Table  4).  That  the  mutants  obtained  were 
B.  pertussis  was  confirmed  by  their  inability  to  grow  on  nutrient  agar,  Gram- 
stain  and  agglutination  in  antiserum.  Whole  cell  SDS-PAGE  analysis  of  Tohama 
mutants  and  parent  strain  revealed  differences  from  strain  18334  (Figure  2). 
Tohama  strains  lacked  the  28  and  30,  KD  protein  bands  while  a  low  molecular 
weight  band,  present  in  Tohama,  was  reduced  in  18334.  However,  subsequent 
studies  have  failed  to  confirm  this.  Tohama,  however,  exhibited  normal  Phase  I 
properties  in  being  unable  to  grow  on  Nutrient  Agar,  and  agglutinating  with 
anti-Phase  I  antiserum.  Growth  on  nalidixic  acid  was  compared  for  mutant 78 
Table  3.  Efficiency  of  plating  of  B.  parapertussis  10520  on  various 
media,  using  colonial  variant  initially  isolated  by  growth 
on  MacConkey  agar.  *Efficiency  of  Plating  (EOP)  is  the  viable 
count  on  each  medium  divided  by  viable  count  on  BGA, 
expressed  as  a  percentage. 
c.  f.  u  ml-1  at  dilution  of  10-6 
Medium  cfu  ml-1  EOP*  (%) 
BGA  6.64  x  109  100 
MacConkey  Agar  5.96  x  109  r1O 
.__ 
Stainer  &  Scholte  5.04  x  109  -is 
-_ 
Agar 
ECMA  0  0 
Nutrient  Agar  4.40  x  109  66 79 
Table  4 
Strain 
Tohama 
L84  I 
D30042 
Taberman 
Isolation  of  B.  pertussis  resistant  mutants  by  NTG 
mutagenesis.  Results  are  the  number  of  resistant  colonies 
of  each  strain  which  grew  around  an  NTG  soaked  paper  disk. 
Number  of.  colonies  resistant':  to 
Rifampicin  Streptomycin  Nalidixic 
acid 
006 
007 
04  14 
000 
Chloramphenicol 
0 
0 
0 
0 80 
and  parent  strains  (Table  5).  These  mutants  were  designated  BPN1  to  BPN6. 
BPN6  was  used  for  subsequent  genetic  studies. 
The  procedure  was  repeated  using'B;  'pertussis  Taberman,  D30042  I  and 
L841.  Nalidixic  acid  resistant  mutants  of  Taberman  were  obtained  and  des- 
ignated  BPT  1  to  8  (Table  5).  L841  also  yielded  nalidixic  acid  resistant  mutants 
while  D30042  yielded  streptomycin  resistant  colonies  designated  CSP1  to  4. 
CSP1  was  used  for  further  study. 
The  procedure  was  repeated  using  rifampicin,  erythromycin  and  chloram- 
phenicol  as  selective  antibiotics,  but  no  mutants  resistant  to  these  antibiotics 
were  obtained. 
3.3  Isolation  of  B.  pertussis-auxotrophic  mutants. 
Isolation  of  auxotrophic  mutants  of  B.  pertussis  was  carried  out  using 
strains  BPN6,  CSP1,  Taberman  P3  and  L841.  The  NTG  treatment  and  penicillin 
enrichment  procedure  was  used  and  CSM  was  used  to  screen  for  auxotrophic  pro- 
perties  and  nutritional  requirements.  However,  the  procedure  proved  to  be 
unsuitable  for  auxotroph  isolation  using  Taberman  P3,  as  CSM  did  not  support 
growth  of  either  presumptive  auxotrophs  or  of  the  wild-type  prototroph.  L841 
was  unsuitable  also,  since  it  was  resistant  to  the  concentration  of  penicillin  G 
which  was  used  in  the  enrichment  procedure. 
Using  strain  CSP1  25  presumptive  auxotrophs  were  obtained  from  a  total 
of  300  colonies  screened.  By  restreaking  each  colony  on  CSM  amino  acid  pool 
plates  19  of  these  were  subsequently  shown  to  be  prototrophic  by  their  ability 
to  grow  on  all  pools  and  on  CSM  without  addition  of  amino  acids. 
The  remaining  colonies  grew  only  on  particular  amino  acid  pools.  Mutants  8, 
10,18  and  21  appeared  to  carry  multiple  auxotrophic  mutations,  but  mutant  24 
grew  only  on  pools  5  and  7  indicating  that  it  was  deficient  in  glycine  pro- 
duction  (Gly  j.  Mutant  11  grew  only  on  pools  8  and  2  indicating  that  it  was 81 
Table  5.  Growth  of  B.  pertussis  Na1R  mutants  on  various  concentrations 
of  nalidixic  acid.  +-  growth 
±-  poor  growth  -  no  growth. 
Bacterial  growth  at  nalidixic  acid  concentration  of 
(u9  ml- 
Strain  20  40  60  80  100 
Tohama  1  +  +  +-- 
2  +  +  +-- 
3  +  +  +-- 
4  +  +  +-- 
5  +  +  +-- 
6  +  +  +-- 
Parent  -  -  --- 
Taberman  1  +  +  +-- 
2  +  +  +-- 
3  +  +  +-- 
4  +  +  +-- 
5  +  +  +-- 
6  +  +  +-- 
3  +  +  +-- 
8  +  +  +-- 
Parent  -  -  --- Figure  2:  SDS-PAGE  analysis  of  whole  cells  of  Tohama  parent, 
Na1R  mutant  and  18334  strains. 
Tracks  1  and  2-  18334 
Toka+Ma  paºýcf  aº"ºd 
Tracks  3-6  -  mutants  BPN  2,4  and  6 82 
i.  ýf  rýic 
ýýýy  ý 
123456 83 
deficient  in  tryptophan  production  (Trp  ).  Mutant  24  (Gly  )  could  not  grow 
in  Stainer  and  Scholte.  liquid  medium  without  the  addition  of  glycine  (0.02%  ) 
whilst  mutant  11  (Trp)  would  not  grow  in  Stainer  and  Scholte  liquid  medium 
unless  tryptophan  was  present  in  the  medium.  These  auxotrophs  were  tested 
for  their  ability  to  grow  on  CSM  in  the  presence  of  varying  concentrations  of 
BSA,  and  in  the  presence  and  absence  of  glycine  or  tryptophan.  (Tables  6&  7). 
A  suspension  of  about  109  cells  ml-1  was  washed  once  in  sterile  saline  and  from 
a  series  of  10-fold  dilutions,  100pl  was  spread  on  BGA,  CSM  (without  any  amino 
acid  content)  CSM  with  various  BSA  concentrations,  and  CSM  containing  glycine 
or  tryptophan.  Auxotroph  24  (Gly  )  failed  to  grow  unless  CSM  was  supplemented 
with  glycine  whilst  auxotroph  11  (Trp  )  grew  only  in  the  presence  of  tryptophan. 
Low  concentrations  of  BSA  failed  to  support  growth  of  auxotrophic  mutants. 
Thus,  these  auxotrophic  mutants  were  found  to  be  suitable  for  use  in  gene 
transfer  studies.  The  procedure  was  repeated  using  Tohama  BPN6,  a  nalidixic  acid 
resistant  mutant  isolated  previously  (Section  2).  2  presumptive  auxotrophs 
were  isolated  and  upon  characterisation,  one  showed  a  requirement  for  threonine 
(Thr  )  (Tables  6&  7)  while  the  other  showed  a  complex  nutritional  requirement. 
In  the  course  of  these  experiments  attempts  were  made  to  screen  single 
colonies  of  B.  pertussis  for  growth  requirements  by  replica  plating  from  BGA 
onto  CSM.  However,  due  to  insufficient  growth  being  picked  up  on  the  velvet 
pad,  from  the  small  B.  pertussis  colonies,  this  proved  to  be  impracticable. 
3.4  Screening  of  B.  pertussis  and  B.  parapertussis  strains  for'n4wrq%.  - 
antibiotic-resistance. 
Although  a  method  for  obtaining  antibiotic  resistant  mutants  of'B.  'pertussis 
was  available,  there  was  still  only  a  limited  range  of  antibiotic  resistant 
strains  which  could  be  used  in  genetic  manipulations.  Therefore  several 
strains  of  B.  pertussis  and'B.  parapertussis  were  screened  for  naturally  occur- 84 
Table  6.  -  Growth  of  B.  pertussis  auxotrophic  mutants  on. 
CSM  in  the  presence  of  various  BSA  concentrations. 
Auxotrophic 
Strain  requirement 
CSP  1 
CSP  1 
BPN  6 
Trp 
Gly 
Thr 
+  growth 
Growth  in  the  presence  of  BSA  at  the 
following  concentrations  (%  w/v) 
0  0.05  0.1  0.15  0.2 
-  no  growth 
-+ 85 
Table  7  Growth  of  auxotrophic  mutants  of  B.  pertussis  in  the  presence 
or  absence  of  amino  acids.  100-'U1  aliquots  of  a  suspension 
of  each'mutant  were  spread  on  CSM  containing  the  appropriate 
amino.,  acid. 
Auxotrophic 
mutant 
CSP1  G1y 
CSP1  Trp 
BPN6  Thr 
Medium 
CSM 
CSM  +  gly 
BGA 
CSM 
CSM  +  trp 
BGA 
CSM 
CSM  +  thr 
BGA 
No.  of  colonies  formed  at 
dilutions  of  :  - 
10-5  10-6  10-7 
0 
186 
confluent 
0 
49 
confluent 
0 
142 
confluent 
0 
5 
102 
0 
3 
171 
0 
16 
218 
0 
0 
>> 
0 
0 
12 
0 
0 
18 86 
-ring  antibiotic  resistance  using  Oxoid  Multodisks  (Table  8).  Laboratory 
strains  such-  as-  18334  and  18323  were  found  to  be  sensitive  to  all  antibiotics 
tested.  Tohama  exhibited  resistance  to  sulphafurazole,  methicillin  and 
streptomycin,  although  Tohama  would  not  grow  on  a  concentration  of  200ug  ml 
-l 
streptomycin,  the  concentration  at  which  the  antibiotic  was  used  in  selective 
media.  Taberman  was  resistant  to  1.5  units  of  Penicillin  G  and  2ug  ml 
1 
ampicillin,  but  this  concentration  was  much  lower  than  the  20ug  ml-1  of 
carbenicillin  used  as  a  selective  agent.  "  B.  parapertussis  strain  NCTC  10520 
was  resistant  to  several  antibiotics  at  the  levels  tested,  but  was  sensitive 
to  inhibition  by  higher  levels  of  the  $-lactams  (20pg  ml-l  carbenicillin) 
and  tetracycline  (20ug  ml-1).  However,  strain  10520  was  resistant  to  chloram- 
pher)icol  at  a  concentration  of  20pg  ml-l,  a  property  which  was  utilised  in 
subsequent  gene  transfer  studies.  CSP1  was  confirmed  as  being  resistant  to 
streptomycin  (200ug  ml-1). 
3.5  Minimum  Inhibitory  Concentrations  (MIC)  of  various  antibiotics 
on  B.  pertussis. 
Following  isolation  of  antibiotic  resistant  mutants  of  B.  Pertussis,  and 
screening  of  strains  for  naturally  occurring  resistance,  a  potential  genetic 
recipient  strain  (44122/7R)  was  further  characterized  to  determine  the  MIC  of 
the  selective  antibiotic,  streptomycin  (Table  9).  In  initial  transfer  of 
plasmids  from  E.  coli  donors,  the'B.  pertussis  44122/7R  recipient  was  required 
to  be  resistant  to  the  selective  antibiotic,  while  the  donor  was  required  to  be 
sensitive.  Therefore,  MIC  values  for  E.  "coli  donor  strains  were  also  deter- 
-  mined_  (Table  9). 
A  range  of  antibiotic  resistant  strains  of  B.  'pe1tüSSis  was  now  available 
and,  together  with  the  auxotrophic  mutants  obtained  previously,  they  could  be 
used  to  develop  a  system  of  gene  transfer  in'B.  pertussis. 0  87 
Table  8  Antibiotic  resistant  in  B.  pertussis  and  B.  parap  ertussis 
as  determined  by  Multodisk  sensitivity  tests.  Oxoid  S3 
Multodisks  wer  e  used  -  See  Appendix  2. 
S-  The  strain  is  sensitive  to  inhibition  by  the  antibiotic  and 
a  zone  of  no  growth  is  present  round  the  disk. 
R-  The  strain  is  resistant  to  inhibition  by  the  antibiotic 
and  there  is  no  zone  of  inhibition  ar  ound  the  disk. 
Species  Strain  Ant  ibiotic  Sensit  ivity 
C  E  SF  CB  P  PN  S  TE 
B.  para-  10520  R  S  RR  R  R  R  R 
pertussis 
it  5952  S  S  SR  R  R  R  S 
B.  Pertussis  44122/7R  S  S  RS  S  S  R  S 
it  18334  S  S  SS  S  S  S  S 
if  18323  S  S  SS  S  S  S  S 
is  Tohama  S  S  RR  S  S  R  S 
of  BPN6  S  S  RR  S  S  S  S 
of  D30042  S  S  SS  S  S  S  S 
"  CSP1  S  S  RS  S  S  R  S 
of  Taberman  S  S  SS  R  R  S  S 
BPT  2'  S  S  SS  R  R  S  S 
P3  S  S  SS  R  -R  R  S 
L84  I  S  S  SS  S  S  S  S 
L84  IV  S  S  RR  R  R  R  S 
D30042  IV  S  S  RR  S  S  R  S 
11615  IV  S  S  RR  R  R  S  S 88 
Table  9-  Resistance  of  E.  coli  donors  and  a  B.  pertussis 
recipient  strain  to  streptomycin 
Growth  in  the  presence  of  streptomycin  (ug  ml-1) 
Organism  10 
E.  Coli 
J53-1/R68.45  - 
JMP  502  - 
JMP  543  + 
N7731/R68:  45supdna-G3  R15 
J53-1/RP4::  Tn7  - 
B.  pertussis 
44122/7R  + 
50  100  200 
+++ 
+-  growth 
--  no  growth 89 
3.6  R  plasmid-mediated  conjugation  and  chromosome  mobilisation  in'E.  "coli. 
The  Inc-P  group  broad  host-range  plasmid  R68.45  can  promote  mobilisation 
of  chromosomal  markers  within  a  wide  range  of  Gram-negative  bacteria  (Holloway, 
1979).  In  this  study,  R68.45  and  several  similar  plasmids  were  used  to 
mobilise  chromosomal  markers  between  strains  of'B.  pertüssis  and  from'B.  pertussis 
to  B.  parapertussis. 
The  ability  of  R68.45  to  transfer  between  strains  and  to  promote  exchange 
of  chromosomal  markers  was  first  examined  in  E.  'coli.  The  plasmid  was  trans- 
ferred  from*E.  coli  strain  J53-1  to  JC3272  by  conjugation  using  the  membrane 
filter  method.  The  frequency  of  plasmid  transfer  was  high,  about  1  recipient 
cell  in  every  100  taking  up  the  plasmid.  Resistance  to  nalidixic  acid,  a 
chromosomal  mutation  carried  by  the  donor  J53-1,  was  also  transferred,  but  at 
a  much  lower  frequency  (Table  10). 
In  plasmid  R68.45  chromosome  mobilising  ability  can  be  stabilised  by 
maintenance  of  the  plasmid  in  the  presence  of  kanamycin  (Haas  and  Holloway, 
1976)  which  maybe  linked  to  the  presence  of  the  insertion  sequence  IS21  on 
the  plasmid  (Willetts  et  al.,  1981).  To  determine  if  this  effect  occurred 
during  mobilisation  of  the  donor  nalidixic  acid  resistance  marker,  conjugation 
between  donor  J53-1  and  recipient  JC3272  strains  was  carried  out  after  growth 
of  the  donor  in  the  presence  or  absence  of  kanamycin  (10ug  ml 
-1  ).  The 
experiments  were  performed  as  plate  matings  (Table  11).  Transfer  of  plasmid 
R68.45  occurred  at  high  frequency  and  was  not  affected  by  the  presence  or 
absence  of  kanamycin  in  the  donor  growth  medium.  However,  J53-1  grown  in 
kanamycin  mobilised  the  NalR  marker  at  a  frequency  60-100  fold  greater  than 
J53-1  grown  in  the  absence  of  kanamycin.  Thus,  in  all  subsequent  experiments 
involving  R68.45  mediated  chromosome.  mobilisation,  kanamycin  was  incorporated 
in  the  donor  liquid  culture,  to  mediate  maximum  mobilisation  of  chromosomal 
markers. 90 
Table  10  -  R68.45  transfer  and  mobilisation  of  a  chromosomal  marker 
(NalR)  from  E.  coli  J53-1  to  JC3272. 
Selection  for  plasmid  carrying  transconjugants  was  on 
nutrient  agar  (NA)  containing  Kanamycin,  carbenicillin 
and  streptomycin. 
Selection  for  Na1R  recombinants  was  on  NA  containing 
nalidixic  acid  and  streptomycin.  Transfer  frequencies 
are  as  described  in  Materials  and  Methods.  Spontaneous 
mutation  rates  of  donor  and  recipient  to  selective 
10 
antibiotic  resistance  were  L  8.2  x  10-. 
Experiment  Plasmid  mean  plasmid  Cma  mean  Cma 
transfer  transfer  frequency  frequency 
No.  frequency  frequency 
1  9.54  x  10-3  5.68  x  10-3  5.0  x  10-9  5.6  x  10-9 
2  6.12  x  10-3  (±  1.37  x  10-3)  6.1  x  10-9  (±  3.3  x  10-10) 
3  1.38  x  10-3  5.9  x  10-9 91 
Table  11  -  Effect  bf  Kanamycin  on  cma  ability  of  R68.45  in  E.  coli 
Donors  were  grown  in  presence  or  absence  of  Kanamycin 
overnight  in  nutrient  broth.  Transfer  and  cma 
frequencies  are  as  described  in  Materials  and  Methods. 
The  marker  mobilised  was  Na1R.  Spontaneous  mutation 
rates  of  donor  and  recipient  to  selective  antibiotics 
-  10 
resistance  were  <  7.8  x  10. 
mean 
Donor  Recipient 
plasmid  transfer  mean  cma 
transfer  frequency  cma  frequency 
J53-1  JC3272  frequency  (SEM)  frequency  (SEM) 
4.6  x  10-1  5.5  x  10-1  7.1  x  10-8  7.3  x  10-8 
Kanamycin  present  6.2  x  10-1  6.7  x  10-8 
5.8  x  10-1  (±4.8  x  10-2)  8.2  x  10-8  (±4.4  x  10-9) 
1.23  x  10-1  3.74  x  10-1  1.56  x  10-9  2.35  x  10-9 
3.1  x  10-1  (±1.6  x  10-1  3.1  x  10-9 
Kanamycin  absent  6.9  x  10-1  2.4  x  10-9  (±4.4  x  10-10) 92 
The  mating  procedure  was  found  to  be  unsuitable  in  attempting  to  transfer 
plasmid  R68.45  from  E.  cdli  J53-1  tö'B.  pertüssis  44122/7R.  This  was 
due  to  the  negative  pressure  passing  through  the  membrane  filter  drawing 
in  atmospheric  contaminants  which  grew  on  the  BGA  used  for  incubation  of  the 
filter.  Therefore,  a  contamination-free  system  was  developed  based  on  the 
plate  mating  method  of  Bradley'et'al.,  (1981).  To  determine  how  mating  pro- 
cedure  affected  the  degree  to  which  plasmid  transfer  occurred,  three  systems 
were  compared  with  the  filter  mating  system  using'E.  coil  donor  and  recipient. 
These  systems  were 
i.  Plate  mating 
ii.  Mating  in  nutrient  broth  (Gibco) 
iii.  Mating  in  nutrient  broth  containing  0.1%  w/v  agar--(Agar  Technical.  No.  3, 
Oxoid). 
It  was  found  that  none  of  the  three  procedures  produced  an  efficiency  of 
plasmid  transfer  equal  to  that  of  the  filter  mating  system.  Of  the  three 
methods  tested  (Table  12),  the  plate  mating  system  gave  rise  generally  to  a 
slightly  higher  transfer  frequency  than  the  broth  mating  systems.  The  presence 
of  agar  in  the  broth  mating  medium  failed  to  enhance  plasmid  transfer,  and  may 
actually  have  reduced  it.  Thus  plasmid  transfer  between  strains  of  E.  coli 
was  mediated  most  efficiently  by  the  filter  mating  system,  but  this  method 
was  not  suitable  for  use  with  B.  pertüssis  due  to  contamination  of  the  filter. 
Therefore,  all  subsequent  plasmid  transfers  which  involved'B.  pertussis,  were 
carried  out  using  the  plate  mating  method,  which  was'much  less  susceptible 
to  contamination  yet  produced  efficient  plasmid  transfer. 
3.7  Determination  of  optimal  donor  1  recipient  ratio  in  'E.  'cöli. 
Thi's  was  carried  out  in  order  to  determine  the  donor  :,  recipient  ratio 
which  gave  maximum  plasmid  transfer  and  chromosome  mobilisation.  lml  of 93 
Table  12  -  Comparison  of  mating  methods  in  E.  coli.  In  all  cases 
the  donor  was  J53-1  (R68.45)  and  the  recipient  was 
JC3272.  Transfer  frequencies  are  as  described  in.. 
Materials  and  Methods.  Spontaneous  mutation  rczes  of 
donor  and  recipient  to  selective  antibiotic  resistance 
was  <5.4  x  10-10 
plasmid  transfer  mean 
Method  of  mating  frequency  (SEM) 
5.24  x  10-2  5.15  x  10-2 
Filter  5.19  x  10-2 
5.03  x  10-2  (±6.3  x  10-4) 
Broth  9.9  x  10-4  1.99  x  10-3 
1.99  x  10-3 
3.01  x  10-3  (±5,8  x  10-4) 
Broth  containing  6.75  x  10-4  7.48  x  10-3 
0.1%  agar  5.9  x  10-4 
9.8  x  10-4  (±1.  I8x  10-4) 
Plate  2.57  x  10-3  2.81  x  10-3 
2.75  x  10-3 
3.11  x  10-3  (±1.5  x  10-4) 94 
donor  E.  coli  J53-1  was  mixed  with  1,5  or  10ml  of  recipient  strain  JC3272, 
and  plate.  matings  were.  carried  out  using  nutrient  agar  as  the  mating  medium 
(Table  13).  The-donor  :  recipient  ratio  had  little  effect  on  the  frequency 
of  plasmid  transfer,  but  a  ratio  of  1:  10  produced  a  10-fold  reduction  in 
chromosome  mobilisation  frequency,  compared  to  a  1:  1  or  1:  5  ratio.  Therefore, 
in  all  subsequent  plasmid  transfer  and  chromosome  mobilisation  studies,  a  donor: 
recipient  ratio  of  1:  1  was  used  as  the  mating  mixture. 
3.8  Plasmid  R68.45  transfer  from'E.  cöli  to'B.  'pertdssis. 
Plasmid  R68.45  was  transferred  from'E.  cdli  J53-1  tö'B.  ''pertussis  44122/7R 
by  conjugation  using  the  plate  mating  method  and  a  1:  1  donor:  recipient  ratio 
(Table  14).  Single  colony  transconjugants  of'  B.  'pertussis  which  exhibited 
plasmid-coded  antibiotic  resistance  were  obtained  following  incubation  of  BGA 
selection  plates  for  4-5  days  at  37°C.  In  the  first  few  attempts  at  trans- 
ferring  the  plasmid,  the  E.  coli  donor  was  found  to  rapidly  outgrow  B.  pertussis 
on  the  mating  medium  during  overnight  incubation  of  the  mating  mixture.  This 
gave  rise  to  spontaneous  streptomycin  resistant  mutants  of  E.  coli  which  grew 
on  the  selection  medium.  Thus,  in  order  to  reduce  overgrowth  of  E.  coli 
cephalexin  (40ug  ml 
1) 
was  incorporated  in  the  mating  medium  which  reduced 
donor  growth  but  still  allowed  selection  of  B.  pertussis  transconjugants  at  a 
similar  frequency  (Table  14).  A  further  modification  of  the  plasmid  transfer 
system,  used  a  mating  period  of  4-6h  as  opposed  to  overnight  (Materials  and 
Methods,  Section  2-6).  This  became  the  incubation  period  of  choice  since 
E.  coli  growth  was  further  reduced  but  still  allowed  plasmid  transfer  to  take 
place. 
B:  pertüssis  transconjugants  showed  resistance  to  kanamycin,  carbenicillin 
and  tetracycline.  R68.45  was  stably  maintained  following  several  subcultures 
on  BGA  after  which,  resistance-to  the'  antibiotics  continued'to  be  exhibited. 95 
Table  13  -  Determination  of  optimal  donor  t  recipient  ratio  for 
plasmid  transfer  and  mobilisation  of  NalR  from  E.  coli 
J53-1  to  E.  coli  JC3272.  Transfer  and  cma  frequencies  are 
as  described  in  Materials  and  Methods.  Transconjugants 
were  selected  on  NA  containing  selective  antibiotics. 
Spontaneous  mutation  frequency  of  donor  and  recipient 
to  selective  antibiotics  was  <6.3  x  10-10. 
Donor  :  recipient  plasmid  mean  plasmid  mean  cma 
transfer  transfer  cma  frequency  frequency 
ratio  frequency  frequency  (SEM) 
(SEM) 
1T1.3  x  10-1  2.1  x  10-1  1.7  x  10-8  1.9  x  10-8 
2.3  x  10-1  1.8  x  10-8  (±1.5  x  10-9) 
2.7  x  10-1  (±4.1  x  10-2)  2.2  x  10-8 
1:  51.9  x  10-1  2.6  x  10-T  1.0  x  10-8  1.53  x  10-8 
4.3  x  10-1  1.6  x  10-8  (±2.9  x  10-9) 
1.6  x  10-1  (±8.5  x  10-2)  2.0  x  10-8 
1:  101.7x  10-1  1.9x  10-1  2.4  x  109  2.03  x  10-8 
2.1  x  10-1  1.6  x  10-9 
1.9  x  10-1  (±1.1  x  10-2)  2.1  x  10-9  (±2.3  x  10-9) 96 
Table  14  -  Transfer  of  plasmid  R68.45  from  E.  coli  J53-1  to  B.  pertussis 
44122/7R  in  the  presenceor  absence  of  cephalexin(  40  ug  ml-1). 
Plasmid  transfer  frequency  is  as  described  on  BGA  containing 
selective  antibiotics.  Spontaneous  mutation  rates  of  donor 
and  recipient  to  Str  and  Km,  Cb 
R 
was  <  5.7  x  10- 
10  RR 
cephalexin  present  plasmid  transfer  mean  transfer 
during  mating  frequency  frequency 
(SEM) 
2.01  x  10-4  2.37  x  10-4 
NO  2.57  x  10-4  (t1.8  x  10-5) 
2.54  x  10-4 
2.03  x  10-4  2.50  x  10-4 
YES  3.01  x  10-4  (±2.8  x  10-5) 
2.48  x  10-4 97 
MIC  values  of  each  antibiotic  were  compared  for  the  parent  strain  44122/7R 
and  for  plasmid  carrying  transconjugants,  designated  44122/7RP.  The  MIC  of  tetra- 
cycline  was  less  than  2.5ug  ml-1  and  greater  than  20pg  ml 
-1  for  the  parent  and 
transconjugants  respectively  while  the  MIC  of  kanamycin  was  less-than  2011g,  ml-1 
and  greater  than  80pg  ml-1  for  parent  and  transconjugants  respectively.  MIC 
of  carbenicillin  was  less  than  lOpg  ml-I  for  the  parent  and  100pg  ml-1  for  the 
transconjugants  (Table  15).  Thus  it  was  possible  for  B.  pertussis  to  inherit 
and  stably  maintain  an  R  plasmid. 
Transfer  of  R68.45  from  B.  pertussis  44122/7RP  to  an  E.  coli  recipient 
JC3272  was  also  studied,  to  determine  the  ability  of  B.  pertussis  to  behave  as 
a  genetic  donor.  It  was  possible,  in  this  case,  to  use  a  donor  which  was 
resistant  to  the  same  antibiotics  as  the  recipient,  since  the  selection  pro- 
cedure  was  based  on  the  inability  of  the  donor  B.  pertussis  to  grow  on  nutrient 
agar.  Transconjugants  of  E.  coli  grew  overnight  on  nutrient  agar  containing 
kanamycin,  carbenicillin  and  streptomycin  following  plate  mating  on  BGA  con- 
taining  cephalexin  (Table  16).  The  frequency  of  plasmid  transfer  to  E.  coli 
from  B.  Pertussis  was  approximately  100-fold  lower  than  from  E.  coli  to 
B.  Pertussis,  suggesting  that  the  ability  of  B.  pertussis  to  act  as  a  genetic 
donor  was  reduced  compared  to  E.  coli. 
To  show  that  transfer  of  plasmid-borne  antibiotic  resistance  between 
E.  coli  and  B.  pertussis  was  due  to  conjugation  and  transfer  of  DNA  by  cell 
to  cell  contact,  rather  than  by  genetic  transformation,  the  frequency  of  transfer 
of  plasmid  R68.45  was  determined  in  the  presence  and  absence  of  deoxyribonuclease 
(DNase  II,  Sigma),  at  a  concentration  of  100pg  ml-1,  in  the  mating  medium. 
Donor  E.  coli  and  recipient  B.  pertussis  strains  were  incubated  together  for 
5h  on  BGA  containing  DNase  II.  Following  selection  of  transconjugants,  no 
difference  was  found  in  the  plasmid  transfer  frequency  in  the  presence  of 
DNase,  indicating  that  naked  plasmid  DNA  was  not  transforming  B.  pertussis 98 
Table  15  -  Differences  in  antibiotic  MIC  values  due  to  the  presence 
of  R68.45  in  B.  pertussis  44122/7R.  Growth  is  denoted 
by  +  and  no  growth  by  - 
Kanamycin  Antibiotic  concentration  ug  ml-1 
Strain  20  30  40  50  60  70  80 
44122/7R  ------- 
44122/7RP  +++++++ 
Carbenicillin  Antibiotic  concentration  ugml-1 
Strain  10  20  50  100  120  150  200 
44122/7R  ------- 
44122/7RP  +++---- 
Tetracycline  Antibiotic  concentration  ug  ml-1 
Strain  2.5  15  10  20  25  30 
44122/7R  ------- 
44122/7RP  ++++--- 99 
Table  16  -  Transfer  of  plasmid  R68.45,  by  conjugation,  from  B.  pertussis 
to  E.  coli.  Transconjugants  were  selected  on  NA  containing 
selective  antibiotics.  Plasmid  transfer  frequency  is  as 
described  in  Materials  and  Methods.  Spontaneous  mutation 
frequencies  were  not  determined. 
Experiment 
Donor  (plasmid)  Recipient  Number 
B.  pertussis 
44122/7RP 
E.  coli  1 
JC3272  2 
(R68.45) 
3 
4 
5 
6 
plasmid  transfer 
frequency 
3.88  x  10-6 
1.66  x  10-6 
2.77  x  10-6 
3.33  x  10-6 
4.65  x  f0-  6 
6.20  x  10-6 
mean  transfer 
frequency  (SEM) 
3.74  x  10-6 
(±6.4  x  10_7) 100 
recipient  cells  and  that  transfer  occurs  by  cell  to  cell  contact  (Table  17). 
To  determine  if  plasmid  R68.45  was  capable  of  transferring  between 
strains  of  B.  pertussis,  44122/7RP  was  used  as  the  donor  strain  with  Taberman 
R1  (resistant  to  rifampicin  RifR)  as  recipient.  Selection  for  plasmid  carrying 
transconjugants  of  R1  was  carried  out  on  BGA  containing  kanamycin,  carben- 
icillin  and  rifampicin.  It  was  found  that  R68.45  was  capable  of  transferring 
between  the  two  strains  at  high  frequency  (Table  18).  However,  a  relatively 
high  frequency  of  spontaneous  mutation  to  rifampicin  resistance  in  the  donor 
strain  was  observed  which  precluded  use  of  this  particular  donor/recipient 
combination  in  studies  on  mobilisation  of  the  chromosomal  streptomycin  resis- 
tance  marker. 
3.9  Transfer  of  other-plasmids  to'E.  -coli-and  B.  pertussis 
Since  R68.45  was  transferred  by  conjugation  from  E.  coli  to'  B.  'pertussis 
several  similar  R  plasmids  were  studied  for  their  ability  to  transfer  to 
B.  pertussis.  These  plasmids  were  RP1,  RP1::  Tn501,  R68.45supdnaG315  and  RP4::  Tn7. 
RPl  and  RP4  are  similar  to  R68.45  and  also  encode  resistance  to  kanamycin  (KmR), 
carbenicillin  (CbR)  and  tetracycline  (Tc  ),  R68.45supdnaG315  is  a  mutant  of 
R68.45.  The  transposon  Tn501  encodes  resistance  to  mercury  (HgR)  while  TO 
encodes  resistance  to  trimethoprim  (TpR)  and  streptomycin  (SmR)  in  E.  coli. 
Initially,  these  plasmids  were  tested  for  their  ability  to  transfer,  by  conju- 
gation,  between  strains  of  E.  coli  using  JC3272  as  recipient.  However,  since  TO 
encodes  streptomycin  resistance  in  E.  coli,  plasmid  RP4::  Tn7  could  not  be 
compared  using  this  system.  The  E.  coli  hosts  in  which  the  plasmids  were 
present  initially  were  tested  for  their  resistance  to  streptomycin,  to  determine 
if  E.  coli  JC3272  and  subsequently'B.  'pertussis  44122/7R  could  be  used  as 
recipients.  All  donor  strains  except  J53-1  (RP4::  Tn7)  were  sensitive  to 
streptomycin  at  the  concentration  at  which  the  antibiotic  is  used  for  trans- 101 
Table  17  -  Plasmid  transfer  from  E.  coli  to  B.  p  ertussis  in  the  presence 
of  DNase  Plasmid  transfer  is  as  defined  in  Materials  and 
Methods.  Spontaneous  mutation  rates  of  donor  to  StrR  and 
recipient  to  KmR  were  <  2.54  x  10-10 
.  Transconjugants 
were  selected  on  BGA  containing  selec  tive  antibiotics. 
Donor  Exp.  plasmid  tran  sfer  mean  transfer 
(plasmid)  recipient  DNase  No.  frequency  frequency 
, 
(SEM) 
E.  coli  B.  pertussis  present  1  1.21  x  10-4  1.34  x  10-4 
J53-1  44122/7R 
2  1.44  x  10-4  (±  6.8  x  10-6) 
(R68.45) 
3  1.38  x  10-4 
absent  1  1.10  x  10-4  1.28  x  10-4 
2  1.49  x  10-4 
-4  ±  -5  3  1.27  x  10  (  1.1  x  10  ) 
A 102 
Table  18  -  Transfer  of  plasmid  R68.45  between  strains  of  B.  pertussis 
Transconjugants  were  selected  on  BGA  containing 
streptomycin  and  rifampicin.  Spontaneous  mutation 
rate  of  the  donor  to  RifR  was  3.6  x  10-7  and  of  the 
recipient  to  StrR  2.9  x  10-9. 
Donor  Experiment  plasmid  mean 
(plasmid)  Recipient  Number  transfer  transfer 
frequency  frequency 
(SEM) 
44122/7RP  Taberman  1  2:  14  x  10-3  2.62  x  10-3 
(R68.45)  R1 
2  2.96  x  10-3  (±2.4  x  10-4 
3  2.75  x  10-3 103-- 
conjugant  selection  (Z00ug  ml-1).  Plasmids  were  transferred  to  recipient 
E.  coli  strains  using  the  plate  mating  method.  Plasmids  RP1  and  RP1::  Tn501 
were  capable  of  transferring  to  JC3272  at  high  frequencies  (Table  19). 
R68.45supdnaG315  however,  -failed  to  transfer  betweeri'E.  'coli  strains.  With 
plasmid  RP1::  Tn501,  the  frequency  of  transfer  of  mercury  resistance  was  similar 
to  the  plasmid  transfer  frequency,  showing  clearly  that  Tn501  was  carried  on 
the  plasmid  into  the  recipient  cell. 
Having  shown  the  plasmids  to  be  conjugative,  with  the  exception  of 
R68.45supdnaG315  and  RP4::  Tn7,  they  were  then  transferred  by  plate  mating  to 
B.  pertussis  44122/7R  (Table  20).  Transconjugants  were  selected  on  BGA  containing 
streptomycin,  kanamycin  and  tetracycline.  Although  R68.45supdnaG315  failed  to 
transfer  efficiently  to  E.  coli  JC3272,  its  ability  to  transfer  to  B.  pertussis 
44122/7R  was  determined,  as  was  the  ability  of  RP4::  Tn7.  Plasmids  RP1  and 
RP1::  Tn501  transferred  to'B.  pertussis  at  relatively  high  frequencies,  but  RP1 
transferred  at  about  10  times  the  frequency  of  RP1::  Tn50l.  Plasmid  RP4::  Tn7 
was  also  found  to  transfer  at  high  frequencies  and  no  resistant  colonies  of 
the  E.  coli  donor  grew  on  selection  plates,  even  though  the  donor  carried  W. 
Plasmid  R68.45supdnaG315  was  found  to  transfer  at  low  frequency  to  B.  pertussis. 
It  was  not  used  in  subsequent  studies  on  chromosome  mobilisation  in  B.  pertussis. 
In  transfer  of  RP1::  Tn50l,  the  frequency  of  inheritance  of-the  transposon  was 
determined  by  direct  selection  on  BGA  containing  streptomycin  and  HgC12  (lOpgml  1) 
in  the  absence  of  kanamycin  or  carbenicillin  (Table  20).  The  frequency  of  Tn501 
transfer  was  similar  to  the  frequency  of  plasmid  transfer  (Table  20)  indicating 
that  all  transconjugants  had  acquired  Tn501  on  the  plasmid.  However,  when  60 
colonies  were  restreaked  on  BGA  containing  kanamycin  and  carbenicillin,  all 
failed  to  grow,  indicating  that  although  the  transposon  was  stably  inherited, 
the  plasmid  was  lost.  By  contrast,  transconjugants  which  were  initially 
selected  on  BGA  containing  kanamycin  and  carbenicillin  were  capable  of  growth 104 
Table  19  Conjugative  ability  of  other  R-plasmids  in  E.  coli  Recipient 
was  E.  coli  JC3272.  Transconjugants  were  selected  on  NA 
containing  kanamycin,  carbenicillin  and  streptomycin.  Plasmid 
transfer  frequency  is  as  defined  in  Materials  and  Methods. 
Transposon  transfer  frequency  is  defined  as  the  number  of 
mercury  resistant  recipients  divided  by  total  number  of 
recipients.  Spontaneous  mutation  rate  of  donor  and 
recipient  to  selective  antibiotic  resistance  was  <  3.1  x  10-10. 
Donor  (plasmid)  plasmid  transfer  mean  transfer 
frequency  frequency  (SEM) 
JMP  502  8.0  x  10-1  7.65  x  10-1 
(RP1)  7.3  x  10-1  (±  3.5  x  10-2) 
JMP  543  7.6  x  10-1  7.25  x  10-1 
(RP1::  Tn50l)  6.9  x  10-1  3.5  x  10-2) 
N7731  1.3  x  10-5  - 
R68.45  supdna  G315 
Donor  (plasmid)  Transposon  transfer  mean  transfer 
frequency  frequency  (SEM) 
JMP  543  6.4  x  10-1  8.0  x  10-1 
(RP1  ::  Tn  501)  9.6  x  10-1  (±  1.6  x  10-1) 105 
Table  20  -  Plasmid  and  transposon  transfer-to:  B.  pertussis  from  E.  coli 
donors  .  Selection  of  transposon  carr  ying  recipients  was  on 
BGA  containing  streptomycin  and  H.  gCl2.  Selection  of 
transconjugants.,  was  on  BGA  containing  streptomycin,  kanamycin 
and  carbenicillin.  Plasmid  transfer  frequencies  are  as 
defined  in  Materials  and  Methods.  Spo  ntaneous  mutation  n 
rates  of  donor  and  recipient  to  select  ive  antibiotics. 
resistance  was  <  7.8  x  10-9. 
E.  coli  B.  pertussis  Exp.  plasmid  mean  plasmid 
No.  transfer  transfer 
(plasmid)  Recipient  frequency  frequency  (SEM) 
JMP  502  4x  10-2  44122/7R  i  3.12  x  10-2 
(RP1) 
f 
2  2.25  x  10-2  (±  8.7  x  10-3) 
JMP  543  44122/7R 
(RP1::  Tn501) 
NY  731  44122/7R 
(R68.45  supdna  G315) 
J53-1  44122/7R 
(RP4::  Tn7) 
E.  coli  donor  B.  pertussis 
(plasmid)  recipient 
JMP  543  44122/7R 
'(RP1::  Tn  501) 
1  5.95  x  10-3  3.8  x  10-3 
2  1.65  x  10-3  (±  2.15  x  10-3) 
1  2.0  x  10-6  4.0  x  10-6 
2  6.0  x  10-6  (±  2.0  x  10-6) 
1  8.23  x  10-4  1.28  x  10-3 
2  1.75  x  10-3  (±  4.6  x  10-4) 
Exp.  Transposon  mean  transposon 
. 
transfer  transfer  freq. 
No.  frequency  (SEM) 
1  7.15  x  10-3  5.01  x  10-3 
2  3.2  x  10-3  (±  1.15  x  10-3) 
3  4.7  x  10-3 106 
on  HgC12  and  stably  maintained  the  plasmid-borne  antibiotic  resistance. 
3.10  Chromosome  mobilisation  in'E.  ''coli. 
Strains  of  B.  pertussis  44122/7R  which  carried  the  various  plasmids  were 
ultimately  used  as  genetic  donors,  to  promote  mobilisation  of  chromosomal 
markers  between  strains  of  B.  pertussis.  However,  prior  to  studies  on 
B.  pertussis,  plasmids  were  first  compared  for  their  abilities  to  mobilise 
chromosomal  markers  between  strains  of  E.  coli.  The  marker  chosen  for  use, 
in  this  comparison,  was  StrR  but  before  comparing  mobilisation  of  StrR  by 
868.45,  RP1  and  RP1::  Tn501,  it  was  necessary  to  transfer  the  plasmids  to  a 
suitable  host  strain  (JC3272)  which  carried  a  high  level  of  streptomycin 
resistance.  This  was  a  simple  procedure  with  R68.45  since  the  original  host 
(J53-1)  was  StrS  which  allowed  direct  plasmid  transfer  to  JC3272  with  selection 
on  NA  containing  kanamycin,  carbenicillin  and  streptomycin.  However,  since 
the  original  hosts  of  RP1  and  RP1::  Tn501  -  JMP502  and  JMP543  respectively  - 
exhibited  a  low  level  of  streptomycin  resistance,  the  plasmids  were  transferred 
initially  to  E.  coli  K12,  a  StrS  prototroph.  Transconjugants  were  selected 
on  ECMA  containing  kanamycin  and  carbenicillin  following  washing  of  the 
bacteria  in  saline.  This  procedure  selected  for  plasmid-carrying  E.  coli  K12 
transconjugants 
on  the  basis  that  auxotrophic  donors  failed  to  grow  on  ECMA 
while  prototrophic  K12  transconjugants  grew  on  ECMA  in  the  presence  of  the 
antibiotics.  Plasmids  RP1  and  RP1::  Tn50l  transferred  at  high  frequency 
(10-2  to  O-  1 
per  recipient).  Single  colony  transconjugants  were  confirmed 
as  being  E.  coli  K12  by  their  ability  to  grow,  upon  subculture,  on  ECMA 
containing  the  selective  antibiotics  but  being  sensitive  to  streptomycin. 
From  the  K12  transconjugants,  a  single  colony  donor  was  used  to  transfer  the 
plasmids  to  JC3272.  By  selecting  on  nutrient  agar  containing  streptomycin, 
kanamycin  and  carbenicillin  high  frequency  plasmid  transfer  to  JC3272  was 107 
Table  21  -  Comparison  of  the  ability  of  plasmids  to  mediate  StrR 
mobilisation  in  E.  coli  plasmid  transfer  and  cma 
frequencies  are  as  defined  in  Materials  and  Methods. 
Transconjugants  and  recombinants  of  E.  coli  K12  were  selected 
on  ECMA  containing  selective  antibiotics.  Spontaneous 
mutation  rates  of  donor  and  recipients  to  prototrophy  and 
StrR  was  <6.9  x  10-9.  In  all  cases,  the  recipient  was 
E.  coli  K12. 
Donor  Exp.  plasmid  mean  transfer 
(plasmid)  No. 
transfer  frequency  cma  mean  cma 
frequency  (SEM)  frequency 
frequency 
(SEM) 
JC  3272  1  2.62  x  10-1  2.85  x  10-1  2.32  x  10-5  3.16  x  10-5 
(RP1)  2  3.09  x  10-1  (±1.19  x  10-1)  4.0  x  10-5  (±1.25  x  10-5) 
JC  3272  1  2.7  x  10-1  5.91  x  10_1  1.57  x  10-6  2.52  x  10_6 
(RP1::  Tn  501)  2  6.3  x  10-1  (±1.75  x  10-1)  3.94  x  10-6  (±7.2  x  10-7) 
3  8.71  x  10-1  2.05  x  10-6 
JC  3272  1  6.36  x  10-2  9.74  x  10-2  8.42  x  10-7  2.85  x  10-6 
(R68  "  45)  2  1.37  x  10-1  (±2.14  x  10-2),  1.6  x  10-6  (±1.65  x  10-6) 
3  9.18  x  10-2  6.13  x  10-6 108 
obtained.  Thus,  JC3272  donors  carrying  plasmids  RP1,  RP1::  Tn501  and  R68.45 
were  now  available  for  use  in  comparing  the  relative  ability  of  each  plasmid 
to  promote  chromosome  mobilisation  in'E.  coli. 
Mobilisation  of  StrR  by  plasmids  R68.45,  RP1  and  RP1::  Tn50l  was  compared 
by  transferring  the  marker  from  the  E.  coli  JC3272  transconjugants  to  E.  coli 
K12  with  selection  on  ECMA  containing  kanamycin  and  carbenicillin,  for  plasmid 
transfer,  and  on  ECMA  containing  streptomycin  (200pg  ml-1)  for  StrR  mobilisation 
(Table  21).  Since  Tn7  encodes  streptomycin  resistance  in  E.  coli  (Barth  et  al., 
1976)  the  ability  of  plasmid  RP4::  Tn7  to  mobilise  a  chromosomal  marker  was 
compared  to  that  of  R68.45  using  nalidixic  acid  resistance  which  is  present 
in  E.  coli  J53-1.  Plasmid  carrying  transconjugants  of  the  JC3272  recipient 
strain  were  selected  on  NA  containing  kanamycin,  carbenicillin  and  streptomycin 
while  Na1R  recombinants  were  selected  on  NA  containing  nalidixic  acid  and 
streptomycin  (Table  22). 
Mobilisation  of  the  StrR  marker  was  mediated  most  efficiently  by  RP1 
while  R68.45  and  RP1::  Tn501  were  approximately  10-fold  less  efficient  (Table  21). 
All  three  plasmids  yielded  transconjugants  at  a  high  frequency. 
In  experiments  to  compare  mobilisation  of  the  J53-1  Na1R  chromosomal 
marker,  RP4::  Tn7  was  found  to  be  slightly  more  efficient  than  R68.45  (Table  22), 
although  the  frequencies  were  generally  lower  than  those  obtained  with  the 
other  plasmids  during  mobilisation  of  StrR  (Table  21).  Plasmid  transfer 
frequencies  were  similar  in  all  cases.  Thus,  all  the  plasmids  were  shown  to 
be  capable  of  promoting  mobilisation  of  StrR  or  Na1R  chromosomal  markers 
between  strains  of  E.  coli. 109 
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3.11  Effect  of  -antigenic-modulation  on  plasmid  transfer-to  B.  pertussis. 
Previous  workers  mated  E.  coli.  donors  with  B.  Pertussis  recipients  in 
the  presence  of  10mM  MgSO4  in  the  mating  medium  (Weiss  and  Falkow,  1982). 
To  determine  if  high  concentrations  of  MgSO4  had  an  effect  on  plasmid  transfer 
frequency,  the-plasmids  RP1,  RP1::  Tn501  and  RP4::  Tn7  were  transferred  from 
E.  coli  JC3272  to  B.  "pertüssis  BPT2  in  the  presence  or  absence  of  20mM  MgSO4 
(Table  23).  The  presence  of  MgSO4  in  the  mating  medium  had  no  effect  on  the 
transfer  of  any  of  the  plasmids  from  E.  coli  to  B.  pertussis.  To  determine 
if  B.  pertussis  recipients  mated  with  E.  coli  donors  in  the  presence  of  MgSO4 
were  more  resistant  to  the  inhibitory  effect  of  fatty  acids  excreted  by  the 
donor,  the  viable  count  of  B.  pertussis  in  matings  carried  out  in  the  presence 
of  MgSO4  was  compared  to  the  viable  count  of  B.  pertussis  on  control  plates 
without  the  addition  of  the  E.  coli  donor.  No  differences  in  viable  count 
were  observed  in  the  presence  of*MgSO4,  suggesting  that'E.  coli  did  not  have 
an  inhibitory  effect  on  B.  pertussis. 
3.12  Visualisation  of  plasmid  DNA  in  agarose  gels. 
In  addition  to  confirming  the  presence  of  plasmids  in  E.  coli  and 
B.  pertussis  by  screening  for  plasmid  encoded  resistance,  it  was  possible  to 
visualise  plasmid  DNA  in  agarose  gels.  Using  the  boiling  method  of  Holmes 
and  Quigley  (1981),  whole  plasmids  were  visualised  following  plasmid  isolation 
from  E.  coli  (Figure  3)  and  from  B.  Pertussis  (Figure  4).  The  isolation 
procedure  was  satisfactory  for  use  with  E.  coli,  but  was  not  as  suitable  for 
plasmid  isolation  from  B.  pertussis.  Plasmid  DNA  was  digested  with  the 
restriction  enzymes  EcoRI  and  HindIIl.  Plasmids  obtained  from  E.  coli  digested 
well,  yielding  the  13  and  25  Md  fragment  characteristic  of  R68.45  or  RP1 
digestion.  With  RP4::  Tn7,  digestion  yielded  additional  bands,  due  to  the 
presence  of  restriction  sites  within  Tn7  (Figure  3).  Unfortunately  digestion Ill 
Table  23  -  Effect  of  20mM  MgSO4  in  the  BGA  mating  medium  on  plasmid  transfer 
from  E.  coli  to  B.  pertussis.  Transconjugants  were  obtained 
on  BGA  containing  selective  antibiotics.  Spontaneous  mutation 
frequencies  of  the  donor  and  recipient  to  NalR  and  StrR  were 
<  2.9  x  10-10.  Transfer  frequencies  are  as  defined  in 
Materials  and  Methods.  Results 
are  means  of  two  observations. 
Vc4uee  r,  %  6rackehs  a"-,  t  rec;  p-,  e4  viub(e  ev  -k  , 
Donor  E.  coli  Recipient  plasmid  transfer  frequency 
(plasmid)  B.  p  ertussis  MgSO4  present  MgSO4  absent 
JC  3272  BPT  2  3.30  x  10-5  1.58  x  10-5 
(RP1  ::  Tn501)  (4.95  x  109)  (2.71  x  109) 
JC  3272  BPT  2  8.43  x  10-4  1.13  x  10-3 
(RP1)  (6.02  x  109)  (1.8  x  109) 
.  JC  3272  BPT  2  1.26  x  10-6  9.34  x  10-7 
(RP4::  Tn7)`;  (1.55  x  109)  (4.28  x  109) 
JC  3272  BPT  2  1.3  x  10-3  9.3  x  10-4 
(R68:  45)  (3.6  x  109)  (1.82  x  109) 
none  BPT  2  (9.6  x  109)  (1.16  x  1010) Figure  3:  Visualisation  of  whole  plasmids  from  E.  coli  and  plasmids 
digested  by  restriction  enzymes  HindIIl  and  EcoRI  in 
agarose  gels. 
Tracks  1  to  4.  EcoRI  and  Hindill  digestion  of  RP1, 
RPLt  ::  Tn7 
i':  -:  -Trt563,  ADNA  and  R68.45. 
A1,14  :  "T￿1 
Tracks  5  to  7.  Whole  plasmids  RP1,  and 
R68.45. 112 
12  345  67 Figure  4:  Visualisation  of  whole  plasmids,  prepared  from 
B.  pertussis,  in  agarose  gels. 
Tracks  3,  Z,  1  R68.45,  RP4::  Tn7,  RP1. 113 
1 
% 
k"OAa,  ý 114 
of  plasmid  DNA  from  B.  pertussis,  which  should  be  modified  at  Hindill 
sites,, 
d;,  t 
not  "_  -'allow 
visualisation  of  restriction 
fragments  in  agarose  gels. 
3.13  R-plasmid  mediated  chromosome  mobilisation  in  B.  pertussis. 
3.13.1  Antibiotic  resistance 
Initial  experiments  to  mobilise  a  chromosomal  marker  in  B.  pertussis 
used  plasmid  R68.45  to  mediate  transfer  of  the  StrR  marker  from  44122/7R. 
The  recipient  strain  chosen  was  Taberman  R1.  Although  plasmid  transfer  occurred 
sýDY1ýMQDJi  wºvta*;  u%  raks  4o  S+Y4  a.,  A  R(FR  weee  tiigh 
at  high  frequency  rmasking 
any  mobilisation  which  may  have  occurred.  A  similar 
. effect  was  observed  with  plasmid  RP1::  Tn501.  A  suitable  donor/recipient  system 
was  observed  with  plasmid  RP1::  TA501.  A  suitable  donor/recipient  system  was 
therefore  required  which  would  reduce  the  levels  of  spontaneous  mutation  to 
selective  antibiotics.  Mobilisation  of  the  44122/7R  StrR  marker  was 
therefore  studied  using,  as  recipients,  a  phosphonomycin  resistant  mutant 
of  Taberman  and  nalidixic  acid  resistant  mutants  of  Tohama  (BPN6)  and 
Taberman  (BPT2).  Donor  strains  of  B.  pertussis  carrying  plasmids  were  tested 
for  resistance  to  phosphonomycin,  as  were  each  of  the  three  resistant  mutants 
available  (Pl,  P2  and  P3)  and  the  Taberman  parent  strain  (Table  24).  Mutant 
P3  was  found  to  be  the  most  resistant  strain  (MIC  >  50Pg  ml-1).  Thus  P3 
was  chosen  as  a  recipient  strain  in  plasmid  transfer  and  chromosome  mobilis- 
ation  experiments-(Table  25).  Plasmids  RP1::  Tn50l,  RP1  and  R68.45  were  used 
to  attempt  mobilisation  of  the  StrR  marker.  Although  plasmid  transfer 
occurred  at  relatively  high  frequency,  the  frequency  of  spontaneous  mutation 
of  the  donor  to  phosphonomycin  resistance  was  also  found  to  be  high,  preventing 
adequate  detection  of  mobilisation  of  the  donor  Str'  marker. 
. 
The  use  of  nalidixic  acid  resistant  strains  of  B.  pertussis  as  recipients 115 
Table  24  -  Characterisation  of  phosphonomycin  resistant  B.  pertussis  strains 
+-  growth  -  no  growth. 
Growth  in  the  presence  of  the  following 
phosphonomycin  concentrations  :  - 
Strain  1  10  50 
p1++- 
p2++- 
p3+++ 
Taberman  +-- 
44122/7RP  +-- 116 
was  found  to  be  more  suitable  for  studies  on  chromosome  mobilisation.  Transfer  of 
R68.45  was  similar  using  either  BPN6  or  BPT2  as  recipients  (Table  26).  RP1::  Tn501 
and  RP4::  Tn7  transfer  frequencies  were  higher  than  R68.45.  R68.45  mobilised 
the  donor  StrR  marker  at  a  level  approximately  1000-fold  higher  than  the 
spontaneous  mutation  frequency  regardless  of  the  recipient  strain  used. 
RP1::  TnSO1  failed  to  mediate  mobilisation  of  the  StrR  marker  to  either  of 
the  NalR  recipients  but  RP4::  Tn7  mediated  mobilisation  of  the  marker  at  high 
frequency,  approximately  100-fold  greater  than  the  cma  using  R68.45. 
3.13.2  Mobilisation  of  prototrophic-markers. 
Single  colony  transconjugants  of  BPN6  (R68.45)  and  BPN6  (RP1::  Tn50l), 
obtained  in  the  previous  experiments,  were  used  as  genetic  donors  to  mobilise 
nutritional  markers  from  the  prototrophic  BPN6  donor  to  an  auxotrophic 
recipient  which  had  been  isolated  as  previously  described.  The  recipient 
used  was  the  glycine  auxotroph  of  CSP1.  Selection  for  plasmid-carrying  trans- 
conjugants  was  carried  out  on  BGA  containing  kanamycin,  carbenicillin  and 
streptomycin,  to  which  the  recipient  was  resistant,  and  selection  for  mobilis- 
ation  of  the  donor  prototrophic  Gly+  marker  was  carried  out  on  CSM  containing 
streptomycin.  To  test  for  linkage  between  the  Gly+  marker  and  the  Na1R 
marker,  co-inheritance  of  the  donor  Na1R  was  determined  by  selecting  for 
recombinants  carrying  this  marker  on  CSM  containing  nalidixic  acid  and 
streptomycin.  Using  BPN6  donors  it  was  not  possible  to  obtain  mobilisation 
of  the  Gly+  marker.  However  recombinants  were  obtained  which  were  Na1R. 
Since  only  prototrophs  will  grow  on  CSM,  any  Na1R  recombinant  must  also 
inherit  the  Gly+  marker,  indicating  that  linked  transfer  of  Gly+  and  NalR 
has  occurred.  R68.45  transferred  plasmid-borne  markers  at  a  low  frequency 
to  CSP1  while  RP1::  Tn501  transferred  at  higher  frequency  (Table  27). 117 
Table  25  -  Plasmid  transfer  and  mobilisation  of  StrR  to  a  phosphonomycin 
resistant  strain  of  B.  pertussis  .  Spontaneous  mutation  rate 
of  donor  44122/7R  to  phosphonomycin  resistance  was 
7.38  x  10-6  and  spontaneous  mutation  rate  of  P3  to  StrR 
was  6.9  x  10-8.  Plasmid  and  cma  frequencies  are  as'defined 
in  Materials  and  Methods.  Results  are  the  mean  of  at  least 
two  observations. 
Donor  Recipient  plasmid  cma 
(plasmid)  transfer  frequency 
frequency  (SEM) 
(SEM) 
44122/7RP  Taberman  9.93  x  10-4  1.19  x  10_4 
(R68.45)  P3  (±  2.82  x  10-5)  (±2.43  x  10-5) 
44122/7RP  Taberman  6.25  x  10-4  9.8  x  10-5 
(RP1)  P3  (±1.14  x  10-4)  (±7.32  x  10-6) 
44122/7RP  Taberman  3.7  x  10-4  9.2  x  10-5 
(RP1::  Tn501)  P3  (±9.61  x  10-5)  (±1.21  x  10-5) 118 
Table  26  -  Plasmid  transfer  and  mobilisation  of  chromosomal  Str' 
between  B.  pertussis  strains  using  NalR  recipients. 
Transfer  and  cma  frequencies  are  as  defined  in  Materials 
and  Methods.  Transconjugants  and  recombinants  were 
selected  on  BGA  containing  antibiotics.  Spontaneous  mutation 
frequencies  of  donor  and  recipient-to  Na1R  and  StrR  were 
<  8.5  x  10-10. 
Donor  Recipient  plasmid  cma 
transfer  frequency 
(plasmid)  frequency  (SEM) 
(SEM) 
44122/7RP  BPN  6  5.45  x  10-5  1.83  x  10-7 
(R68:  45)  (±1.2  x  10-5)  (±5.7  x  10-8) 
44122/7RP  BPN  6  2.98  x  10-3  <  1.6  x  10-10 
(RP1::  Tn  501)  (±9.83  x  10-4) 
44122/7RP  BPN  6  8.76  x  10-4  7.93  x  10-6 
(RP4::  Tn7)  (±1.32  x  10-4)  (±1.95  x  10-6) 
44122/7RP  BPT  2  8.03  x  10-5  7.43  x  10-8 
(R68.45)  (±1.3  x  10-6)  (±3.2  x  10-8) 
44122/7RP  BPT  2  1.59  x  10-3  <  6.0  x  10-9 
(RP1  ::  Tn50.1).  (±2.45  x  10-4) 
44122/7RP  BPT  2  9.23  x  10-4  7.15  x  10-6 
(RP4::  Tn7)  (±1.9  x  10_4)  (±8.7  x  10-7) 119 
Table  27  -  Mobilisation  of  a  nutritional  marker  (Gly+)  and  antibiotic 
resistance  (Nal 
R) 
between  strains  of  B.  pertussis, 
Plasmid  transfer  and  cma  frequencies  are  as  defined  in 
Materials  and  Methods.  Transconjugants  and  Na1R 
recombinants  were  selected  on  BGA  containing  antibiotics. 
Prototrophic  recombinants  were  selected  on  CSM  containing 
streptomycin.  Spontaneous  mutation  rate  of  the  recipient 
to  gly+  was  1.9  x  10-9  and  to  NalR  6.4  x  10-10. 
Spontaneous  mutation  rates  of  donor  and  recipient  to' 
StrR  and  NalR  was  <  6.3  x  10-10.  Results  are  the  means  of 
two  observations. 
Donor  Recipient  plasmid  transfer  cma 
frequency  frequency 
(plasmid)  (SEM)  (SEM) 
BPN  6  CSP1  (G1y  )  1.64  x  10-6  2.13  x  10-9 
(for  Na1R) 
(R68.45)  (±8.2  x  10-7)  (±7.8  x  10-10 
1.06  x  10-9 
(for  G1y+) 
BPN  6  CSP  1  (G1y  )  2.48  x  10-3  8.6  x  10-10 
(RPN::  Tn50l)"  (for  Na1R) 
(±6  5x  10-4)  . 
8.6  x  10-10 
(for  G1y+) 120 
As  an  alternative,  a  marker  from  44122/7R  transconjugants  was  studied 
using  the  threonine  requiring  auxotroph  of  BPN6  as  recipient.  Three  plasmids 
were  compared  for  their  ability  to  mobilise  the  Thr+  marker  from  44122/7R 
donors  (Table  28).  RP1  transferred  to  BPN6  (Thr  )  at  high  frequency  while 
R68.45  and  RP1::  Tn50l  transferred  at  a  lower  frequency.  Mobilisation  of 
Thr+  chromosomal  marker  from  7R  donors  was  found  to  be  mediated  most  efficiently 
by  RP1.  Cma  frequencies  produced  by  RP1::  Tn50l  and  R68.45  were  lower  and 
doubt  must  be  cast  on  the  ability  of  RP1::  Tn50l  and  R68.45  to  mobilise  this 
marker  due  to  the  high  spontaneous  mutation  rate  of  the  recipient  to  Thr+ 
which  was  found  to  be  2.7  x  10- 
6. 
Mobilisation  of  NalRand  a  prototrophic  marker  from  another  donor,  BPT2 
was  also  examined.  Plasmid-carrying  transconjugants  of  BPT2  were  obtained 
in  the  antigenic  modulation  experiment  (Table  23).  As  a  suitable  recipient 
for  Na1R  mobilisation  44122/7R  was  used,  since  it  was  StrR  and  showed  no 
resistance  to  nalidixic  acid.  Plasmids  used  to  mediate  mobilisation  of  the 
Na1R  marker  were  R68.45,  RP1::  Tn5O1  and  RP4::  Tn7,  the  last  named  having  mediated 
mobilisation  of_the  44122/78  StrR  marker  at  high  frequencies  (Table  26). 
However,  it  was  only  possible  to  use  this  plasmid  if  the  transposon  did  not 
encode  streptomycin  resistance,  as  it  does  in  E.  coli.  Therefore,  the 
BPT2/RP4::  Tn7  donor  strain  was  checked  for  its  ability  to  grow  on  streptomycin, 
and  was  found  to  be  sensitive.  It  was  subsequently  used  as  a  genetic  donor 
in  experiments  using  a  StrR  recipient.  Transfer  of  plasmids  from  BPT2  to 
44122/7R  was  found  to  occur  at  high  frequency  (Table  29).  Mobilisation  of 
the  Na1R  marker  occurred  at  a  frequency  between  10-8  and  10 
7 
with  R68.45 
and  RP1::  Tn501,  but  with  RP4::  Tn7  the  frequency  of  mobilisation  was  increased 
100  to  1000  fold. 
Co-transfer  of  Na1R  and  a  prototrophic  nutritional  marker  was  studied 
using  the  glycine  and  tryptophan  -  requiring  auxotrophs  of  CSP1.  These 
strains,  being  streptomycin  resistant,  were  suitable  recipients.  Recombinant 121 
Table  28  -  Mobilisation  of  Thr+  between  strains  of  B.  pertussis 
Transfer  and  cma  frequencies  are  as  defined  in  materials 
and  Methods.  Transconjugants  were  selected  on  BGA  containing 
antibiotics.  Recombinants  were  selected  on  CSM  containing 
nalidixic  acid.  Spontaneous  mutation  rate  of  the  recipient 
to  prototrophy  was  2.7  x  10-6.  Spontaneous  mutation  rate 
of  donor  and  recipient  to  Na1R  and  Str'  was  <6.9  x  10-9. 
Results  are  the  means  of  at  least  two  observations. 
Donor  Recipient  plasmid  transfer  cma 
(plasmid)  frequency  frequency 
(SEM)  (SEM) 
44122/7R 
(RP1)  BPN  6  (Thr  )  1.96  x  10-3  2.39  x  10-5 
(±5.42  x  10-4)  (±8  63  x  10-6)  . 
44122/7R  BPN  6  (Thr^)  8.42  x  10-4  2.78  x  10-6 
(RP1::  Tn  501)  (±1.21  x  10-4)  (±7.54  x  10-7) 
44122/7RP  BPN  6  (Thr  )  5.21  x  10-4  7.38  x  10-7 
(R68.45)  (±7.6  x  10-5)  (±2.12  x  10-7) 122 
Table  29  -  Mobilisation  of  Na1R  between  strains  of  B.  pertussis. 
Plasmid  transfer  and  cma  frequencies  are  as  defined  in 
Materials  and  Methods.  Transconjugants  and  Na1R  recombinants 
were  selected  on  BGA  containing  antibiotics.  Spontaneous 
mutation  rates  of  donor  and  recipient  to  resistance  to  the 
selective  antibiotics  was  <  4.2  x  10-10.  Results  are  the 
means  of  at  least  two  observations. 
Donor  Recipient  plasmid  transfer  cma 
(plasmid)  frequency  frequency 
(SEM)  (SEM) 
BPT  2  44122/7R  2.89  x  10-2  5.67  x  10-8 
(R68.45)  (±5.6  x  10-3)  (±1.8  x  10-8) 
BPT  2  44122/7R  1.1  x  10-1  4.01  x  10-8 
(RP1  ::  Tn  501)  (±5.0  x  10-3)  (±8.0  x  10-9) 
BPT  2  44122/7R  3.2  x  10-2  3.82  x  10-5 
(RP4::  Tn  7)  (+1.6  x  10-2) 
(±1.6  x  10-6) 123 
prototrophs  were  selected  on  CSM  containing  streptomycin,  while  recombinants 
carrying  the  mobilised  Na1R  marker  were  selected  on  CSM  containing  streptomycin 
and  nalidixic  acid.  Plasmids  transferred  to  CSPl  (Trp  )  at  a  high  frequency 
in  all  cases  whilst  mobilisation  of  the  Na1R  marker  was  mediated  at  high 
frequency  by  R68.45  and  RP4::  Tn7  and  at  a  lower  frequency  by  RP1::  Tn50l 
(Table  30). 
In  all  cases  the  cma  frequency  of  the  NalR  marker  was  markedly  higher 
than  the  spontaneous  mutation  frequency  of  the  recipient.  It  was  not  possible 
to  evaluate  mobilisation  of  the  Trp+  marker,  due  to  a  high  spontaneous 
mutation  of  the  recipient  to  Trp+  (Table  30).  Using  the  CSP1  (Gly  )  auxo- 
troph  as  recipient,  plasmid  transfer  again  occurred  at  high  frequency.  The 
spontaneous  mutation  frequency  of  CSP1(G1y  )  to  Gly+  was  low,  about  10-10, 
which  allowed  selection  of  recombinants  carrying  the  mobilised  Gly+  marker  at 
frequencies  of  about  10-5  with  R68.45  and  RP4::  Tn7,  but  at  less  than  10 
8 
with  RP1::  Tn50l  (Table  30).  Interestingly,  mobilisation  of  the  Na1R  marker 
also  occurred  with  R68.45  and  RP4::  Tn7  when  selection  was  made  for  proto- 
trophic  Na1R  recombinants.  Roughly  half  of  the  prototrophic  recombinants 
were  Na1R  with  RP4::  Tn7  and  roughly  one  fifth  with  R68.45.  These  results 
suggest  linkage  of  the  NalR  and  Gly+  markers. 
3.14  Plasmid  transfer  and  chromosome'  mobilisation  to'an  avirülent 
B.  pertussis  mutant. 
B.  pertussis  strain  BP347,  a  Tn5-induced  transposon  insertion  mutant 
which  lacks  the  ability  to  produce  haemolysin  (Hly  )  F-HA,  Pertussis  toxin 
and  dermonecrotic  toxin,  was  used  as  a  recipient  to  determine  if  it  was 
possible  to  restore  haemolytic  activity  from  a  donor  strain,  44122/7R  by 
mobilising  the  Hly+  genes.  Plasmids  used  in  this  study  were  RP1,  RP1::  Tn5Ol 
and  RP4::  Tn7  (Table  31).  Plasmid  transfer  was  lower  in  these  crosses  than 124 
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Table  31  -  Plasmid  transfer  and  mobilisation  of  StrR  to  a  Tn5-induced 
transposon  insertion  mutant  of  B.  pertussis.  Spontaneous 
mutation  rate  of  donor  and  recipient  to  resistance  to 
selective  antibiotics  was  <  3.5  x  10-10.  Transconjugants 
were  selected  on  BGA  containing  kanamycin,  carbenicillin  and 
nalidixic  acid.  Recombinants  were  selected  on  BGA  containing 
streptomycin  and  nalidixic  acid.  Results  are  means  of 
three  observations. 
Donor  Recipient  plasmid  transfer  StrR  cma 
(plasmid)  frequency  frequency 
(SEM)  (SEM) 
44122/7RP  (R68:  45)  BP  347  2.9  x  10-5  4.9  x  10-8 
(±3.7  x  10-6)  (±9.8  x  10-9) 
44122/7R  (RP1::  Tn501)  BP  347  6.3  x  10-6  <  10-9 
(±1.4  x  10-6) 
44122/7R  (RP4::  Tn7)  BP  347  9.23  x  10-4 
(±1.2  x  10-4) 
7.15  x  10-6 
(±8.7  x  10-7) 126 
was  obtained  previously  with  other  recipients  and  no  Hly+  colonies  were 
obtained  from  a  total  of  about  1000  transconjugant  colonies'examined  for 
haemolytic  activity  from  each  plasmid.  However,  mobilisation  of  the  donor 
streptomycin  resistance  marker  occurred.  RP4::  Tn7  was  most  efficient  at 
mobilising  this  marker,  while  R68.45  mobilised  at  about  a  100-fold  lower 
frequency.  RP1::  Tn501  failed  to  mediate  mobilisation  of  the  StrR  marker. 
No  StrR  recombinants  were  haemolytic. 
3.15  Plasmid  transfer  and  chromosome  mobilisation  betweei'B.  "pertussis 
and  B.  parapertussis. 
Initial  attempts  to  mobilise  chromosomal  markers  from'B.  "pertussis  to  the 
closely  related  B.  parapertussis  used,  as  a  selective  mechanism,  the  inability 
of  Phase  I  B.  pertussis  to  grow  on  nutrient  agar.  Donor  B.  pertussis  were 
transconjugants  of  44122/7R  containing  plasmids  R68.45,  RP1::  Tn5Ol  or  RPl. 
Although  some  degree  of  plasmid  transfer  was  apparent,  control  plates  indicated 
that  spontaneous  mutation  of  B.  parapertussis  to  StrR  was  very  high,  thus 
obscuring  any  mobilisation  which  may  have  been  taking  place.  A  high  frequency  of 
spontaneous  resistance  to  carbenicillin  was  also  observed  although  resistance 
to  kanamycin  did  not  appear  In  addition,  a  high  frequency  of  spontaneous 
mutation  of  the  donor  to  Gna+  (ability  to  grow  on  nutrient  agar)  was  also 
observed.  In  order  to  overcome  spontaneous  mutation  of  the  donor  to  Gna+  the 
selection  medium  was  changed  to  MacConkey  Agar,  containing  kanamycin  and  tetra- 
cycline  or  streptomycin  to  select  for  StrR  mobilisation.  A  single  colony  of 
B.  parapertüssis  which  could  grow  on  MacConkey  Agar  and  was  sensitive  to 
streptomycin,  kanamycin  and  carbenicillin  was  isolated  by  testing  30  colonies 
grown  on,  unsupplemented  MacConkey  Agar.  for  their  resistance.  This  colony 
was  used  as  the.  recipient  B.  "pätapdrtüssis. 
All  plasmids  in  the  donor  B.  pertüssis  44122/7R  strains  transferred  to 127 
Table  32  -  Plasmid  transfer  and  chromosome  mobilisation  of  StrR  from 
B.  pertussis  to  B.  parapertussis  with  selection  of 
recombinants  and  transconjugants  on  nutrient  agar.  Control 
plates  show  spontaneous  mutation  rate  of  donor  to  ability  to 
grow  on  nutrient  agar  (Gna+)  and  mutation  rates  of  recipient 
to  selective  antibiotics.  Transfer  and  recombination 
frequencies  are  as  defined  in  Materials  and  Methods.  Results 
are  means  of  two  observations. 
Donor  Recipient  plasmid  transfer  StrR  Cma 
(plasmid)  B.  parapertussis  frequency  (SEM)  frequency 
(SEM) 
44122/7R  10520  3.06  x  10-4  4.03  x  10-4 
(RP1::  Tn501)  (±6.9  x  10-5)  (±8.2  x  10-5) 
44122/7R  10520  6.8  x  10-2  1.23  x  10-2 
(RP1)  (±9.5  x  10-3)  (±3.7  x  10-3) 
44122/7RP  10520  9.1  x10-3  9.78  x  10-3 
(R68.45)  (±1.2  x  10-3)  (±1.0  x  10-3) 
Control  plates 
mutation  rate  mutation  rate  mutation  rate  mutation  rate 
of  B.  pertus  is  of  regipient  of  recipient  to  of  recipient  to 
donor  to  Gna  to  Cb  Str  to  Km 
9.15  x  10-4  2.36  x  10-3  9.29  x  10-4  <  7.0  x  10-7 128 
B.  parapertussis  at  high  frequency  and  R68.45  transferred  at  a  frequency 
about  5  times  that  of  RP1  (Table  331.  By  contrast,  mobilisation  of  the  StrR 
marker  was  mediated  at  the  highest  frequency  by  RP1. 
Although  use  of  MacConkey  Agar  was  suitable  for  selection  of 
B.  parapertussis  recombinants,  an  alternative  selection  mechanism,  which  used 
BGA  for  selection,  was  used.  This  was  due  mainly  to  problems  associated  with 
the  selection  of  B.  parapertussis  variants  on  MacConkey  Agar.  Antibiotic 
sensitivity  tests  (Table  8)  showed'B.  ''parapertussis  10520  to  be  resistant  to 
chloramphenicol  (l0ug  ml 
1). 
The  frequency  of  mobilisation  of  the  Na1R 
marker  from  BPT2  donors  to'  B.  'parapertussis  was  compared  by  selection  of 
recombinants  on  BGA  containing  chloramphenicol  and  nalidixic  acid.  This 
method  of  selection  was  compared  to  selection  on  nutrient  agar  containing 
chloramphenicol  and  nalidixic  acid.  The  plasmids  used  in  these  studies  were 
R68.45,  RP1::  Tn50l  and  RP4::  Tn7  (Table  34).  Transfer  frequencies  of  the 
plasmids  differed  depending  on  the  selection  medium  used.  RP4::  Tn7  was  more 
efficient  at  promoting  chromosome  mobilisation.  Plasmid  transfer  frequency, 
of  both  plasmids,  was  higher  when  transconjugants  were  selected  on  BGA,  but 
the  frequency  of  mobilisation  was  marginally  improved  by  recombinant  selection 
on  NA. 
3.16  Transposon  mutagenesis  in'B:  'pertüssis. 
By  introducing  plasmids  into  '  B:  'pertüssis  which  failed  to  replicate  and 
carried  a  transposon,  the  transposon  could  be  delivered  to  the  bacterial 
chromosome  causing  insertion  mutations  which,  in  previous  reports  were  detected 
by  the  loss  of  a  biological  property  (Weiss  and  Falkow,  1983).  Two  plasmids 
which  were.  suitable  delivery  vehicles  of'transposons  to'B.  'pettüAsis  pUW964 
and  pUW942  (described  in  Materials  and  Methods,  Section  2.1.1).  They  were 
used,  in  this  work,  to  deliver  Tn5  and  Tn501  respectively,  to  the  chromosome 129 
Table  33  -  Plasmid  transfer  and  chromosome  mObilisation  of  streptomycin 
resistance  from  B.  pertussis  to  B.  parapertussis,  with 
selection  on  MacConkey  agar.  Spontaneous  muta  tion  rates 
of  donor  and  recipient  to  selective  antibiotic  resistance 
were  <  5.1  x  10-10.  Results  are  means  of  two  observations. 
Transfer  frequencies  are  as  defined  in  Material  s  and  Methods. 
Donor  recipient  plasmid  transfer  cma  frequency 
(plasmid)  B.  parapertussis  frequency  (SEM) 
(SEM) 
44122/7RP  10520  3.15  x  10-3  3.9  x  10-7 
(R68.45)  (±7.8  x  10-4)  (±5.7  x  10-8) 
44122/7R  10520  5.9  x  10-4  4.06  x  10-6 
(RP1)  (±8.1  x  10-5)  (±6.3  x  10-7) 
44122/7R  10520  2.58  x  10-3  2.69  x  10-7 
(RP1::  Tn501)  (±9.6  x  10-4)  (±5.1  x  10-8) 130 
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of  B.  pertussis  BPT2.  Since  the  original  host'E.  'Cdli  strain  of  pUW964 
was  Na1R,  which  precluded  use  of  nalidixic  acid  as  the  selective  antibiotic, 
the  plasmid  was  transferred  to  JC3272,  via  an  intermediate  StrS  host  (K12) 
since  the  original  host  strain  of  this  plasmid  was  also  StrR  (Table  35).  The 
plasmids  transferred  at  high  frequencies  between'E.  cöli  strains.  Using 
JC3272  carrying  pUW964  as  donor  and  B.  pertussis  BPT2  as  recipient  single 
colony  transposon  insertion  mutants  were  obtained  by  selection  on  BGA  contain- 
ing  kanamycin  and  nalidixic  acid.  It  was  found  that  the  initial  concentration 
of  kanamycin  used  (10ug  ml-1)  for  selection  of  transconjugants  was  inhibitory 
to  growth.  By  selecting  on  5ug  ml  kanamycin,  single  colonies  of  '  B.  pertussis 
1 
expressing  Tn5  kanamycin  resistance  were  capable  of  growth.  (Table  36). 
Transposon  transfer  frequency  was  low,  but  was  still  about  1000  times  the 
spontaneous  mutation  frequency.  However,  it  was  not  possible  to  study  these 
mutants  further  as,  upon  restreaking  on  kanamycin,  they  failed  to  grow. 
Plasmid  pUW942,  carrying  Tn501  was  transferred  directly  from  its  original  NalS 
host  to  B.  pertussis  BPT2,  by  selection  on  BGA  containing  HgC12  and  nalidixic 
acid  (Table  37).  After  the  plasmid  transferred,  50  colonies  which  grew  in 
the  presence  of  HgC12  were  tested  for  loss  of  kanamycin  and  carbenicillin 
resistance,  which  would  indicate  loss  of  the  plasmids.  None  of  the  colonies 
tested  were  resistant  to  kanamycin  and  carbenicillin  but  continued  to  exhibit 
resistance  to  mercury,  indicating  that  all  carried  Tn50l  and  were  transposon 
insertion  mutants.  The  50  colonies  were  then  tested  for  their  nutritional 
characteristics,  by  streaking  on  CSM.  None  of  the  colonies  grew  on  CSM, 
indicating  that  all  carried  auxotrophic  mutations.  However,  further  character- 
isation  of  nutritional  requirements  by  streaking  on  CSM  amino  acid  'pool' 
plates  failed  to  show  auxotrophic  requirements  as  all  mutants  grew  on  all  of 
the  amino  acid  pools.  All  mutants  were  tested  for  their  haemolytic  ability 
on  BGA.  All  colonies  were  haemolytic  as  was  the  parent  BPT2. 132 
Table  35  -  Transfer  of  the  chimeric  plasmid  pUW  964  to  E.  coli  JC3272 
via  K12  intermediate,  with  selection  on  ECMA  and  NA. 
HB  101  reversion  frequency  to  prototrophy  was  <  6.0  x  10-8, 
K12  reversion  to  selective  antibiotic  resistance  was 
<_7.2  x  10-8.  JC  3272  reversion  to  kanamycin  and 
carbenicillin  resistance  was  <3.8  x  10-10.  Transfer  frequencies 
are  defined  in  Materid.  $  and  Methods.  Results  are  means  of 
3.  observations. 
Donor  plasmid  transfer 
(plasmid)  Recipient  frequency_ 
(SEM) 
HB101  (pUW  964)  K12  1.8  x  10-2 
(±1.2  x  10-3) 
K12  (pUW  964)  JC  3272  9.35  x  10-4 
(±1.1  x  10-4) 133 
Table  36  -  Transfer  of  the  suicide  plasmid  pUW  964  from  E.  coli 
to  B.  pertussis  Transposon"containing  recipients  were 
selected  on  BGA  containing  nalidixic  acid  and  kanamycin. 
Spontaneous  mutation  of  recipient  to  KmR  was  <9.5  x  10-10, 
-  10 
spontaneous  mutation  of  donor  to  Nal  was  "<  1.7  x  10. 
Transposon  inheritance  frequency  is  defined  as  the  number 
of  KmR  recipients  divided  by  total  number  of  recipients. 
transposon  mean 
Donor  (plasmid)  Recipient  Expt.  no  inheritance  inheritance 
frequency  frequency  (SEM) 
E.  coli  JC3272  B.  pertussis  1  4.07  x  10-7  4.15  x  10-7 
(pUW  964)  BPT  223.79  x  10-7 
3  4.65  x  10-7  (±2.58  x  10-8) 134 
Transposon-induced  mutagenesis  by  Tn5  in'B.  -parapertuttis  was  also 
studied  (Table  38).  By  selecting  for'B.  paräpertussis  10520  transposon 
insertion  mutants  on  SSA  supplemented  with  BSA  (0.05')  and  containing  chlor- 
amphenicol  and  kanamycin,  pinhead  colonies  grew.  Transposition  apparently 
occurred  at  high  frequency  and  colonies  of'  B.  "patapettüssis  produced  a  dis- 
tinctive  brown  halo.  However,  it  was  not  possible  to  restreak  the  colonies 
on  BGA  containing  low  levels  of  antibiotics  due  to  overgrowth  of  the  donor 
strain  carried  over  from  the  original  selection  plates. 
3.17  Restriction  modification-in  B.  pertüssis. 
Chromosomal  DNA  from  several  strains  of  'B.  pertussis  and'B.  '  'parapertussis 
was  digested  with  the  restriction  enzymes  HindIII  and  EcoRI.  Digestion  patterns 
were  visualised  by  ethidium  bromide  staining  in  agarose  gel  electrophoresis 
(Figure  5).  DNA  was  found  to  be  susceptible  to  digestion  with'EcoRI  but  not 
HindIII.  The  activity  of  the  HindIIl  was  checked  by  digestion  of  methylated 
and  non-methylated  bacteriophage  X  (lambda)  DNA,  and  was  found  to  be  capable 
of  digesting  non-methylated  DNA  but  not  methylated  DNA,  while'EcoRI  digested 
both  types,  Therefore,  it  appeared  that  B.  pertussis  and'B.  parapertussis 
DNA  was  methylated  at  sites  of  HindIIl  digestion. 
3.18  Bacteriophage  studies. 
3.18.1  Induction  of  a  lysogenic  bacteriophage  from'B.  ''pertuStis. 
The  possibility  that  virulent  strains  of  'B.  '  pertussis  may  harbour  a  lyso- 
genic  bacteriophage  which,  upon  lytic  infection  of'B.  parapertüs$is,  can  cause 
a  change  of  serotype  has  already  been  considered  (See  Introduction,  Section  4.2). 
B.  pertussis  strain  134  was  studied  to  determine  if  such  a  bacteriophage  could 
be  detected  either  by  spontaneous  release,  or  by  induction  from  the  lysogenic 135 
Table  37  -  Transfer  of  the  suicide  plasmid  pUW942  from  E.  coli  to 
B.  Pertussis,  Transposon  containing  recipients  were 
selected  on  BGA  containing  mercuric  chloride  and  nalidixic 
acid.  Spontaneous  mutation  of  recipient  to  H'g  R 
was 
<  4.1  x  10-10  while  spontaneous  mutation  of  the  donor 
to  NalR  was  <  6.1  x  10-10.  Transposon  inheritance 
frequency  is  the  number  of  Hg 
R 
recipients  divided  by  total 
number  of  recipients. 
Donor  Exp.  transposon  mean 
(plasmid)  Recipient  No.  inheritance  inheritance 
frequency  frequency  (SEM) 
E.  coli 
UW937  (pUW942)  B.  pertussis  1  4.0  x  10-6  4.15  x  10-6 
BPT  223.27  x  10-6 
3  5.19  x  10-6  (±5.6  x  10-7) 136 
Table  38  -  Transfer  of  suicide  plasmid  pUW  964  from  E.  coli  to 
B.  parapertussis  by  selection  on  SSA  containing 
chloroamphenicol  .  Transposon  transfer  frequency  is 
defined  as  the  number  of  KmR  B.  parapertussis  recipients 
divided  by  total  number  of  recipients.  Spontaneous 
mutation  frequency  of  the  recipient  to  KmR  was 
<3x  10-9,  while  spontaneous  mutation  of  the  donor 
.  to  Cm  was  <  6.2  x  10- 
10  R 
Donor 
(plasmid) 
E.  coli 
HB101  (pUW  964) 
Recipient 
B.  parapertussis 
10520 
transposon  transfer 
frequency 
2.1  x  10-2 
1.57  x  10-2 
mean  transfer 
frequency  (SEM) 
1.84  x  10-2 
(±2.6  x  10-3) Figure  5 
Y 
Digestion  by  restriction  enzymes'EcoRI  and'HindIIl  of 
chromosomal  DNA  from'B:  'pertüssis  and'B.  'parapertussis. 
Tracks  1  and  2.  B.  parapertussis  10520  DNA  digested  with 
'EcoRI  (Track  1)  and  HindIIl  (Track  2). 
Tracks  3  and  4.  B.  pertussis  44122/7R  DNA  digested  with 
EcoRI  and  HindIIl  respectively. 
Tracks  5  and  6.18334  DNA  digested  as  above. 
Tracks  7  and  8.  L84  Phase  I  DNA  digested  as  above. 
Tracks  9  and  10.  Methylated  A  phage  DNA  digested  as  above. 
Tracks  11  and  12.  Non-methylated  A  phage  DNA  digested  as  above. aR1 
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state  using  mitomycin  C.  A  repeat  of  the  experiment  of  Lapaeva'et'al.  (1981) 
was  carried  out,  in  which  varying  concentrations  of  mitomycin  C  were  added  to 
cultures  of"B.  pertüssis  134.  Phage  lysate  (see  Materials  and  Methods, 
Section  2.2.10)  was  added  tö'B..  'päräpertüssis  indicator  bacteria  on  which  any 
phage  presentsvo  uld  be  seen  as  a  lytic  or  lysogenic  plaque.  However,  no 
plaques  were  visible  on  the  B.  parapertussis  lawn,  suggesting  that  there  was 
no  release  of  a  bacteriophage  from'B.  pertussis  either  spontaneously  or  following 
mitomycin  C  treatment.  It  was  not  possible  to  use  B.  'pertussis  as  the  indicator 
organism  due  to  its  inability  to  grow  in  the  overlay  medium. 
3.18.2  Replication  of  bacteriophage  Mu  in'B.  pertüssis. 
Bacteriophage  Mu  cts  62 
,a  temperature-sensitive  derivative  of  Mu,  which 
forms  viable  phage  particles  at  non-permissive  temperatures  (42°C)  was  intro- 
duced  into  B.  pertussis  44122/7R  by  conjugation.  The  Mu  prophage  was  delivered 
to  B.  pertussis  on  plasmid  RP4  and  transconjugants  were  selected  on  BGA  contain- 
ing  streptomycin,  kanamycin  and  carbenicillin  (Table  39).  To  determine  if 
B.  pertussis  was  capable  of  supporting  the  lytic  cycle  of  bacteriophage  growth, 
100ml  of  an  exponential  culture  of  B.  'pertussis  44122/7R  (RP4::  Mucts62)  grown 
at  37°C  was  further  incubated  at  39°C  or  42°C  for  1-2h.  Culture  supernate 
was  examined  for  the  presence  of  phage  by  adding  100pl  of  each  of  a  series  of 
10-fold  dilutions  of  the  lysate  to  an  indicator  organism  -  in  this  case'E.  coli 
K12.  The  phage  and  bacterial  suspensions  were  incorporated  in  3ml  agarose 
overlays.  Following  incubations,  plaques  were  visible  on  the*E.  oli  lawn 
(Table  40)  indicating  that  Mu  had  (nee»  r.  idoced-.  via  the  lytic  cycle  in'B.  -pertussis 
which  was  induced  at  39°C  and  at  42°C.  About  1x  104  viable  phage  particles 
were  produced  per  ml  of'B  pertüssis  culture. 139 
Table  39  -  Transfer  of  plasmid  RP4  ::  Mu  cts  62  from  E.  coli  to 
B.  pertussis  by  selection  on  BGA.  Plasmid  transfer  frequency 
is  as  defined  in  Materials  and  Methods.  Spontaneous  resistance 
of  donor  and  recipient  to  selective  antibiotics  occurred 
at  frequencies  less  than  9.7  x  10-10. 
Exp.  plasmid  transfer  mean  transfer 
Donor  Recipient  No.  frequency  frequency 
(plasmid)  (SEM) 
E.  coli  B.  pertussis  1  1.0  x  10-3  1.30  x  10-3 
J53-1  44122/7R  2  1.4  x  10-3  (±1.5  x  10-4) 
(RP4::  Mucts62)  3  1.52  x  10-3 140 
Table  40  -  Induction  of  a  temperature-sensitive  mutant  of  bacteriophage 
Mu  from  B.  pertussis  44122/7R  (RP4::  Mu  cts  62)  determined 
by  plaque  formation  on  E.  coli  K12  indicator  bacteria  in_ 
agarose  overlays. 
Lysate  incubation  -  plaque-forming  units 
dilution  temperature-  (p.  f.  u.  )  per  ml  of 
lysate 
neat  42°C  1.21  x  104 
10-1  42°C  9.0  x  103 
neat  39°C  1.43  x  104 
10-1  39°C  9.0  x  103 
neat  37°C  0 141 
3.19  Effect  of'plasmid'presence'on'stimuläti6n'öf'neutrophil9'by 
B.  'pertussis. 
The  presence  of  a  plasmid-encoded  protein  the  product  of  the  traT  gene, 
on  the  surface  of'E.  'coli  cells  carrying  plasmid  R6.5,  enhances  resistance  of 
the  bacterium  to  phagocytosis  (Aquero'et'al.,  1984).  Since  plasmids  such  as 
R68.45  and  RP1  also  encode  similar  transfer  proteins,  these  plasmids  were 
examined  for  their  ability  to  enhance  resistance  to  phagocytosis  in  B.  pertussis. 
Initially,  E.  coli  JC3272  strains  carrying  various  plasmids  were  compared.  In 
several  independent  observations,  it  was  found  that  stimulation  of  phagocytes, 
as  measured  by  chemiluminescence,  (Allen  et'al.,  1976)  was  reduced  by  the 
presence  of  R68.45  and  RP1.  Although  the  degree  to  which  chemiluminescence 
was  reduced  varied  between  experiments,  RP1  and  R68.45  exhibited  a  similar 
effect  in  each  experiment.  The  presence  of  RP1::  Tn501  in  E.  coli  was  found 
to  greatly  enhance  the  neutrophil  chemiluminescent  response  (Figure  6).  In 
B.  pertussis  44122/7R  phagocytosis  was  not  found  to  be  significantly  affected 
by  plasmid  presence.  The  presence  of  Tn501  on  the  plasmid  RP1  appeared  to 
slightly  reduce  the  initial  high  level  of  chemiluminescence  but  had  no  effect 
thereafter  (Figure  7).  However,  when'B.  pertussis  BPT2  was  studied  (Figure  8), 
it  was  found  that  the  presence  of  R68.45  caused  a  delay  in  neutrophil  stimulation 
but  did  not  have  an  effect  on  the  levels  of  stimulation.  The  presence  of 
Tn501  on  the  plasmid  was  found  to  enhance  chemiluminescence  significantly. 
Plasmid  RP4::  Tn7  was  found  to  dramatically  increase  the  levels  of  chemilumin- 
escence  with  BPT2  but  was  not  tested  in  44122/7R. 
Whole  cell  SDS-PAGE  was  carried  out  on  E.  coli  JC3272  and'  B.  'pertussis 
44122/7R  strains  which  carried  the  plasmids.  Any  major  change  in  protein 
profiles  due  to  plasmid  or  transposon  coded  proteins  would  be  observed. 
However,  no  change  in  whole  cell  profiles  was  discernible  with  either  E.  coli 
or  B.  pertussis  transconjugants  (Figure  9). Figure  6:  Effect  of  plasmid  presence  on  neutrophil  chemilumines  cent 
response  to'E.  soli  JC3272  wild  type  and  E.  'coli  JC3272 
containing  plasmids  R68.45,  RP1  and  RP1::  Tn501. 
"""""""""  Control  -  no  bacteria  added. 
ý-----  JC3272  (RP1::  Tn501) 
-------  JC3272 
-"-"-"-  JC3272  (RP1) 
JC3272  (R68.45) 
Chemiluminescence  is  measured  in  arbitrary  units. 142 
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Tracks  1-4  E.  coli  JC3272  wild  type, 
JC3272  (R68.45),  JC3272  (RP1::  Tn501) 
and  JC3272  (RP1). 
Tracks  5-8  B.  pertussis  44122/7R  wild  type, 
44122/7RP  (R68.45),  44122/7R  (RP1::  Tn501) 
and  44122/7R  (RP1). 145 
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3.20  Transformation  in'B.  'pertussis 
Originally  observed  by  Branefors-  (1964),  this  work  was  repeated  using 
DNA  from  44122/7R  as  donor  in  an  attempt  to  transform  the  Str'  marker  to  StrS 
44122/75  recipients.  Using  the  procedure  described  in  Materials  and  Methods, 
Section  2.2.4  no  transformants  were  obtained,  although  a  few  small  colonies 
grew  on  selection  plates  (BGA  containing  streptomycin).  However,  these 
colonies  were  not  confirmed  as  B.  "pertüssis  since  they  grew  on  nutrient  agar, 
appeared  as  Gram-positive  cocci  in  microscopy  and  failed  to  agglutinate  in 
anti-B.  p  rtussis  antiserum. 
When  transformation  was  carried  out  in  the  presence  of  CaC12,  at  various 
concentrations,  no  transformation  was  observed,  although  as  before,  several 
small  colonies  appeared  which  could  not  be  confirmed  as  being  B.  pertussis. 
Since  no  transformation  was  detected,  the  B.  pertussis  44122/7S  recipient 
strain  was  studied  for  its  ability  to  produce  deoxyribonuclease  (DNase),  which 
could  prevent  transformation  by  digestion  of  incoming  DNA.  A  plate  assay 
was  used  and  as  a  positive  control,  Staphylococcus  aureus  Wood  46  was  tested 
in  parallel.  Both  organisms  were  examined  for  DNase  activity  at  pH  6.8, 
7.4  and  7.8  (Table  41,  Figure  10).  'Stapp.  aureus  produced  DNase  at  all  pH 
values  but  B.  pertussis  did  not.  Therefore  the  non-transformability  of 
B.  pertussis  could  not  be  attributed  to  extracellular  DNase  production. 147 
Table  41  DNase  production  at  various  pH  values  by  Staph  aureus  and 
B.  pertussis.  Organisms  were  grown  on  a  suitable  medium 
containing  DNA.  The  plates  were  flooded  with  1N  HC1  giving 
rise  to  precipitation  of,  DNA  with  zones-of-clearing  in  areas 
of  enzyme  activity. 
Strain  Diameter  (mm)  of  zone  of  clearing 
pH  6.8  7.4  7.8 
Staph 
aureus  577 
Wood  46 
B.  pertussis 
44122/7S  000 Figure  10  :  Determination  of  the  ability  of'B.  'pertussis  44122/7S 
to  produce  extracellular  DNase  using  a  plate  assay. 
Top  -  Stap  h.  aureus  Wood  46. 
Bottom  -  B.  p  ertussis  44122/7S. 148 149 
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4.1  Development  of  a  minimal  medium. 
Imaizum'et"al.  (1983)  investigated  the  effect  of  the  addition  of  various 
types  of  cyclodextrins  to  SSA  and  found  methylated  ß-clyclodextrin  to  be  the 
most  effective  in  allowing'B.  pertüssis  growth  from  small  inocula.  The 
medium  was  called  Cyclodextrin  Solid  Medium  (CSM)  and  contained  Casamino  Acids 
but  no  BSA.  In  comparison  with  BGA,  CSM  was  found  to  support  growth  of 
approximately  the  same  number  of  colonies  as  BGA  and  omission  of  Casamino  Acids 
led  to  less  rapid  growth  of  the  colonies.  In  the  current  study,  CSM  containing 
Casamino  Acids  was  found  to  give  a  viable  count  from  small  inocula  comparable 
to  that  on  BGA,  as  found  by  Imaizumi'et'al.  (1983).  Omission  of  Casamino  acids, 
in  addition  to  reducing  colony  growth,  led  to  about  a  100-fold  reduction  in 
plating  efficiency,  in  contradiction  to  the  findings  of  Imaizumi  et  al.  (1983). 
Inclusion  of  BSA  in  the  medium  restored  the  plating  efficiency  to  a  high  level, 
with  an  attendant  increase  in  growth  rate  while  inclusion  of  both  BSA  and 
casamino  acids  further  increased  plating  efficiency,  indicating  that,  singly, 
the  components  fail  to  remove  all  the  inhibitors  present.  Although  the  effect- 
iveness  of  MeßCD  in  overcoming  inhibition  may  not  have  been  as  marked  as  claimed 
by  Imaizumi,  addition  of  BSA  and  casamino  acids  makes  CSM  a  useful  medium  for 
use  in  genetic  studies.  However,  for  isolation  of  auxotrophic  mutants  and 
for  their  use  as  recipients  in  transfer  of  nutritional  markers,  the  BSA  concen- 
tration  may  have  been  sufficiently  high  to  provide  the  mutants  with  the  required 
amino  acids.  Although  lower  concentrations  of  BSA  were  suitable  for  B.  pertussis 
growth,  absence  of  BSA  failed  to  support  growth.  Auxotrophic  mutants,  which 
were  subsequently  isolated,  could  not  grow  on  CSM  containing  BSA  unless  the 
required  amino  acid  was  provided.  This  was  also  found  to  be  the  case  for  a 
Trp  mutant  which  failed  to  grow  in  the  presence  of  0.15%  BSA  (Weiss  and  Falkow, 
1983).  BSA  and  MeßCD,  in  the  medium,  appear  to  have  a  synergistic  effect  on 
growth  from  small  inocula.  This  can  be  explained  if  the  effect  of  the  Me8CD 151 
is  the  same  as  that  of  BSA.  Both  components-  may  neutralise  growth  inhibitors  - 
by  interacting  with-fatty  acids  in  the.  medium.  Cyclodextrins,  in  common  with 
albumin,  are  capable  of  operating  as  carriers  of  fatty  acids  in  tissue  cultures 
(Yamane'et'al.,  1981).  Albumin  has  been  shown  to  be  beneficial  in  the  culture 
of  the  genus  Leptosnira  (Johnson  and  Gary,  1962).  Alternatively,  MeßCD  may 
stabilise  and  enhance  uptake  of  an  essential  component  such  as  glutathione  by 
incorporation  of  reduced  glutathione  in  the  cavity  of  the  McBCD  molecule. 
Having  stabilised  the  component,  MeßCD  may  enhance  uptake  into  the  bacterial 
cell. 
Growth  of'B.  päräpertüssis  was  found  to  be  supported  by  SSA  but  only  a 
small  proportion  of  the  total  cell  population  was  capable  of  growth  on  MacConkey 
Agar.  However  a  single  colony  from  MacConkey  Agar  gave  a  plating  efficiency 
of  74%,  following  growth  in  liquid  media.  The  growth  of'B.  parapertussis  on 
this  medium  may  have  selected  a  variant  which  may  represent  a  phase-shift 
type  of  variation.  Selection  on  SSA  could  be  used  to  isolate  variants  of 
B.  pertussis  (Peppler,  1982)  at  low  frequency.  Variants  capable  of  growth  on 
nutrient  agar  were  isolated  in  a  similar  manner  (Peppler  and  Schrumpf,  1984a) 
as  were  variants  of  B.  'bronchiseptica  by  selection  on  Brucella  agar  (Peppler 
and  Schrumpf,  1984b).  It  may  be,  therefore,  that  growth  of'B.  parapertussis 
on  MacConkey  Agar  selects  for  variants,  in  the  cell  population,  which  are 
analagous  to  Phase  III'B:  'bronchiseptica  (Nakase,  1957)  or  Phase  IV'B.  pertussis 
(Leslie  and  Gardner,  1931)..  These  variants  produced,  after  4-5  days  incubation, 
outgrowths  from  the  colony  giving  rise  to  a  star-like  appearance.  Since 
clonal  proliferation  at  the  periphery  of  a  colony  begins  with  a  subset  of  all 
cells  in  the  colony  (Shapiro,  1984)  it  may  be  that  there  was  a  further  population 
of  variant  cells  within  the  original  variant  population.  Further  study  of 
these  properties  would  confirm  if'B.  ''parapertussis  undergoes  phase-variation 
typical  of  the  other  members  of  the  genus. 152 
4.2  Mutagenesis. 
Mutant  isolation  is  an  essential  step  in  the  development  of  a  system  of 
experimental  genetics  of  a  hitherto  neglected  organism  in  which  a  stock  of 
mutants  is  lacking.  The  use  of  NTG  in  mutagenesis  induces  a  high  frequency 
of  mutation  at  doses  which  result  in  little  killing.  Although  NTG  has  been 
used  in  isolation  of  mutants  of  various  bacterial  species,  the  optimal  condit- 
ions  for  mutagenesis  have  been  mostly  elucidated  using  E.  'coli  K12  (Adelberg 
et  al.,  1965).  However,  NTG  mutagenesis  can  result  in  the  creation  of 
multiple  mutations  and  as  a  general  rule,  individual  mutations  should,  if  a 
suitable  genetic  system  exists,  be  transferred  into  an  isogenic  background 
by  transfer  to  a  non-mutagenised  recipient  (Sparling,  1983).  The  method  of 
isolation  of  B.  'pertüssis  antibiotic  resistant  mutants  used  NTG  at  an  initial 
concentration  of  200pg  ml-l.  Mutants  of  'B.  pertüssis  strain  Taberman  and 
Tohama  which  were  nalidixic  acid  resistant  arose  about  1.5  cm  from  the  centre 
of  the  paper  disk,  suggesting  that  there  was  an  optimal  concentration  of  NTG 
at  which  such  mutants  are  induced.  NTG  activity  has  been  shown  to  be  optimal 
at  about  100ug  ml 
-l 
at  pH  6.0,  although  a  pH  value  of  7.0  reduced  mutagenic 
activity  by  only  30%  (Adelberg'et'al.,  1965).  It  may  be  that-an  optimum  NTG 
concentration  exists  at  which  Na1R  mutants  of'B.  pertussis  arise  since  Na1R 
colonies  were  about  equidistant  from  the  centre  of  the  disk.  Treatment  of 
Phase  I  B.  pertussis  with  NTG  has  been  found  to  induce  a  high  level  of  phase 
change  (C.  Duggleby,  Personal  Communication).  Similarly,  NTG  treatment  to 
obtain  antibiotic  resistant  mutants  has  given  rise  tp  organisms  which  have 
properties  consistent  with  those  of'B.  päräpettüssis  (Kumazawa  and  Yoshikawa, 
1978)  leading  to  speculation  that'B.  "parapertüssis  is  a  mutant  of'B.  pertussis 
which  arises  in  nature  due  to  the  selective  pressue  of  antibiotics.  This  is 
unlikely,  however,  since  only  erythromycin  is  used  in  antibiotic  therapy,  and 
is  usually  administered  in  the  paroxysmal  stage  of  the  disease,  when  the 153 
aetiological  agent  has  all  but  disappeared  from  patients. 
In  this  study,  phase  change  was  not  induced  by  NTG  treatment.  Mutants 
and  wild  type  strains  all  exhibited  phase  I  properties  :  they  agglutinated 
in  Phase  I  antiserum  and  failed  to  grow  on  nutrient  agar.  However,  it  may  be 
that  mutant  and  wild  type  Tohama  isolates  lacked  the  28  and  30  KD  protein  bands 
as  revealed  by  SDS-PAGE,  although  subsequent  work  has  cast  doubt  on  this. 
Loss  of  these  proteins  has  been  associated  with  phase  shift  and  loss  of  biolog- 
ical  activities  (Parton  and  Wardlaw,  1975;  Wardlaw'et'al.,  1976;  Dobrogosz 
et  al.,  1979). 
Isolation  of  B.  pertussis  auxotrophic  mutants  was  carried  out  by  a  method 
similar  to  that  of  Miller  (1972).  Some  strains  (L84  Phase  I  and  Phase  IV 
strains)  showed  resistance  to  penicillin  G  in  the  auxotroph  enrichment  procedure. 
The  natural  resistance  of  some'B.  ''pertüssis  strains  to  penicillin  G  has  been 
previously  observed  (Field  and  Parker,  1980),  although  the  antibiotic  was 
bacteriostatic  at  5pg  ml-1.  In  this  study,  the  susceptibility  of  each  strain 
to  penicillin  G  may  have  contributed  to  the  differences  observed  in  the  number 
of  presumptive  auxotrophs  obtained.  e.  g.  Strain  CSP1  gave  rise  to  auxotrophs 
more  readily  than  BPN6,  but  the  parent  of  BPN6  (Tohama)  was  found  to  be 
resistant  to  low  levels  of  ampicillin,  reflecting  reduced  effectiveness  of  the 
penicillin  G  procedure. 
4.3  Intrinsic  antibiotic  resistance  in'B.  ''pertussis. 
Relatively  few  studies  on  the  susceptibility  of'B.  pertüssis  to  various 
antibiotics  have  been  performed  '  in'  vitro.  The  only  antibiotic  to  which  the 
organism  is  uniformly  sensitive'i`n'vitro  is  erythromycin  (Field  and  Parker, 
1980;  Bannatyne  and  Cheung,  1982;  Zackrisson'et  al.,  1983).  Low  level 
resistance  to  trimethoprim  has  been  reported  (Zackrisson'et'al.,  1983)  and 154 
the  organism  has  been  found  to  exhibit  resistance  to  some  cephalosporins 
(Shi'shidö'et'al.,  19801.  Mutants  of  'B.  '  'pertüssis,  which  would  be  suitable 
for  use  in  genetic  studies  were  not  available  at  the  outset  of  this  study. 
The  only  antibiotic  resistant  strain  available  locally  was  the  StrR  44122/7R 
of  Branefors  (1964J,  although-Weiss  and  Falkow  (1982)  used  spontaneous  StrR 
and  RifR  mutants  of  Tohama  as  recipients  in  plasmid  transfer  studies.  Screening 
of  available  strains  for  naturally-occurring  antibiotic  resistance  yielded  no 
suitable  antibiotic  resistance  markers  for  use  in  genetic  systems  which  involved 
transfer  of  plasmids  encoding  ß-lactam  resistance.  However,  B.  parapertussis 
10520  was  found  to  be  resistant  to  chloramphenicol,  a  property  which  was 
utilised  in  transfer  of  plasmids  and  chromosomal  markers  from  CmS  B.  'pertussis 
donors.  Although  little  evidence  of  antibiotic  resistance  in  Phase  I  strains 
was  apparent,  Phase  IV  strains  tested  showed  resistance  to  antibiotics  where 
the  corresponding  Phase  I  strain  did  not.  This  is  in  keeping  with  other 
findings  which  show  tolerance  to  erythromycin  and  resistance  to  tetracycline, 
oleic  acid,  rifampicin  and  penicillin  G  to  be  characteristic  of  degraded  strains 
(Weiss  and  Falkow,  1984;  Peppler  and  Schrumpf,  1984). 
4.4  Determination  of  optimal  conditions  for  plasmid  transfer  and  chromosome 
mobilisation  in  E.  coli. 
All  matings  in  these  experiments  were  initially  done  as  filter  matings 
which  yielded  high  plasmid  transfer  frequencies.  This  method  has  been 
extensively  used  in  studies  on  plasmid-mediated  chromosome  mobilisation,  using 
R68.45  and  RP1,  in  other  species  CJacob'et'al.,  1976;  Megias'et'al.,  1982). 
In  this  study  frequency  of  mobilisation  of  the  donor  Na1R  marker  was  about 
10 
9 
to  10 
8. 
Although  R68.45  is  a  varient  of  R68  which  has  enhanced  cma 
ability  (Haas  and  Hollaway,  1976),  mobilisation  frequencies  were  still  relatively 
low.  Subsequently,  the  use  of  transposons  to  generate  Hfr  like  donors  was 155 
studied  (see  below?.  The  stability  of'cma  ability  in  R68.45  has  been  shown 
to  be.  increased  by  maintenance  of  the  donors  on  kanamycin  (Haas  and  Holloway, 
1976),  thus  indicating  that  resistance  to  kanamycin  can  be  used  as  a  selective 
marker  for  strains  which  harbour  ä'cma-proficient  plasmid  (Currier  and  Morgan, 
1982).  The  presence  of  kanamycin,  in  this  study,  was  found  to  enhance  cma 
in  E.  coli  and  in  cases  where  'E.  coli  or'B.  pertüssis  transconjugants  were  used 
as  genetic  donors,  kanamycin  was  included  in  the  medium. 
In  order  to  produce  a  system  of  mating  which  would  yield  high  plasmid 
transfer  and  chromosome  mobilisation  frequencies,  and  be  suitable  for  use  with 
B.  pertussis,  several  types  of  mating  systems  were  investigated.  Filter 
matings  produced  highest  transfer  frequencies  between'E.  cöli  strains  but  were 
prone  to  atmospheric  contamination  when  used  with'B.  "pertussis.  Mating  of 
donor  and  recipient'E.  'coli  cells  in  broth  containing  0.1%  agar  has  been  shown 
to  result  in  a  very  large  increase  in  the  number  of  transconjugants  obtained, 
when  compared  to  mating  in  broth  in  the  absence  of  agar  (Groot  Obbink  and 
Ackerman,  1980).  Mobilisation  of  the  ApR  marker  increased  2000  times  in  the 
presence  of  0.1%  agar  and  it  was  postulated  that  agar  facilitates  formation  of 
mating  aggregates.  However,  the  present  study  indicated  that  R-plasmid  - 
borne  antibiotic  resistance  was  transferred  at  a  slightly  lower  rate  in  the 
presence  of  agar  in  broth  and  the  massive  increases  described  by  Groot  Obbink 
and  Ackerman  (1980)  were  not  apparent. 
Plasmids  such  as  those  of  the  N  and  P  groups  were  suspected  as  being  better 
able  to  transfer  on  solid  media  rather  than  in  liquids  (Dennison  and  Baumberg, 
1975).  This  was  confirmed  by  Bradley'et'al.  (1980)  who  demonstrated  a  2000- 
fold  increase  in  transfer  frequency  with  plasmids  of  the  N  and  P  groups  compared 
to  broth  matings,  the  P  group  plasmid  studied  being  RP1.  It  appears  as  a 
general  rule  that  matings  performed  on  solid  surfaces  are  much  more  efficient 
than  those  in  liquid  media  Beringer  and  Hopwood,  1976;  Haas  and  Hollaway, +, 
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1976;  Chatterjee,  1980).  Mobilisation  of  chromosomal  markers  by  R68.45 
is  mediated  at  comparable-efficiency  in  both  plate  and  filter  matings,  which 
. are  much  more  efficient  than  those.  in  broth  (Ramada  et  al.,  1979). 
In  the  present  study,  filter  matings  on  solid  media  were  found  to  mediate 
approximately  a  50-fold  increase  in  plasmid  transfer  frequency  between  E.  coli 
strains  compared  to  broth  mating.  Plate  matings  were  marginally  more 
efficient  at  allowing  plasmid  transfer.  than  broth  matings  but  were  preferred, 
for  use  with  B.  Pertussis,  to  filter  matings  due  to  their  greater  freedom 
from  contamination.  The  great  differences  between  transfer  frequencies  on 
solid  and  liquid  media  observed-by  other  workers  may  have  been  due  to  the 
gentle.  shaking  which  was  used  in  their  broth  matings  but  not  in  this  study. 
This  may  have  had  the  effect  of  disrupting  mating  aggregates  and  preventing 
plasmid  transfer. 
Another  variable  which  may  have  an  effect  on  plasmid  transfer  was  donor: 
recipient  ratio.  Although  most  workers  carry  out  plasmid  transfers  with  donor: 
recipient  ratios  of  1:  1,  Chatterjee  (1980),  in  transferring  R68.45  to  Erwinia 
chrysanthemi  used  donor:  recipient  ratios  of  1:  5  or  1:  10,  but  did  not  comment 
on  any  differences  which  may  have  been  observed.  In  the  present  study,  using 
ratios  of  1:  1,1:  5  and  1:  10,  no  effect  on  plasmid  transfer  between  E.  coli 
strains  was  evident  but  at  1:  10  mobilisation  of  the  Na1R  marker  was  reduced 
10-fold.  In  another  report,  a  500-fold  increase  in  mobilisation  was  reported 
as  donor:  recipient  ratio  changed  from  5:  1  to  1:  30  (Hamada'et  al.,  1979). 
4.5  Plasmid  transfer  from'E:  'c6li.  tö'B.  pertüs-tis. 
A  problem  in  developing  the  plasmid'transfer  system  between'E.  'e6li  and 
B.  pertüssis  was  to  allow  sufficient  time  for  mating  and  plasmid  transfer  to 
occur  while-prohibiting  overgrowth  of*E:  'Cöli  to  such  an  extent  to  ensure  that 157 
mutants  resistant  to  the  selective  antibiotic  did  not  arise.  This  was  over- 
come  by  addition  of  cephalexin  to  the  mating  medium  (Regan  and  Lowe,  1977; 
Stauffer  et'al.,  1983)  which,  while.  allowing'B.  'pertu$sis  to  grow,  prevented 
overgrowth  of'E;  'coli  in  overnight  matings.  Addition  of  cephalexin  had  no 
effect  on  plasmid  transfer.  Alternatively.  B.  pertüssis  cells  were  grown 
alone,  before.  mating  with  E.  coli  for  a  short  period  of  time  between  4  and  6 
hours.  This  procedure  reduced  the  amount  of'E.  ''Coli  growth  and  still  allowed 
sufficient  time  for  plasmid  transfer  to  occur. 
Plasmid  R68.45  transferred  from'E.  ''coif  to  B.  'pertussis  at  frequencies 
about  10-fold  less  than  the  lowest  frequency  observed  for  transfer  between 
E.  coil  strains.  This  compared  favourably  with  other  inter-species  transfers. 
For  example,  R68.45  transfrred  from'Ps.  ''deruginosa  to  Paracoccus  denitrificans 
at  frequencies  of  10 
8 
to  10 
7 
per  recipient  (Paraskeva,  1979)  and,  in  a 
situation  more  analagous  to  the  present  study,  R68.45  transferred  at  about 
5x  10 
3 
per  recipient  from'E.  'cöli  to'Legiönellä'pneumophila  an  organism  in 
which  similar  problems  of  fastidious  growth  are  encountered  (Dreyfus  and 
Iglewski,  1985). 
Plasmid  RP4  has  been  found  to  transfer  at  about  10-5  per  recipient  to 
B.  pertussis  from  E.  coli  (Weiss  and  Falkow,  1982).  In  the  light  of  these 
observations,  the  plasmid  transfer  system  developed  here  compares  favourably. 
If  the  B.  pertussis  transconjugants  obtained  were  to  be  of  use  in  studying 
chromosome  mobilisation,  they  must  be  capable  of  acting  as  genetic  donors. 
This  was  shown  to  be  the  case,  as  R68.45  was  found  to  transfer  into  a  suitable 
E.  coli  recipient  at  a  frequency  about  100-fold  lower  than  the  transfer 
frequency  from  E:  'cali  to'B.  'pertüssis.  No  attempt  was  made  to  screen  for 
transfer  of  a  B.  'pertussis  chromosomal  marker  since  it  was  unlikely  that  any 
transferred  gene  would  undergo  recombination  in'E.  'cöli.  Transfer  of  R68.45 158 
between  strains  of  'B.  '  pertüssis,  using  Taberman  R1  as  recipient,  was  as  high 
as  the  observed  frequency  between*E.  -Cöli  strains,  indicating  that  the  inter- 
species  barrier  has  a  major  effect  on  plasmid  transfer  and  expression.  This 
may  reflect  the  evolutionary  diversity  of  donor  and  recipient  restriction 
and  modification  systems.  It  may  be  that  the  more  closely  related  the  donor 
and  recipient  are,  in  evolutionary  terms,  the  less  the  plasmid  is  susceptible 
to  restriction  and  modification  by  the  new  host  systems,  and  the  species 
barrier  becomes  a  less  formidable  obstacle. 
In  a  similar  situation  to  that  of  B.  "pertüssis,  R68.45  transferred  at  a 
frequency  of  10-5  from  L.  pneumophila  to  E.  'coli  while  transfer  to  another 
L.  pneumophila  strain  occurred  at  a  100-fold  greater  frequency  (Dreyfus  and 
Iglewski,  1985).  A  more  extreme  example  of  this  was  in  studies  on  transfer 
of  RP4  from  E.  coli  to  the  gliding  bacterium'Myxococcus'xanthus  (Breton  et  al., 
1985).  RP4  transferred  to'M.  ''xanthus  at  a  frequency  of  10 
8, 
but  could  not 
replicate  in  this  organism  and  integrated  into  the  host  chromosome.  However, 
RP4  transferred  to  another  strain  of  M.  xanthus  at  a  frequency  of  10-3  but 
again  failed  to  replicate.  This  strain  was  known  to  possess  a  lower  level 
or  absence  of  restriction  enzyme  activity  suggesting  that  the  expression  and 
replication  of  the  plasmid,  in  distantly  related  species,  is  governed  by  the 
host  restriction  systems.  It  seems,  therefore,  that  the  ability  of  these 
plasmids  to  replicate  in'B.  "pertüssis;  'E:  'coli  and'L.  'pneumophila,  but  not  in 
M.  fanthus  may  reflect  the  evolutionary  divergence  of  restriction  enzyme 
systems.  The  possibility  that  transfer  of  plasmid-borne  antibiotic  resistance 
was  due-to  transformation  was  excluded  due  to  continued  transfer  on  medium 
which.,  contained  DNase.  During  cell  to  cell  contact,  the  transferring  DNA 
would  not  be  susceptible  to  the  action  of  DNase. 
Using  transconjugants  of'B.  "pettüssis  44122/7R  as  genetic  donors  and 
Taberman  R1  (Rif  R)'as 
recipient,  it  was  not  possible  to  obtain  mobilisation 159 
of  the  donor  StrR  marker.  This  was.  due_to  a  high  level  of  spontaneous 
mutation  of  donor  and  recipient  to  the  selective  antibiotics.  In  other 
Gram-negative  species,  StrR  and  Rif 
R 
have  been  shown  to  be  linked  (Bachmann, 
, 
1983;  Mekalanos'et'al.,  1979),  and  linkage  of  these  markers  was  also  reported 
to  occur  in  B.  'pertussis  (Weiss  and  Falkow,  1983). 
4.6  Transfer  of  other  plasmids  tö'B.  'pertussis. 
Plasmids  RP1  and  RP1::  Tn50l  transferred  at  high  frequencies  between  strains 
. of  E.  coli  and  transposon  Tn501  was  expressed  in  the  recipient.  R68.45supdnaG315 
however,  transferred  at  extremely  low  frequencies.  This  plasmid  has  been 
shown  to  possess  enhanced'cma  ability  in  Rhizobium  spp.  (Ludwig  and  Johansen, 
1980)  but  data  on  its  transferability  was  not  given.  Although  the  plasmid 
_, 
transferred  at  low  frequency  to  B.  pertüssis  44122/7R,  it  was  not  included 
in  the  range  of  plasmids  which  were  used  to  mobilise  chromosomal  markers  in 
this  organism.  Low  transferability  would  create  an  even  lower  rate  of 
mobilisation.  All  plasmids,  including  RP4::  Tn7,  were  transferable  from 
E.  coli  to  B.  'pertussis  44122/78  using  streptomycin  to  select  for  recipients. 
Although  TO  encodes  resistance  to  streptomycin  in'E.  cöli  (Barth'et  al.,  1976) 
selection  with  high  streptomycin  concentrations  (200Ng  ml-1)  was  found  to 
prevent  donor  growth,  although  this  concentration  of  antibiotic  has  been  used 
to  select  for  transconjugants  of'Caüldbacter  which  carry  TO  (Ely  and  Croft, 
1982).  For  use  of  RP4::  Tn7  in  mobilising  StrR  donor  markers  and  employing 
the  plasmid  to  mediate-  mobilisation  to  StrR  recipients,  it  was  essential  that 
TO  did  not  encode  Str'  iri'B:  'pertüssis.  This  was  found  to  be  the  case. 
Expression  of  transposonwencoded  resistance  genes  has  been  shown  to  be  host 
dependent.  For  example,  Tn5  encodes  for  StrR  in  addition  to  KmR  in 
'Rhizöbium'meliloti  but  does  not  encode  Str'  in'E.  coli  (De  Vos  et  al.,  1984) 
since  the  necessary  streptomycin  phosphotransferase  is  not  expressed  in 160 
E.  coli  (Putnoky'et  al.,  1983).  Tn5-encoded  StrR  is  also  expressed  in 
C.  crescentus,  'Ps.  putida  and'Acinetobäcter  calcoaceticus,  but  not  in 
Klebsiella  aerogenes  (OýNeill'et'al.,  1984).  Recently  it  has  been  shown 
that  Tn5  encodes  StrR  in  B.  pertussis  but  not  in  E.  coli  (Weiss  and  Falkow, 
1984).  Although  no  similar  studies  on  host  dependent  expression  have  been 
carried  out  with  Tn7,  it  is  possible  that,  as  with  Tn5,  there  may  be  differ- 
ences  in  gene  expression  in  non-enteric  bacteria. 
Transconjugants  which  carried  plasmids  RP1  and  RP1::  Tn501  were  compared 
for  their  ability  to  mobilise  chromosomal  markers  between  strains  of  B.  pertussis. 
The  presence  of  transposons  and  insertion  sequences  has  been  shown  to  affect 
the  ability  of  the  plasmid  to  form  Hfr-like  donors  and  subsequently  to  promote 
chromosome  mobilisation  (Kleckner'et  al.,  1977).  The  cma  ability  of  R68.45 
in  A.  tum.  efaciens  could  be  improved  by  insertion  of  homologous  Tn5  sequencies 
on  the  chromosome  and  in  the  plasmid,  leading  to  Hfr  formation  and  enhanced 
chromosome  mobilising  ability  (Pischl  and  Farrand,  1983).  Hfr  formation 
was  more  likely  to  be  the  reason  for  enhanced  cma,  rather  than  R-prime  formation 
since  gene  transfer  occurred  in  a  polarised  manner,  and  R-prime  plasmids  would 
have  contained  chromosomal  material  from  both  sides  of  the  Tn5  insertion  site, 
which  they  did  not.  The  insertion  of  Tn501  into  plasmid  RP1  greatly  enhanced 
the  ability  of  this  plasmid  to  promote  chromosome  transfer  in  Rh.  sphaeroides 
(Pemberton  and  Bowen,  1981),  promoting  polarised  transfer  from  possibly  two 
origins  on  the  chromosome.  Tnl  and  Tn5  failed  to  enhance  mobilisation  and 
the  cma  enhancing  ability  of  Tn501  may  have  been  due  to  the  high  frequency 
with  which  Tn501  transposes,  allowing  formation  of  Hfr  like  donors  to  occur 
more  readily  (Stanisich  et  al.,  1977).  In  cases  where  transconjugants  of 
B.  pertussis  carrying  RP1::  Tn5Ol  were  selected  on  HgC121  the  transposon  was 
maintained,  but  plasmid-borne  antibiotic  resistance  was  lost  i.  e.  the  plasmid 
behaved  as  a  suicide  vehicle  for  delivery  of  Tn50l  to  the  B.  pertussis  chromo- 161 
some.  A  possible  explanation  for  this  is  that  transposition  of  Tn501  to 
the  bacterial  chromosome  occurred  but  the  absence  of  selection  for  plasmid 
maintenance  caused  the  plasmid  to  disappear  from  the  population,  leaving 
Tn501  in  the  chromosome.  It  is  therefore  feasible  to  generate  transposon 
insertion  mutants  using  RP1::  Tn5Ol  as  a  delivery  plasmid.  Another  explanation 
is  that,  upon  selection  of  transconjugants  on  kanamycin  and  carbenicillin,  the 
entire  plasmid,  via  cointegrate  formation,  inserted  into  the  chromosome. 
Tn501  cointegrates  are  efficiently  resolved  to  final  transposition  products 
only  after  growth_i'n  the  presence  of  Hg  salts  (Sherratt'et'al.,  1981).  If 
selection  was  carried  out  in  kanamycin  and  carbenicillin,  then  resolution  of 
cointegrates  would  not  occur  and  the  entire  plasmid  may  have  integrated  into 
the  chromosome.  Selection  on  Hg  salts  alone  will  induce  cointegrate  resol- 
ution,  which  may  leave  the  plasmid  unable  to  replicate. 
4.7  Effect  of  antigenic  modulation  on  plasmid  transfer. 
Weiss  et  al.  (1983)  found  that  the  frequency  of  plasmid  transfer  from 
E.  coli  to  B.  pertüssis  was  increased  by  addition  of  10mM  MgSO4  to  the  mating 
medium.  This  procedure  may  have  induced  antigenic  modulation  in  the 
B.  pertussis  recipients,  changing  them  from  X-mode  to  C-mode  (Lacey,  1960). 
Antigenic  modulation  is  known  to  be  induced  at  MgSO4  concentrations  of  10-11mM 
(Brownlie;  et  al.,  1983).  Antigenic  modulation  involves  changes  in  cell- 
envelope  composition  (Wardlaw'et'al.,  1976;  Wardlaw  and  Parton,  1979)  which 
may  have  had  an  effect  on  plasmid  transferability  if  C-mode  cells  form  conju- 
gative  aggregates-more-readily-than  X-mode  cells.  An  alternative  explanation 
is  that,  in  mating  of  donor  and  recipient,  fatty  acids  excreted  by  the'E.  coli 
donor  had  a  bactericidal  or  inhibitory  effect  on  X-mode'B.  *  pettü  gis,  while 
C-mode  cells,  being  resistant  to  fatty  acid  inhibition  (Pollock,  1949)  were 
unaffected.  Results  in  this  study  showed  that  mating  in  medium  containing 162 
MgSO4  (ZOmMZ  had  no  effect  on  plasmid  transferability  and  that  no  killing 
of  B.  'pertüssis  cells  by'E.  cöli  occurred. 
4.8  Agarose'gel'  elddtröpfieresis'Of'plesmid'DNA. 
Initial  attempts  to  visualise  plasmid  DNA  prepared  from'B:  'pertussis  used 
the  methods  of  Portnoy'et'al.  (1981),  Holmes  and  Quigley  (1981)  and  the  SCFSB 
(Materials  and  Methods,  Section  2.2.2)  as  used  in  the  laboratory  of  D.  Sherratt, 
University  of  Glasgow.  Although  the  Portnoy  and  SCFSB  procedures  were  suit- 
able  for  the  preparation  of  plasmid  DNA  from'E:  'cali,  they  were  not  as  suitable 
for  B.  pertussis.  The.  boiling  procedure  of  Holmes  and  Quigley  was  highly 
effective  when  used  for*E.  coli  and  plasmids"prepared  by  this  method  were 
susceptible  to  digestion  by  restriction  enzymes.  However,  the  procedure  was 
less  suitable  for  use  with'B.  -  pertüssis.  A  problem  was  apparent  at  the  stage 
of  cell  lysis.  E.  coli  cells  resuspended  evenly  in  STET  lysis  buffer,  thus 
giving  rise  to  more  efficient  lysis  by  lysozyme,  as  indicated  by  the  'fluffy' 
pellet  recovered  after  centrifugation.  With  B.  pertussis,  cells  tended  to 
clump  in  STET,  despite  the  inclusion  of  Triton  X-100,  and  were  not  as  suscept- 
ible  to  lysozyme  activity.  The  pellet  following  centrifugation,  contained 
some  whole  cells.  Thus,  recovery  of  plasmid  DNA  would  have  been  inefficient, 
which  explains  the  difficulty  in  obtaining  clearly  visible  bands  in  agarose 
gels. 
4.9  Chromosome  mobilisation  iri'E:  'cdli. 
Although  plasmids  such  as  R68.45,  RP1  and  RP4  have  been  used  widely  as 
tools  for  studying  the  genetics  of  many  bacterial  species,  the  relative  abilities 
of  each  plasmi'd,  to  promote'chromosomemobilisation  in  E.  coli  has  received  little 
attention.  In  this  study,  the,  ability  of  plasmids  RP1,  RP1::  Tn501  and  R68.45  to 
mobilise  StrR  in  E.  coli  was  compared.  In  addition,  the  ability  of  RP4::  Tn7  to 163 
mobilise  Na1R  was  compared  with  R68.45,  to  determine  which  of  the  plasmids 
was  most  efficient  at  promoting  mobilisation  before  use'in'B.  'pettüssis.  The 
most  efficient  plasmids  relative  to  R68.45,  itself  a  mutant  of  R68.44  which 
mobilises  markers  at  high  frequencies  (Haas  and  Holloway,  1976),  were  RP1  and 
RP4::  Tn7.  In  other  species,  R68.45  has  been  more  efficient  than  RP4  in 
promoting  mobilisation  e.  g.  in'Rh:  'leguminosarum  (Beringer  et  al.,  1978). 
The  presence  of  Tn501  on  RP1,  enabled  mobilisation  to  occur  in'Rh.  ''sphaeroides 
while  RP1  itself  was  not  fertile  (Pemberton  and  Bowen,  1981).  In  this  study, 
RP1::  Tn50l  failed  to  enhance  mobilisation  of  the'E.  'cdli  StrR  marker.  Tn501 
was  found  to  insert  into  RP1  at  many  sites  (Bennett'et'al.,  1978)  and  displayed 
regional  specificity.  If  this  was  true  also  of  chromosomal  insertion,  then 
the  mobilisation  of  StrR  may  be  low  because  none  of  the  preferred  insertion 
sites  are  close  to  this  marker.  Thus,  formation  of  Hfr  like  donors  may  occur, 
but  StrR  transfer  occurs  at  low  frequencies,  or  not  at  all,  if  the  conjugation 
bridge  is  broken  before  transfer  of  the  marker.  A  similar  situation  may 
explain  the  high  frequency  of  mobilisation  of  the  NalR  marker  which  was  observed 
using  RP4::  Tn7.  In  E.  coli,  Tn7  has  a  'hot  spot'  in  the  chromosome  into  which 
it  inserts  at  high  frequency  (Lichtenstein  and  Brenner,  1981).  This  site 
lies  between  the  dnaA  and  ilv  markers,  at  minute  82  on  the'E.,  coli  linkage  map 
(Barth  et  al.,  1978).  The  Na1R  (gyrA)  mutation  lies  at  48  minutes  (Bachmann, 
1983).  Therefore,  insertion  of  RP4::  Tn7  at  this  position  may  allow  a  high 
frequency  of  transfer  of  the  marker  if  conjugation  lasts  for  a  sufficient 
length  of  time.  -  at  least  34  minutes. 
4.10  Chromosome  mobilisation  in'B.  'pertussis. 
Initial  attempts  to  mobilise  chromosomal  antibiotic  resistance  markers  in 
"  B.  pertüssis  were.  thwarted  by  high  spontaneous  mutation  rates  to  the  selective 
antibiotics.  However,  using  Na1R  recipients,  mobilisation  of  the  donor  StrR 164 
marker  occurred  most  efficiently  with.  plasmids  RP4::  Tn7  and  R68.45.  In  all 
cases,  mobilisation  of  antibiotic  resistance  markers  and,  in  subsequent 
experiments,  prototrophic  markers  was  mediated  most  efficiently  by  RP4::  Tn7 
and  R68.45.  The  basis  of  high  frequency  mobilisation  by  RP4::  Tn7  may  be 
similar  to  that  in'E.  cöli  i.  e.  there  is  a  unique  chromosomal  'hot  spot'  in 
the  bacterial  chromosome  of'B.  pertussis,  into  which  RP4::  Tn7  forms  an  Hfr- 
like  donor  by  a  transposition-recombination  event.  The  'hot  spot'  may  be 
close  to  the  resistance  markers  under  study.  Such  'hot  spots'  have  been 
shown  to  be  present  in  other  species  such  as'C.  'crescentus  (Ely,  1982), 
Vibrio  spp.  (Thomson'et'al.,  1981);  '  Xarithömonas'campestris  (Turner'et  al., 
1984)  and  Ps.  'aeruginosa  (Caruso  and  Shapiro,  1982).  Transposition  of  Tn7, 
followed  by  plasmid  integration-via  the  homologous  DNA  sequences,  may  lead 
to  polarised  gene  transfer.  Differences  in  mobilisation  frequencies  for  a 
selected  marker  from  100-fold  to  about  equal  by  RP4::  Tn7  and  R68.45  may  be 
due  to  mobilisation  from  a  single  site,  by  RP4::  Tn7  while  R68.45  mobilises 
from  multiple  origins  (Haas  and  Holloway,  1978),  and  is  less  suitable  for 
localisation  of  genes  in  linkage.  studies.  In  addition,  R68.45  mobilises  only 
short  sequences  of  the  chromosome  (Hermann  and  Gunther,  1984).  However, 
formation  of  an  Hfr  like  donor  via  TO  transposition,  similar  to  FP2  donors 
which  behaved  as  an  Hfr  like  donor  and  allowed  mapping  of  the  whole  chromosome 
(Herrmann  and  Gunther,  1984),  would  allow  a  wide  range  of  genetic  studies 
on  linkage  in  B.  'pertüssis.  Formation  of  such  a  donor  via  RP4::  Tn7  transpos- 
ition  and  mobilisation  from  a  single  origin  would  be  a  suitable  system. 
RP1::  Tn50l,  although-capable'of  transferring  plasmid  genes  at  high  frequency, 
exhibited  only  low  chromosome  mobilisation  ability,  on  occasions  lower  than  that 
of  the  parent  RP1..  This,  was  in  contradiction  to  the  findings  of  Pemberton  and 
Bowen  (1981).  Tn50l,  in  Biertussis  has  been  found  to  insert  in,  virtually  all 
cases  tested,  into  a  single  site,  on  the  chromosome  (Weiss  and  Falkow,  1983).  In- 
Rh.  sphaeroides,  one  or  possibly  two  transfer  origins  were  present  upon  RP1::  Tn501 165 
integration  into  the  chromosome  (Pemberton  and  Bowen,  1981).  It  may  be 
that,  in  this  study,  Tn501  insertion  is  at  a  site  distant  from  the  selected 
marker,  or,  if  it  inserts  at  a  single  site,  then  that  site  may  be  within  the 
selected  gene,  thus  causing  a  polar  mutation  and  non-expression  of  the  chromo- 
somal  marker. 
A  satisfactory  outcome  of  these  studies  was  the  use  of  CSM  as  a  selective 
medium  for  mobilisation  of  donor  prototrophic  markers.  It  was  possible  to 
begin  a  comparison  of  co-transfer  of  prototrophic  and  antibiotic  resistance 
markers  and  only  the  lack  of  suitable  auxotrophic  strains  now  prevents  this 
system  being  used  for  studies  on  linkage  of'B.  pertussis  chromosomal  genes. 
It  was  possible  to  compare  linkage  of  two  markers,  Na1R  and  Gly+  by  selection 
of  recombinants  on  CSM  containing  nalidixic  acid.  In  order  to  grow  on  CSM 
in  the  presence  of  the  antibiotic,  the  auxotrophic  (Gly  )  mutation  must  first 
be  corrected,  followed  by  transfer  of  the  antibiotic  resistance  gene.  Only 
those  bacteria  which  have  inherited  both  markers  will  grow  on  the  selective 
medium.  Therefore,  it  was  possible  to  begin  to  compare  the  ability  of  cma- 
proficient  plasmids  to  promote  co-transfer  of  genes  in  B.  pertussis.  Only 
one  other  report  of  linkage  in  B.  pertussis  exists,  in  which  StrR  and  RifR 
were  shown  to  be  linked  by  co-transfer  by  plasmid  pUW942  (Weiss  and  Falkow, 
1983).  A  problem  encountered  in  the  current  study  was  the  high  reversion 
rate  of  some  of  the  auxotrophic  mutants  to  prototrophy,  which  excluded  their 
use  in  linkage  studies.  This  may  be  overcome  by  generation  of  a  series  of 
transposon  induced  auxotrophic  mutants  which  would  remove  the  problems  of 
multiple  mutations  and  spontaneous  reversion  since  only  one  copy  of  a  trans- 
poson  such  as  Tn5  would  be.  present  in  the  chromosome.  Since  transposons  rarely 
excise  spontaneously  from  the  chromosome,  auxotrophic  mutations  would  be  stable. 
Only  one  other  study  of  mobilisation  of  prototrophic  markers  it'B.  pertussis 
has  been  carried  out.  In  a  less  detailed  report,  Weiss  and  Falkow  (1983) 166 
mobilised  a  donor  Trp+  marker  to  an  auxotrophic  recipient  at  a  frequency 
1000  times  the_reversinn  frequency.  Plasmid  R68.45  has  been  used  to  mediate 
mobilisation  of  a  Thy-  marker  in'Legiönellä'pneumophila  at  a  frequency  about 
1000  times  that  of  the.  spontaneous  reversion  rate.  (Dreyfus  and  Iglewski, 
1985). 
Using  this  gene  transfer  system,  correction  of  a  Tn5-induced  Hly 
(deficient  in  haemolysin  production)  mutation,  in'B.  pertussis  BP347,  was 
attempted.  Mobilisation  of  the  donor  StrR  marker  occurred  with  RP4::  Tn7  at 
about  100  times  greater  frequency  than  that  observed  with  R68.45.  However, 
no  Hly+  recombinants  were  observed  in  either  case.  An  interesting  observation 
was  that  the  BP347  recipient,  although  resistant  to  kanamycin  was  not,  as 
reported  by  Weiss  and  Falkow  (19841,  resistant  to  streptomycin.  However, 
these  workers  reported  that  a  mutant  selected  for  chromosomal  streptomycin 
resistance  was  resistant  to  much  higher  concentrations  of  antibiotic  than  was 
the  Tn5  mutant.  This  may  explain  why  it  was  possible  to  obtain  mobilisation 
of  a  donor  StrR  chromosomal  marker  in  the  presence  of  Tn5  in  the  recipient. 
4.11  Chromosomemobilisation'to'B.  ''parapertüssis. 
Inter-species  transfer  of  chromosomal  genes  by  plasmid  R68.45  has  been 
used  to  transfer  RifR  and  StrR  genes  from  Rhizobium'leguminosarum  to 
R.  meliiloti  (Johnston'et'al.,  1978).  Since  a  close  phylogenetic  relationship 
exists  between  B.  "pertussis  and'B.  paräpertüssis  as  measured  by  DNA-DNA 
hybridisation  (Kloos*et'al.,  19781,  it  would  be  reasonable  to  expect  that 
mobilisation  of  ä'B.  pertüssis  chromosomal  marker  across  the  species  barrier 
to'  B.  'parapertdssis  could  occur.  If  this  was  the  case,  then  it  may  be  possible 
to  obtain  expression  of  genes  involved  in  e.  g.  production  of  pertussis  toxin 
in'B.  päräpertüssis. 167 
Initial  attempts  to  transfer  plasmids  and  chromosomal  genes  from 
B.  pertussis  to  B.  parapertussis  used  as  a  selective  mechanism,  the  ability 
of  the  recipient  to  grow  on  nutrient  agar.  However,  this  proved  to  be 
impractical  due  to  the  high  spontaneous  reversion  rate  of  the  recipient  to 
the  selective  antibiotic  and  of  the  donor  to  Gna  (ability  to  grow  on  nutrient 
agar).  This  is  a  similar  phenomenon  to  that  observed  by  Peppler  and  Schrumpf 
(1984)  who  isolated  variants  of  B.  pertussis  which  were  capable  of  growing  on 
nutrient  agar.  Weiss  and  Falkow  (1984)  also  observed  a  high  rate  of  spontane- 
ous  phase  shift  in  B.  pertussis. 
It  was  possible  to  use  MacConkey  Agar  as  a  selective  medium  for  B.  para- 
Pertussis  transconjugants.  However,  due  to  the  low  plating  efficiency  of 
B.  parapertussis,  and  the  possibility  of  selection  of  variants  within  the 
population,  this  system  was  not  regarded  as  being  satisfactory.  However,  using 
BGA  containing  nalidixic  acid  and  chloramphenicol  to  select  for  B.  parapertussis 
recombinants,  it  was  possible  to  obtain  expression  of  the  B.  pertussis  BPT2 
Na1R  marker.  As  in  earlier  experiments,  plasmid  RP4::  Tn7  was  the  most  efficient 
at  promoting  mobilisation  of  the  donor  marker.  Using  this  system  it  may  be 
possible  to  use  B.  parapertussis  as  a  recipient  in  studies  aimed  at  mapping 
the  B.  pertussis  chromosome.  Because  of  its  less  fastidious  nature,  isolation 
of  B.  parapertussis  auxotrophs  may  be  easier  and  more  suitable  for  use  as 
recipients  in  mobilisation  of  nutritional  markers.  An  available  selection 
mechanism  may  be  to  use  SSA  plates  on  which  phase  I  B.  pertussis  will  not  grow. 
Such  studies  may  allow  the  location  of  genes  involved  in  the  regulation  or 
production  of  pertussis  toxin. 
4.12  Transposon  mutagenesis  in  B.  pertussis. 
The  advantage  of  transposon  mutagenesis  methods  in  preference  to  chemical 
mutagens  have  already  been  discussed.  Although  it  was  demonstrated  that 168 
plasmid  RP1::  Tn501  could  be  used  to  generate  Tn501  insertion  mutants  of 
B.  pertussis,  two  suicidal  chimeric  plasmids  were  studied  for  their  abilities 
to  deliver  transposons.  Using  plasmid  pUW964,  small  Km'  colonies  were 
obtained  which  could  not  be  further  characterised.  However,  mutants 
carrying  Tn501,  from  plasmid  pUW942,  failed  to  demonstrate  plasmid  borne 
antibiotic  resistance.  Weiss  and  Falkow  (1983)  found  that,  in  some  cases, 
it  was  possible  to  create  genetic  donors  by  insertion  of  the  entire  plasmid 
into  the  chromosome,  and  that  Tn501  insertions  generated  a  dominant  class  of 
thiamine  -  requiring  auxotrophic  mutants.  In  this  study,  no  such  genetic 
donors  were  found  but  generation  of  auxotrophic  mutants  may  have  occurred, 
although  further  characterisation  of  the  mutants  proved  inconclusive. 
Transposon  insertion  mutagenesis  of  B.  parapertussis  yielded  large 
numbers  of  mutants,  by  selection  on  SSA.  Although  further  characterisation 
was  not  possible,  it  would  be  of  interest  to  determine,  using  such  mutants, 
if  there  is  a  stepwise  phase  variation  in  this  organism  and  to  compare  the 
properties  of  the  mutants  to  those  of  the  spontaneous  variants  which  were 
capable  of  growth  on  MacConkey  Agar. 
4.13  Restriction  modification  in  B.  Pertussis 
The  presence  of  a  HindIIl  like  restriction  enzyme  in  B.  pertussis  was 
r 
fist  reported  by  Greenaway  (1980)  and  confirmed  by  Weiss  and  Falkow  (1982) 
who  demonstrated  that  modification  of  HindIIl  restriction  sites  on  plasmid 
R388  occurred  by  B.  pertussis.  In  the  present  study  it  was  shown  that 
chromosomal  DNA  from  B.  pertussis  and  B.  parapertussis,  while  being  susceptible 
to  the  action  of  EcoRI,  could  not  be  digested  with  HindIIl.  As  a  control 
for  enzyme  activity,  HindIIl  failed  to  digest  methylated  A  DNA  but  digested 
non-methylated  A  DNA.  Thus,  it  appears  that  B.  parapertussis,  like  B.  pertussis 
probably  contains  an  enzyme  with  HindIIl-like  activity  and  its  own  DNA  is 169 
protected  by  methylation.  In  accordance  with  the  enzyme  nomenclature 
rules  of  Smith  and  Nathans  (1973),  the  restriction  enzyme  from  B.  pertussis 
has  been  named  BpeI  (Roberts,  1983). 
4.14  Bacteriophage  studies. 
Various  theories  of  bacteriophage  induced  conversion  of  B.  parapertussis 
to  B.  pertussis  have  been  postulated  in  recent  years  (see  Introduction), 
although  little  experimental  evidence  exists  in  support  of  them.  However, 
following  the  reports  of  isolation  of  lysogenic  bacteriophage  from  B.  pertussis 
by  Lapaeva  et  al.  (1980)  and  Mebel  et  al.  (1981)  experiments  aimed  at  repeating 
their  work  were  undertaken.  None  of  the  experiments  in  this  study  to  observe 
formation  of  phage  particles  using  Mitomycin  C  or  to  observe  spontaneous  lysis 
by  viable  phage  particles  yielded  results  compatible  with  those  obtained  by 
the  previous  workers.  Since  these  studies,  no  further  reports  of  phage 
conversion  have  been  forthcoming. 
However,  B.  pertussis  was  shown,  in  the  present  study,  to  be  capable  of 
supporting  growth  of  a  bacteriophage.  The  thermoinducible  Mucts62  (Howe,  1973) 
inserted  into  plasmid  RP4  (Boucher  et  al.,  1977)  was  transferred  by  conjugation 
to  B.  pertussis  and  production  of  viable  phage  particles  was  induced  by  growing 
transconjugants  in  broth  at  39°C  or  42°C.  This  showed  that  when  inserted 
into  RP4,  the  Mu  prophage  can  be  introduced  into  B.  pertussis,  a  species 
taxonomically  distinct  from  the  few  enteric  bacteria  which  form  the  normal 
host  range  of  Mu;  E.  coli  K12,  Shigella  dysenteriae  (Taylor,  1963)  and 
Citrobacter  freundii  (de  Graaf  et  al.,  1973).  In  addition,  the  Mu  genome  was 
expressed  in  B.  pertussis  and  led  to  formation  of  plaque-forming  particles 
on  an  E.  coli  lawn.  The  presence  of  Mu  on  plasmid  RP4  was  shown  to  reduce 
the  transfer  frequency  of  the  plasmid  from  E.  coli  to  R.  meliloti  (Boucher 
et  al.,  1977)  and  a  similar  effect  occurred  in  transfer  of  RP1  (=RP4)  and 170 
RP4::  Mu  cts  62  to  B.  pertussis.  This  may  be  due,  however,  to  different 
donor  strains  being  used  to  transfer  the  two  plasmids.  Expression  of  the 
Mu  genome  and  production  of  viable  phage  particles  gave  rise  to  5x  102 
to  3x  105  p.  f.  u.  ml  in  Pseudomonas  solanacearum  (Boucher  et  al.,  1977). 
This  was  comparable  to  the  yield  of  particles  produced  from  B.  pertussis 
at  39°C  or  42°C.  Thus,  by  using  a  plasmid  vector  which  has  a  broad  host- 
range  in  Gram-negative  bacteria  (Datta  and  Hedges,  1972;  Olseland  Shipley, 
1973)  it  was  possible  to  obtain  expression  of  a  narrow  host  range  bacterio- 
phage  in  a  wide  range  of  ecologically  diverse  species. 
4.15  Effect  of  plasmids  on  stimulation  of  neutrophil  chemiluminescence. 
The  presence  of  certain  R-factors  in  E.  coli  conferred  upon  the  organism 
the  property  of  resistance  to  serum  bactericidal  activity  (Fietta  et  al., 
1977).  Further  study  with  plasmid  R6.5  indicated  that  the  serum  -  resistance 
gene  product  of  this  plasmid  was  the  traT  protein  (Moll  et  al.,  1980).  The 
protein  was  subsequently  found  to  be  responsible  for  the  enhancement  of  E.  coli 
resistance  to  phagocytosis  (Aguero  et  al.,  1984).  Thus,  it  was  shown  that 
an  R-plasmid  gene  was  capable  of  modifying  the  bacterial  cell  surface  to 
favour  invasiveness.  Since  R-plasmids  such  as  RP1  and  R68.45  carry  genes 
which  allow  for  self-transmissibility  (tra  genes)  the  effect  of  the  presence 
of  such  plasmids  on  phagocytosis  of  E.  coli  and  B.  pertussis  was  studied. 
Differences  in  resistance  to  phagocytosis,  as  indicated  by  stimulation  of 
neutrophils,  were  apparent  between  strains.  In  E.  coli  JC3272,  RP1  and 
R68.45  exhibited  an  ability  to  reduce  the  chemiluminescent  response,  an  effect 
which  was  not  as  apparent  in  B.  pertussis  44122/7R  transconjugants  as  in  BPT2 
transconjugants.  However,  in  BPT2,  the  presence  of  R68.45  may  have  delayed 
the  neutrophil  response.  Unlike  plasmid  R6.5,  RP4  has  been  shown  to  have 
no  effect  on  E.  coli  resistance  to  serum  (Fietta  et  al.,  1977),  and  appears 171 
in  correlation,  to  have  little  effect  on  stimulation  of  phagocytes.  However 
RP1,  R68  and  R68.45  decrease  virulence  and  serum  resistance  in'P.  aeruginosa 
PAD  (Wretlind  et  al.,  1985).  These  alterations  do  not  appear  to  be  due  to  a 
single  factor  such  as  tra  gene-dependent  cell  surface  alterations.  The 
presence  of  traT.  on  low  copy  number  plasmids  may  not  produce  a  significant 
reduction  in  phagocytosis  since  the  traT  gene  cloned  into  low  copy  number 
vectors  produces  a  much  less  well  defined  anti-phagocytic  effect  than  in  high 
copy  number  vectors  (Aguero  et  al.,  1984).  The  presence  of  transposons  Tn501 
and  Tn7  caused  a  massive  increase  in  chemiluminescence  due  to  E.  coli  and 
B.  pertussis  BPT2.  This  may  be  due  to  an  alteration  of  the  cell  surface  by  a 
transposon  encoded  product.  Tn7  and  Tn50l  have  not  been  characterised  with 
respect  to  membrane  proteins  which  they  may  produce,  but  TnlO  has  been  shown 
to  produce  a  36,000D  membrane  protein  which  was  inducible  in  the  presence  of 
tetracycline  (Levy  and  McMurray,  1974).  Such  a  protein  may  appear  in  whole 
cell  SDS-PAGE  analysis,  but  no  difference  in  profiles  of  E.  coli  or  B.  pertussis 
due  to  the  presence  of  Tn7  or  Tn501,  or  plasmids  were  observed,  when  compared 
to  parent  strains  which  did  not  carry  plasmids. 
4.16  Transformation. 
Although  several  reports  of  transformation  of  StrR  (Branefors,  1964; 
Al  Sallami,  1981)  and  prototrophic  markers  (Kloos'et  al.,  1978)  exist,  no 
transformation  of  StrR  was  obtained  in  the  present  study.  Due  to  the  nature 
of  the  experimental  method,  there  are  several  stages  at  which  contaminating 
organisms  may  be  introduced.  Thus,  the  only  colonies  which  grew  on  selective 
media  were  contaminants,  which  casts  suspicion  on  the  previous  reports. 
Neither  the  Branefors  nor  the  Kloos  studies  were  ever  subject  to  independent 
verification  by  other  workers  and  it  may  be  that  the  transformation  method 
was  not  suitable  for  use  in  developing  a  gene  transfer  system.  This  is  not 
because  B.  pertussis  cannot  be  transformed.  Weiss  and  Falkow  (1982)  demon- 
strated  transformation  by  plasmid  DNA  which  had  been  modified  at  the  HindIII 
sites.  B.  pertussis  does  not  produce  DNase,  as  demonstrated  in  this  study. 172 
Transformation  in  B.  pertussis  therefore  remains  obscure  and  requires 
further  study. 
4.17  Conclusions. 
The  components  of  a  system  which  will  allow  transfer  of  B.  pertussis 
chromosomal  genes  have  been  developed  and  used  to  demonstrate  conclusively 
that  it  is  possible  to  begin  a  detailed  genetic  study  of  this  organism. 
It  is  now  possible  to  isolate  strains  which  carry  selectable  properties 
and  to  use  them  in  the  production  of  a  genetic  map  of  the  B.  pertussis 
chromosome.  In  addition,  the  use  of  B.  parapertussis  as  a  recipient  in 
gene  transfer  may  allow  location  of  virulence-associated  genes.  Evidence 
has  been  found  that  B.  parapertussis  may  undergo  a  form  of  phase  variation, 
which  would  be  worthy  of  further  study.  Very  few  bacteria  of  medical 
or  agricultural  importance  have  been  characterised  genetically,  and  the  use 
of  plasmids  and  transposons  to  study  properties  of  these  bacteria,  such  as 
nodulation  in  Rhizobium  and  the  mechanisms  of  virulence  of  Vibrio  cholerae 
and  L.  pneumophila  is  at  an  early  stage.  Use  of  such  techniques  in  the  study 
of  B.  pertussis  will  provide  a  powerful  new  tool  in  the  elucidation  of  the 
mechanisms  of  pathogenesis  of  whooping  cough. 173 
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APPENDIX  1-  Media  Preparation 
Bordet-Gengou  Agar 
40g  of  dehydrated  Bordet-Gengou  Agar  Base  (Gibco  Europe  Ltd.  )  was  added 
to  1L  of  distilled  water  containing  10%  (v/v)  glycerol.  The  medium  was 
steamed  to  dissolve  and  sterilised  by  autoclaving  at  15  p.  s.  i.  for  15  min 
(121°C).  The  medium  was  then  cooled  to  50°C  in  a  water  bath,  and  20%  sterile 
defibrinated  horse  blood  was  added  and  well  mixed.  Antibiotics  were  added 
as'required.  The  medium  was  poured  into  sterile  single  or  triple  vent  9cm 
plastic  petri-dishes  (Sterilin,  Feltham,  Middlesex).  Bubbles  were  removed 
by  brief  flaming.  To  remove  excess  surface  water,  plates  were  left  at  room 
temperature  overnight.  Plates  were  stored  at  4°C  and  used  within  3  weeks 
of  preparation. 
Stainer  and  Scholte  Medium  (Stainer  and  Scholte,  1971). 
The  following  are  dissolved  in  800m1  of  distilled  water. 
9/1 
L-glutamate  (monosodium  salt)  10.72 
L-proline  0.24 
NaCl  2.5 
KH2PO4  0.5 
KC1  0.2 
MgC12.6H20  0.1 
CaCl 
2 
0.02 
Tris  (hydroxymethyl-methylamine)  6.075 
The  pH  was  adjusted  to  7.4  with  2.5N  HC1.  The  volume  was  made  up  to 
990m1  with  distilled  water  and  autoclaved  at  15  p.  s.  i.  for  15  mins.  Before  use 
the  following  were  dissolved  in  10ml  of  distilled  water  and  filter  sterilized 
with  a  Millipore  filter  of  pore  size  0.45)Jm1  (Millipore  S.  A.  Molsheim,  France). 
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The  total  volume  Was  then  added  to  the  bulk  medium. 
9/1 
L-cysteine  0.04 
FeSO4-7H20  0.1 
Ascorbic  acid  0.02 
Nicotinic  acid  0.004g 
Glutathione  O.  lg 
Cyclodextrin  Solid  Medium  (CSM) 
This  was  prepared  according  to  Imaizumi  et  al.  (1983)  using  Stainer 
and  Scholte  medium  as  the  basal  medium.  CSM  contained  0.5g  per  litre  of 
Casamino  Acids  (Casein  Hydrolysate,  Peptone  No.  5,  Gibco  Ltd.  ),  1.0g  per 
litre  of  Heptakis  (2,6-0-Dimethyl)  ß-Cyclodextrin  (MeßCD)  obtained  from 
Dr.  Imaizumi,  Teijin  Institute  for  Biomedical  Research,  Tokyo,  Japan  and 
15.  Og  per  litre  of  agar  (Oxoid  Agar,  Technical  No.  3).  Bovine  serum  albumin 
(Sigma)  7.5%  w/v  was  added  to  final  concentration  of  0.05%  (w/v).  For  use 
as  a  minimal  medium,  Casamino  Acids  were  omitted  and  amino  acid  solutions 
(0.2%  w/v)  added  to  give  a  final  concentration  of  20pg/ml. 
E.  coli  Minimal  Agar  (ECMA)  (Clowes  and  Hayes,  1968). 
9/1 
NH4C1  5.0 
NH4NO3  1.0 
Na2SO4  2.0 
K2HPO4  3.0 
KH2PO4  1.0 
MgSO4.7H20  0.1 
Oxoid  Agar  Technical  No.  3  15.0 176 
Ingredients  were  added  to  1L  of  distilled  water  and  autoclaved  at  15  p.  s.  i. 
for  15  min.  20m1  of  glucose  10%  w/v  was  added  before  pouring.  Thiamine 
-1 
(0.02%  w/v)  was  added  to  a  final  concentration  of  2pg  ml. 
1%  Casamino  Acids  Solution 
log  Casamino  Acids  (Casein  Hydrolysate  acid,  Peptone  No.  5.  Gibco  Ltd.  ) 
O.  lg  MgC12.6H20 
0.015g  CaCl  2 
5g  NaCl 
The  ingredients  were  dissolved  in  980m1  of  distilled  water  and  the  pH  adjusted 
to  7.0  with  2.5N  NaOH.  For  culture  storage  at  -70°C  20%  glycerol  (v/v)  was 
added  and  1ml  amounts  dispensed  in  bijoux  bottles.  The  medium  was  autoclaved 
at  15  p.  s.  i.  for  15  min. 
Cohen  and  Wheeler  Medium  (Cohen  and  Wheeler,  1946) 
Casamino  Acids  (Casein  Hydrolysate  acid,  - 
Peptone  No.  5)  (Gibco)  log 
Yeast  extract  (Gibco)  2.5g 
Soluble  starch  1.5g 
MgC12.6H20  25%  solution  1.6ml 
CaCl 
2 
10%  solution  O.  lml 
FeSO4.7H20  1%  solution  1.  Oml 
CuSO4.5H20  1%  solution  0.05m1 
L-arginine  0.01%  solution  1.  Oml 
L-histidine  0.005%  solution  1.  Oml 
KH2PO4  0.5g 
Starch  was  dissolved  by  steaming  for  30  min.  The  remaining  ingredients  were 
added  and  the  total  volume  made  up  to  1L  with  distilled  water.  The  pH  was 
adjusted  to  7.8  with  1N  NaOH. 177 
APPENDIX  2-  Antibiotic  and  amino  acid  screening 
Oxoid  multodisks 
Oxoid  S3  Multodisks  have  8  arms  which  are  impregnated  with  antibiotics 
at  the  following  concentrations  : 
Antibiotic  Code  Concentration 
Chloramphenicol  C  lOpg 
Erythromycin  E  l0ug 
Sulphafurazole  SF  l00ug 
Methicillin  CB  lOpg 
Penicillin  G  P  1.5  Units 
Ampicillin  PN  2pg 
Streptomycin  S  lOpg 
Tetracycline  TE  lOug 
Amino  acid  solutions 
For  selection  of  prototrophic  recombinants  and  isolation  of  auxotrophic 
mutants,  the  following  mixtures  of  amino  acids,  purines  and  pyrimidines 
(pools)  were  incorporated  in  CSM  at  concentrations  of  20pg  ml-1. 
Pool  Number 
1  2  3  4  5 
6  Adenine  phenylalanine  alanine  arginine  leucine 
7  Cytosine  serine  ornithine  glycine 
8  Guanine  tryptophan  threonine  aspartate  isoleucine 
9  Thymidine  tyrosine  methionine  histidine 
10  Uracil  lysine  valine 178 
APPENDIX  3-  Buffers  for  chemiluminescence  studies 
Hepes  -  buffered  saline  (HBS) 
NaCl  8g 
KC-1  0.4g 
MgC12.6H20  0.2g 
CaCl 
2 
0.14g 
glucose  lg 
HEPES  2.388g 
phenol  red  10ml  of  0.5%  w/v  solution 
distilled  water  1L 
HEPES  is  N-2-hydroxyethyl  piperazine  N'-2-ethane  sulphuric  acid. 
Divalent  cation-free  HBS-EDTA  was  prepared  by  omitting  the  calcium  and 
magnesium  salts  and  adding  0.292g  of  EDTA  (ethylenediaminetetra-acetic 
acid)  per  litre. 
HBS  and  HBS-EDTA  were  buffered  to  pH  7.6  with  1N  NaOH. 179 
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